Section 54

EurekaMag Full Text Articles Chapter 53,514


Hossain, N.; Schatz, F.; Paidas, M.J. 2009: Heparin and maternal fetal interface: why should it work to prevent pregnancy complications?. Thrombosis Research 124(6): 653-655
Triolo, G.; Mariano, F. 2008: Heparin and more. Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 25(1): 105
Yi Qian; Jing Pan; Xiaodong Zhou; Weiser, P.; Hong Lu; Shih, F.F.; Porche-Sorbet, R.; Eby, C.; Lijuan Zhang 2010: Heparin and oversulfated heparin byproduct induce thrombin generation through contact system activation in plasma of patients with HIT. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 16(3): 251-260
Gonçalves, F.S.; Barretto, L.S.S.; Arruda, R.P.; Perri, S.H.V.; Mingoti, G.Z. 2014: Heparin and penicillamine-hypotaurine-epinephrine (PHE) solution during bovine in vitro fertilization procedures impair the quality of spermatozoa but improve normal oocyte fecundation and early embryonic development. In Vitro Cellular and Developmental Biology. Animal 50(1): 39-47
Jagroop, I.Anita.; Mikhailidis, D.P. 2012: Heparin and platelet activation. Thrombosis Research 130(4): 685; Author Reply 686
Xu, C.; Xu, G.; Tu, W.; Wu, X.; Fang, X.; Huang, T. 2011: Heparin and prednisone-associated priapism: two case reports. Andrologia 43(1): 68-70
Vaheri, A.; Vaheri, A. 2007: Heparin and related polyionic substances as virus inhibitors. 1964. Apmis: Acta Pathologica Microbiologica et Immunologica Scandinavica 115(5): 565-570; Discussion: 571-572
Li, J.; Wu, H.Mei.; Zhang, L.; Zhu, B.; Dong, B.Rong. 2010: Heparin and related substances for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2010(9): Cd005631
Longo-Sorbello, G.S.A.; Gao, H.; Mishra, P.J.; Kamen, B.; Soto, A.; Jimeno, J.; Aracil, M.; Paz de Paz, M.F.; Bertino, J.R.; Banerjee, D. 2009: Heparin and suramin alter plitidepsin uptake via inhibition of GPCR coupled signaling. Journal of ChemoTherapy 21(5): 550-557
Van Doormaal, F.F.; Büller, H.R. 2010: Heparin and survival in cancer patients. Hematology/Oncology Clinics of North America 24(4): 777-784 IX-X
Margetts, P. 2009: Heparin and the peritoneal membrane. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 29(1): 16-19
Naina, H.V.K.; Harris, S. 2008: Heparin and thrombocytopenia: guilty till proven innocent?. Archives of Internal Medicine 168(19): 2169-2170; Author Reply 2171
Asero, R.; Tedeschi, A.; Cugno, M. 2010: Heparin and tranexamic Acid therapy may be effective in treatment-resistant chronic urticaria with elevated d-dimer: a pilot study. International Archives of Allergy and Immunology 152(4): 384-389
Stoker, S.B.; Pollard, J. 1946: Heparin and trauma effects in blood. Journal of Physiology 105: 15
Heit, J.A.; Lahr, B.D.; Petterson, T.M.; Bailey, K.R.; Ashrani, A.A.; Melton, L.J. 2011: Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study. Blood 118(18): 4992-4999
Udit, A.K.; Everett, C.; Gale, A.J.; Reiber Kyle, J.; Ozkan, M.; Finn, M.G. 2009: Heparin antagonism by polyvalent display of cationic motifs on virus-like particles. Chembiochem: a European Journal of Chemical Biology 10(3): 503-510
Conti, C.Richard. 2007: Heparin anticoagulation. Clinical Cardiology 30(4): 154-155
Tanaka, K.A.; Thourani, V.H.; Williams, W.H.; Duke, P.G.; Levy, J.H.; Guyton, R.A.; Puskas, J.D. 2007: Heparin anticoagulation in patients undergoing off-pump and on-pump coronary bypass surgery. Journal of Anesthesia 21(3): 297-303
Alsayegh, F.; Al-Rasheed, M.; Al-Muhaini, A.; Al-Humoud, E.; Al-Ostaz, M.; Mousa, S.A. 2009: Heparin anticoagulation responsiveness in a coronary care unit: a prospective observational study. Cardiovascular Therapeutics 27(2): 77-82
Bulpitt, C.J. 1967: Heparin as an Analgesic in Myocardial Infarction: A Double-blind Trial. British Medical Journal 3(5560): 279-281
Zacharski, L.R.; Lee, A.Y. 2008: Heparin as an anticancer therapeutic. Expert Opinion on Investigational Drugs 17(7): 1029-1037
Borsig, L. 2010: Heparin as an inhibitor of cancer progression. Progress in Molecular Biology and Translational Science 93: 335-349
Matsuoka, T.; Inoue, K.; Mizuno, K.; Kita, Y.; Nakanishi, S.; Asai, S.; Taoka, R.; Soda, T.; Terai, A. 2012: Heparin as bridging anticoagulant and antiplatelet therapy during the perioperative period. Hinyokika Kiyo. Acta Urologica Japonica 58(5): 223-226
Rodríguez-Torres, M.del.Pilar.; Díaz-Torres, L.Armando.; Romero-Servin, S. 2014: Heparin assisted photochemical synthesis of gold nanoparticles and their performance as SERS substrates. International Journal of Molecular Sciences 15(10): 19239-19252
Rostelato-Ferreira, S.; Leite, G.B.; Cintra, A.él.C.O.; da Cruz-Höfling, M.A.; Rodrigues-Simioni, L.éa.; Oshima-Franco, Y. 2010: Heparin at low concentration acts as antivenom against Bothrops jararacussu venom and bothropstoxin-i neurotoxic and myotoxic actions. Journal of Venom Research 1: 54-60
Senak, M. 2008: Heparin at the center of the storm. American Health and Drug Benefits 1(6): 23-24
Liu, Y.; He, Y.; Wu, X.; Zhang, S.; Chong, Z.; Jiang, Y.; Zhou, C.; Jin, X. 2014: Heparin attenuates HMGB1 expression in arterial tissue subjected to limb ischemia/reperfusion. International Journal of Cardiology 176(2): 543-546
Mu, E.; Ding, R.; An, X.; Li, X.; Chen, S.; Ma, X. 2014: Heparin attenuates lipopolysaccharide-induced acute lung injury by inhibiting nitric oxide synthase and transforming growth factor -β/Smad signaling pathway. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 26(11): 810-814
Nurunnabi, M.; Khatun, Z.; Moon, W-Choon.; Lee, G.; Lee, Y-Kyu. 2012: Heparin based nanoparticles for cancer targeting and noninvasive imaging. Quantitative Imaging in Medicine and Surgery 2(3): 219-226
Esquibies, A.E.; Karihaloo, A.; Quaggin, S.E.; Bazzy-Asaad, A.; Cantley, L.G. 2014: Heparin binding VEGF isoforms attenuate hyperoxic embryonic lung growth retardation via a FLK1-neuropilin-1-PKC dependent pathway. Respiratory Research 15: 32
Dapino, D.; Teijeiro, J.; Cane, F.; Marini, P.E. 2014: Heparin binding analysis of boar sperm and its relation with farrowing capacity. Acta Veterinaria Hungarica 62(1): 96-105
Vieira, T.C.R.G.; Reynaldo, D.P.; Gomes, M.P.B.; Almeida, M.S.; Cordeiro, Y.; Silva, J.L. 2011: Heparin binding by murine recombinant prion protein leads to transient aggregation and formation of RNA-resistant species. Journal of the American Chemical Society 133(2): 334-344
Kumar, S.; Tomar, A.K.; Singh, S.; Gill, K.; Dey, S.; Singh, S.; Yadav, S. 2014: Heparin binding carboxypeptidase e protein exhibits antibacterial activity in human semen. International Journal of Biological Macromolecules 64: 319-327
Vieira, T.C.R.G.; Cordeiro, Y.; Caughey, B.; Silva, J.L. 2014: Heparin binding confers prion stability and impairs its aggregation. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 28(6): 2667-2676
Chillakuri, C.R.; Jones, C.él.; Mardon, H.J. 2010: Heparin binding domain in vitronectin is required for oligomerization and thus enhances integrin mediated cell adhesion and spreading. Febs Letters 584(15): 3287-3291
Mulder, G.M.; Nijboer, W.N.; Seelen, M.A.; Sandovici, M.; Bos, E.M.; Melenhorst, W.B.W.H.; Trzpis, M.; Kloosterhuis, N.J.; Visser, L.; Henning, R.H.; Leuvenink, H.G.D.; Ploeg, R.J.; Sunnarborg, S.W.; van Goor, H. 2010: Heparin binding epidermal growth factor in renal ischaemia/reperfusion injury. Journal of Pathology 221(2): 183-192
Nash, R.J.; Heimburg-Molinaro, J.; Nash, R.J. 2009: Heparin binding epidermal growth factor-like growth factor reduces ethanol-induced apoptosis and differentiation in human embryonic stem cells. Growth Factors 27(6): 362-369
Kaukonen, K-Maija.; Herwald, H.; Lindbom, L.; Pettila, V. 2013: Heparin binding protein in patients with acute respiratory failure treated with granulocyte colony-stimulating factor (filgrastim)--a prospective, placebo-controlled, double-blind study. Bmc Infectious Diseases 13: 51
Solomon, J.P.; Bourgault, S.; Powers, E.T.; Kelly, J.W. 2011: Heparin binds 8 kDa gelsolin cross-β-sheet oligomers and accelerates amyloidogenesis by hastening fibril extension. Biochemistry 50(13): 2486-2498
Nakayama, Y.; Okahashi, R.; Iwai, R.; Uchida, K. 2007: Heparin bioconjugate with a thermoresponsive cationic branched polymer: a novel aqueous antithrombogenic coating material. Langmuir 23(15): 8206-8211
Carlsson, P.; Kjellén, L. 2012: Heparin biosynthesis. Handbook of Experimental Pharmacology 2012(207): 23-41
Gu, L.; Wang, H.; Guo, Y-Lan.; Zen, K. 2008: Heparin blocks the adhesion of E. coli O157:H7 to human colonic epithelial cells. Biochemical and Biophysical Research Communications 369(4): 1061-1064
Atai, N.A.; Balaj, L.; van Veen, H.; Breakefield, X.O.; Jarzyna, P.A.; Van Noorden, C.J.F.; Skog, J.; Maguire, C.A. 2013: Heparin blocks transfer of extracellular vesicles between donor and recipient cells. Journal of Neuro-Oncology 115(3): 343-351
Davidson, I.; Hackerman, C.; Kapadia, A.; Minhajuddib, A. 2009: Heparin bonded hemodialysis e-PTFE grafts result in 20% clot free survival benefit. Journal of Vascular Access 10(3): 153-156
Allemang, M.T.; Schmotzer, B.; Wong, V.L.; Chang, A.; Lakin, R.O.; Woodside, K.J.; Wang, J.; Kashyap, V.S. 2014: Heparin bonding does not improve patency of polytetrafluoroethylene arteriovenous grafts. Annals of Vascular Surgery 28(1): 28-34
Vanassche, T.; Lauw, M.N.; Connolly, S.J.; Eikelboom, J.W. 2014: Heparin bridging in peri-procedural management of new oral anticoagulant: a bridge too far?. European Heart Journal 35(28): 1831-1833
Bonnet-Zamponi, D.; Aumont, M-Claude.; Comets, E.; Bruhat, C.; Chauveheid, M-Paule.; Duval, X.; Huisse, M-Genviève.; Diquet, B.; Berrut, G.; Mentre, F.; Delpierre, S.; Legrain, S. 2011: Heparin bridging therapy and bleeding events in octogenarian inpatients with atrial fibrillation starting anticoagulation: results of an ancillary study. Journal of the American Geriatrics Society 59(11): 2174-2178
Lahtela, H.; Rubboli, A.; Schlitt, A.; Karjalainen, P.P.; Niemelä, M.; Vikman, S.; Puurunen, M.; Weber, M.; Valencia, J.è; Biancari, F.; Lip, G.Y.H.; Airaksinen, K.E.J.; Lahtela, H.; Porela, P.; Airaksinen, K.E.J.; Niemelä, M.; Kervinen, K.; Biancari, F.; Karjalainen, P.; Mikkelsson, J.; Ylitalo, A.; Puurunen, M.; Laine, M.; Vikman, S.; Annala, A.-P.; Tuomainen, P.; Nyman, K.; Sia, J.; Schlitt, A.; Kirchhof, P.; Weber, M.; Ehret, J.; Thiele, H.; Woinke, M.; Kreuzer, J.; Rubboli, A.; Vecchia, L.; Lip, G.Y.H.; Valencia, J. 2012: Heparin bridging vs. uninterrupted oral anticoagulation in patients with Atrial Fibrillation undergoing Coronary Artery Stenting. Results from the AFCAS registry. Circulation Journal: Official Journal of the Japanese Circulation Society 76(6): 1363-1368
Truss, N.J.; Armstrong, P.C.J.; Liverani, E.; Vojnovic, I.; Warner, T.D. 2009: Heparin but not citrate anticoagulation of blood preserves platelet function for prolonged periods. Journal of Thrombosis and Haemostasis: Jth 7(11): 1897-1905
Barna, G.áb.; Sebestyén, A.; Dunai, Z.A.; Csernus, B.áz.; Mihalik, R. 2012: Heparin can liberate high molecular weight DNA from secondary necrotic cells. Cell Biology International 36(12): 1281-1286
Ling, Y.; Yang, Z.-Y.; Yin, T.; Li, L.; Yuan, W.-W.; Wu, H.-S.; Wang, C.-Y. 2011: Heparin changes the conformation of high-mobility group protein 1 and decreases its affinity toward receptor for advanced glycation endproducts in vitro. International Immunopharmacology 11(2): 187-193
Jones, C.J.; Beni, S.; Limtiaco, J.F.K.; Langeslay, D.J.; Larive, C.K. 2011: Heparin characterization: challenges and solutions. Annual Review of Analytical Chemistry 4: 439-465
Liao, W.-Y.; Ho, C.-C.; Hou, H.-H.; Hsu, T.-H.; Tsai, M.-F.; Chen, K.-Y.; Chen, H.-Y.; Lee, Y.-C.; Yu, C.-J.; Lee, C.-H.; Yang, P.-C. 2015: Heparin co-factor Ii enhances cell motility and promotes metastasis in non-small cell lung cancer. Journal of Pathology 235(1): 50-64
Cai, W.-W.; Gu, Y.J.; Wang, X.-N.; Chen, C.-Z. 2009: Heparin coating of small-caliber decellularized xenografts reduces macrophage infiltration and intimal hyperplasia. Artificial Organs 33(6): 448-455
Church, F.C.; Hoffman, M.R. 1994: Heparin cofactor Ii and thrombin Heparin-binding proteins linking hemostasis and inflammation. Trends in Cardiovascular Medicine 4(3): 140-146
Aihara, K.-I.; Azuma, H.; Akaike, M.; Sata, M.; Matsumoto, T. 2009: Heparin cofactor Ii as a novel vascular protective factor against atherosclerosis. Journal of Atherosclerosis and Thrombosis 16(5): 523-531
Aihara, K.-i. 2010: Heparin cofactor Ii attenuates vascular remodeling in humans and mice. Circulation Journal: Official Journal of the Japanese Circulation Society 74(8): 1518-1523
Rau, J.C.; Deans, C.; Hoffman, M.R.; Thomas, D.B.; Malcom, G.T.; Zieske, A.W.; Strong, J.P.; Koch, G.G.; Church, F.C. 2009: Heparin cofactor Ii in atherosclerotic lesions from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. Experimental and Molecular Pathology 87(3): 178-183
Aihara, K.-i.; Azuma, H.; Akaike, M.; Kurobe, H.; Takamori, N.; Ikeda, Y.; Sumitomo, Y.; Yoshida, S.; Yagi, S.; Iwase, T.; Ishikawa, K.; Sata, M.; Kitagawa, T.; Matsumoto, T. 2009: Heparin cofactor Ii is an independent protective factor against peripheral arterial disease in elderly subjects with cardiovascular risk factors. Journal of Atherosclerosis and Thrombosis 16(2): 127-134
Sumitomo-Ueda, Y.; Aihara, K.-I.; Ise, T.; Yoshida, S.; Ikeda, Y.; Uemoto, R.; Yagi, S.; Iwase, T.; Ishikawa, K.; Hirata, Y.; Akaike, M.; Sata, M.; Kato, S.; Matsumoto, T. 2010: Heparin cofactor Ii protects against angiotensin II-induced cardiac remodeling via attenuation of oxidative stress in mice. Hypertension 56(3): 430-436
Pandey, S.K.; Singh, A.; Dubey, A.P.; Mishra, T.K.; Kapoor, S. 2014: Heparin cofactor Ii thrombin complex as a biomarker for mucopolysaccharidosis: Indian experience. Indian Pediatrics 51(2): 128-130
Ikeda, Y.; Aihara, K.-i.; Yoshida, S.; Iwase, T.; Tajima, S.; Izawa-Ishizawa, Y.; Kihira, Y.; Ishizawa, K.; Tomita, S.; Tsuchiya, K.; Sata, M.; Akaike, M.; Kato, S.; Matsumoto, T.; Tamaki, T. 2012: Heparin cofactor II, a serine protease inhibitor, promotes angiogenesis via activation of the AMP-activated protein kinase-endothelial nitric-oxide synthase signaling pathway. Journal of Biological Chemistry 287(41): 34256-34263
Langford-Smith, K.J.; Mercer, J.; Petty, J.; Tylee, K.; Church, H.; Roberts, J.; Moss, G.; Jones, S.; Wynn, R.; Wraith, J.E.; Bigger, B.W. 2011: Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseases. Journal of Inherited Metabolic Disease 34(2): 499-508
Randall, D.R.; Colobong, K.E.; Hemmelgarn, H.; Sinclair, G.B.; Hetty, E.; Thomas, A.; Bodamer, O.A.; Volkmar, B.; Fernhoff, P.M.; Casey, R.; Chan, A.K.; Mitchell, G.; Stockler, S.; Melancon, S.; Rupar, T.; Clarke, L.A. 2008: Heparin cofactor II-thrombin complex: a biomarker of MPS disease. Molecular Genetics and Metabolism 94(4): 456-461
Schwartz, L.B. 2008: Heparin comes clean. New England Journal of Medicine 358(23): 2505-2509
Beigi, A.A.; HadiZadeh, M.S.; Salimi, F.; Ghaheri, H. 2014: Heparin compared with normal saline to maintain patency of permanent double lumen hemodialysis catheters: a randomized controlled trial. Advanced Biomedical Research 3: 121
Hemeda, H.; Kalz, J.; Walenda, G.; Lohmann, M.; Wagner, W. 2013: Heparin concentration is critical for cell culture with human platelet lysate. CytoTherapy 15(9): 1174-1181
Garvin, S.; FitzGerald, D.C.; Despotis, G.; Shekar, P.; Body, S.C. 2010: Heparin concentration-based anticoagulation for cardiac surgery fails to reliably predict heparin bolus dose requirements. Anesthesia and Analgesia 111(4): 849-855
Davidson, S.J.; Tillyer, M.L.; Keogh, J.; Hall, J.; Kelleher, A.A. 2012: Heparin concentrations in neonates during cardiopulmonary bypass. Journal of Thrombosis and Haemostasis: Jth 10(4): 730-732
Keogh, J.; Davidson, S.J.; Machin, M.; Hall, J.; Kelleher, A.A. 2009: Heparin concentrations in neonates during cardiopulmonary bypass as measured by the activated clotting time and anti-Xa assay. Anaesthesia 64(12): 1388-1389
Ignjatovic, V.; Newall, F.; Monagle, P. 2012: Heparin concentrations in neonates during cardiopulmonary bypass: a rebuttal. Journal of thrombosis and haemostasis: JTH 10(9): 1972
Mullin, M. 2010: Heparin confusion. Radiologic Technology 82(1): 11
Maguire, C.M.; Mahfoud, O.K.; Rakovich, T.; Gerard, V.A.; Prina-Mello, A.; Gun'ko, Y.; Volkov, Y. 2014: Heparin conjugated quantum dots for in vitro imaging applications. Nanomedicine: Nanotechnology Biology and Medicine 10(8): 1853-1861
Rosania, L. 2010: Heparin crisis 2008: a tipping point for increased FDA enforcement in the pharma sector?. Food and Drug Law Journal 65(3): 489-501 Ii
Skop, N.B.; Calderon, F.; Levison, S.W.; Gandhi, C.D.; Cho, C.H. 2013: Heparin crosslinked chitosan microspheres for the delivery of neural stem cells and growth factors for central nervous system repair. Acta Biomaterialia 9(6): 6834-6843
Minsky, B.B.; Nguyen, T.V.; Peyton, S.R.; Kaltashov, I.A.; Dubin, P.L. 2013: Heparin decamer bridges a growth factor and an oligolysine by different charge-driven interactions. Biomacromolecules 14(11): 4091-4098
Kos, M.Kerec.; Bogataj, M.; Mrhar, A. 2008: Heparin decreases permeability of pig urinary bladder wall preliminarily enhanced by chitosan. Drug Development and Industrial Pharmacy 34(2): 215-220
Nitz, M.; Rullo, A.; Ding, M.X.Y. 2008: Heparin dependent coiled-coil formation. Chembiochem: a European Journal of Chemical Biology 9(10): 1545-1548
Seeger, F.H.; Rasper, T.; Fischer, A.; Muhly-Reinholz, M.; Hergenreider, E.; Leistner, D.M.; Sommer, K.; Manavski, Y.; Henschler, R.; Chavakis, E.; Assmus, B.; Zeiher, A.M.; Dimmeler, S. 2012: Heparin disrupts the CXCR4/SDF-1 axis and impairs the functional capacity of bone marrow-derived mononuclear cells used for cardiovascular repair. Circulation Research 111(7): 854-862
Viskov, C.; Elli, S.; Urso, E.; Gaudesi, D.; Mourier, P.; Herman, F.; Boudier, C.; Casu, B.; Torri, G.; Guerrini, M. 2013: Heparin dodecasaccharide containing two antithrombin-binding pentasaccharides: structural features and biological properties. Journal of Biological Chemistry 288(36): 25895-25907
Lindstedt, S.; Pierre, L.; Hlebowicz, J.; Ingemansson, R. 2013: Heparin does not seem to improve the function of pulmonary grafts for lung transplantation. Scandinavian Cardiovascular Journal: Scj 47(5): 307-313
Meng, S.; Rouabhia, M.; Shi, G.; Zhang, Z. 2008: Heparin dopant increases the electrical stability, cell adhesion, and growth of conducting polypyrrole/poly(L,L-lactide) composites. Journal of Biomedical Materials Research. Part a 87(2): 332-344
Aronow, H.D. 2012: Heparin dose and harm: absence of evidence or evidence of absence?. Journal of Invasive Cardiology 24(4): 157-158
Rosin, M.W.; Holt, D. 2013: Heparin dose and postoperative bleeding in patients undergoing cardiopulmonary bypass. Journal of Extra-Corporeal Technology 45(4): 228-234
Garvin, S.; Fitzgerald, D.; Muehlschlegel, J.D.; Perry, T.ör.E.; Fox, A.A.; Shernan, S.K.; Collard, C.D.; Aranki, S.; Body, S.C. 2010: Heparin dose response is independent of preoperative antithrombin activity in patients undergoing coronary artery bypass graft surgery using low heparin concentrations. Anesthesia and Analgesia 111(4): 856-861
Wahby, K.A.; Jhajhria, S.; Dalal, B.D.; Soubani, A.O. 2014: Heparin dosing in critically ill patients undergoing therapeutic hypothermia following cardiac arrest. Resuscitation 85(4): 533-537
Lim Fat, M.J.; Al-Hazzaa, M.; Bussière, M.; dos Santos, M.P.; Lesiuk, H.; Lum, C. 2013: Heparin dosing is associated with diffusion weighted imaging lesion load following aneurysm coiling. Journal of Neurointerventional Surgery 5(4): 366-370
Kincaid, K. 2007: Heparin during neonatal bypass. Perfusion 22(2): 143
Thalheimer, U.; Triantos, C.; Samonakis, D.; Patch, D.; Burroughs, A.K. 2009: Heparin effect on thromboelastography after transjugular intrahepatic portosystemic shunt procedure. Scandinavian Journal of Gastroenterology 44(12): 1463-1470
Julianelli, V.; Farrando, B.; Alvarez Sedó, C.; Calvo, L.; Romanato, M.; Calvo, J.C. 2012: Heparin enhances protamine disulfide bond reduction during in vitro decondensation of human spermatozoa. Human Reproduction 27(7): 1930-1938
Higgins, W.J.; Fox, D.M.; Kowalski, P.S.; Nielsen, J.E.; Worrall, D.M. 2010: Heparin enhances serpin inhibition of the cysteine protease cathepsin L. Journal of Biological Chemistry 285(6): 3722-3729
Hedberg, A.; Fismen, S.; Fenton, K.A.; Fenton, C.; Osterud, B.; Mortensen, E.S.; Rekvig, O.Petter. 2011: Heparin exerts a dual effect on murine lupus nephritis by enhancing enzymatic chromatin degradation and preventing chromatin binding in glomerular membranes. Arthritis and Rheumatism 63(4): 1065-1075
Arimateia, D.S.; da Silva Brito, A.; de Azevedo, F.M.; de Andrade, G.P.V.; Chavante, S.F. 2015: Heparin fails to inhibit the leukocyte recruitment for an extended time following inflammatory stimulus. Pharmaceutical Biology 53(1): 72-77
Mitchell, M.D.; Anderson, B.J.; Williams, K.; Umscheid, C.A. 2009: Heparin flushing and other interventions to maintain patency of central venous catheters: a systematic review. Journal of Advanced Nursing 65(10): 2007-2021
Berge, E. 2007: Heparin for acute ischaemic stroke: a never-ending story?. Lancet. Neurology 6(5): 381-382
Kement, M.; Censur, Z.; Oncel, M.; Buyukokuroglu, M.E.; Gezen, F.C. 2011: Heparin for adhesion prevention: comparison of three different dosages with Seprafilm in a murine model. International Journal of Surgery 9(3): 225-228
Akhtar, M.A.; Sur, S.; Raine-Fenning, N.; Jayaprakasan, K.; Thornton, J.G.; Quenby, S. 2013: Heparin for assisted reproduction. Cochrane Database of Systematic Reviews 8: Cd009452
Akhtar, M.Ahsan.; Sur, S.; Raine-Fenning, N.; Jayaprakasan, K.; Thornton, J.; Quenby, S.; Marjoribanks, J. 2015: Heparin for assisted reproduction: summary of a Cochrane review. Fertility and Sterility 103(1): 33-34
Wilshaw, R.H.; Hannon, J.H.; Stoker, S.B. 1947: Heparin for coronary thrombosis. British Medical Journal 2(4533): 838
Yu, Y.-H.; Shen, L.-Y.; Zou, H.; Wang, Z.-J.; Gong, S.-P. 2010: Heparin for patients with growth restricted fetus: a prospective randomized controlled trial. Journal of Maternal-Fetal and Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine the Federation of Asia and Oceania Perinatal Societies the International Society of Perinatal Obstetricians 23(9): 980-987
Alikhan, R.; Bedenis, R.; Cohen, A.T. 2014: Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction). Cochrane Database of Systematic Reviews 2014(5): Cd003747
Alikhan, R.; Cohen, A.T. 2009: Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction). Cochrane Database of Systematic Reviews 2009(3): Cd003747
Liu, Z.; Zhu, H.; Ma, X. 2014: Heparin for treatment of sepsis: a systemic review. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 26(3): 135-141
Tovar, A.M.F.; Capillé, N.V.M.; Santos, G.R.C.; Vairo, B.C.; Oliveira, S.-N.M.C.G.; Fonseca, R.J.C.; Mourão, P.A.S. 2012: Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects. Thrombosis and Haemostasis 107(5): 903-915
Pitarresi, G.; Fiorica, C.; Palumbo, F.S.; Rigogliuso, S.; Ghersi, G.; Giammona, G. 2014: Heparin functionalized polyaspartamide/polyester scaffold for potential blood vessel regeneration. Journal of Biomedical Materials Research. Part a 102(5): 1334-1341
Hashii, N.; Kawasaki, N.; Itoh, S.; Qin, Y.; Fujita, N.; Hattori, T.; Miyata, K.; Bando, A.; Sekimoto, Y.; Hama, T.; Kashimura, M.; Tatsumi, M.; Mabuchi, K.; Namekawa, H.; Sakai, T.; Hirose, M.; Dobashi, S.; Shimahashi, H.; Koyama, S.; Herr, S.O.; Kawai, K.; Yoden, H.; Yamaguchi, T. 2010: Heparin identification test and purity test for OSCS in heparin sodium and heparin calcium by weak anion-exchange high-performance liquid chromatography. Biologicals: Journal of the International Association of Biological Standardization 38(5): 539-543
Lee, K.; Lee, H.; Bae, K.Hyun.; Park, T.Gwan. 2010: Heparin immobilized gold nanoparticles for targeted detection and apoptotic death of metastatic cancer cells. Biomaterials 31(25): 6530-6536
Benítez, M.; González Gómez, I.; González Carmelo, I.; Palma, A.; Cruz, S.; Rodríguez, E.; Amián, A.; Fernández M, F.; Merino, M.J.; Fernández G, F.; Suárez, C.; Onaindía, J.M.; González, J. 2007: Heparin immune thrombocytopenia in a hemodialysis patient. A case report. Literature review. Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 27(6): 756-760
Shen, X.; Fang, J.; Lv, X.; Pei, Z.; Wang, Y.; Jiang, S.; Ding, K. 2011: Heparin impairs angiogenesis through inhibition of microRNA-10b. Journal of Biological Chemistry 286(30): 26616-26627
Dockeray, G.C.; Kawerau, E. 1940: Heparin in Subacute Bacterial Endocarditis. British Medical Journal 2(4168): 703
Chamorro, A. 2008: Heparin in acute ischemic stroke revisited. Revue Neurologique (Paris) 164(10): 815-818
Levene, D.L. 1973: Heparin in clinical medicine. Canadian Family Physician Medecin de Famille Canadien 19(2): 75-76
Macmillan, A.E. 1947: Heparin in empyema; report of a case. Diseases of the Chest 13(6): 686-688
Chacko, M.K.; Mathew, T.; Sugathan, P.; Nair, L.V. 1998: Heparin in psoriasis. Indian Journal of Dermatology Venereology and Leprology 64(6): 273-274
Pechlaner, C.; Joannidis, M. 2007: Heparin in sepsis treatment. Lancet 370(9589): 738; Author Reply 738
Massie, F.M. 1945: Heparin in the Abdomen : A Clinical Report. Annals of Surgery 121(4): 508-516
Hiremath, M.; Elder, J.; Newall, F.; Mitchell, S.; Dyas, R.; Monagle, P. 2011: Heparin in the long-term management of ligneous conjunctivitis: a case report and review of literature. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 22(7): 606-609
Gresele, P.; Busti, C.; Paganelli, G. 2012: Heparin in the prophylaxis and treatment of venous thromboembolism and other thrombotic diseases. Handbook of Experimental Pharmacology 207: 179-209
Dernaika, T.A.; Kinasewitz, G.T. 2008: Heparin in the treatment of severe sepsis: a new look at an old therapy. Critical Care Medicine 36(11): 3098-3099
Loewe, L.; Hirsch, E. 1947: Heparin in the treatment of thromboembolic disease. Journal of the American Medical Association 133(17): 1263-1268
Maeck, J.V.S.; Zilliacus, H. 1948: Heparin in the treatment of toxemia of pregnancy; a preliminary report. American Journal of Obstetrics and Gynecology 55(2): 326-331
Yaoita, E.; Yoshida, Y.; Nameta, M.; Zhang, Y.; Fujinaka, H.; Magdeldin, S.; Xu, B.; Yamamoto, T. 2014: Heparin increasing podocyte-specific gene expressions. Nephrology 19(4): 195-201
Hoefgen, S.; Coburger, I.; Roeser, D.; Schaub, Y.; Dahms, S.O.; Than, M.E. 2014: Heparin induced dimerization of APP is primarily mediated by E1 and regulated by its acidic domain. Journal of Structural Biology 187(1): 30-37
Shen, Y-Xiang.; Zhu, Z-Yu.; Wu, H. 2012: Heparin induced fulminant thrombocytopenia:one case report. Zhonghua Xin Xue Guan Bing Za Zhi 40(2): 98
Zaman, S.R.; Rawlins, J.M. 2014: Heparin induced thrombocytopaenia (HIT) as a cause of free flap failure in lower limb trauma. Journal of Plastic Reconstructive and Aesthetic Surgery: Jpras 67(6): 884-886
Maurer, S.H.; Wilimas, J.A.; Wang, W.C.; Reiss, U.M. 2009: Heparin induced thrombocytopenia and re-thrombosis associated with warfarin and fondaparinux in a child. Pediatric Blood and Cancer 53(3): 468-471
Ban-Hoefen, M.; Francis, C. 2009: Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital. Thrombosis Research 124(2): 189-192
Kouerinis, I.A.; Kourtesis, A.; El-Ali, M.; Sergentanis, T.; Plagou, A.; Argiriou, M.; Theakos, N.; Giannakopoulou, A. 2008: Heparin induced thrombocytopenia diagnosis in cardiac surgery: is there a role for thromboelastography?. Interactive Cardiovascular and Thoracic Surgery 7(4): 560-563
Chaubey, S.; Davidson, S.J.; Desouza, A.C. 2009: Heparin induced thrombocytopenia in a patient with factor V Leiden following cardiac surgery. Interactive Cardiovascular and Thoracic Surgery 9(6): 1023-1025
Nocera, P.; Thiranos, J.C.; Steib, A.; Morelli, U. 2008: Heparin induced thrombocytopenia in patients with ventricular assistance device bridge-to-transplantation. a case series. Minerva Cardioangiologica 56(6): 697-701
Meera, R.; Rachel, D.; Ramakrishnapillai, V.; Vijayaraghavan, G. 2007: Heparin induced thrombocytopenia management with bivalirudin. Indian Heart Journal 59(4): 354-355
Dandekar, U.; Young, J.; Kalkat, M.; Satur, C.M.R. 2004: Heparin induced thrombocytopenia type Ii complicating coronary artery bypass surgery: a tale of caution. Interactive Cardiovascular and Thoracic Surgery 3(1): 121-123
Thachil, J. 2008: Heparin induced thrombocytopenia with thrombosis: a two step process?. Hematology 13(3): 181-182
Majeed, T.A. 2010: Heparin induced thrombocytopenia-type 2. Asian Journal of Transfusion Science 4(2): 137
Cohen, R.A.; Castellano, M.; Garcia, C.A. 2012: Heparin induced thrombocytopenia: case presentation and review. Journal of Clinical Medicine Research 4(1): 68-72
Alaraj, A.; Wallace, A.; Tesoro, E.; Ruland, S.; Amin-Hanjani, S.; Charbel, F.T.; Aletich, V. 2010: Heparin induced thrombocytopenia: diagnosis and management. Journal of Neurointerventional Surgery 2(4): 371-378
Ahmed, I.; Majeed, A.; Powell, R. 2007: Heparin induced thrombocytopenia: diagnosis and management update. Postgraduate Medical Journal 83(983): 575-582
Castelli, R.; Cassinerio, E.; Cappellini, M.D.; Porro, F.; Graziadei, G.; Fabris, F. 2007: Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects. Cardiovascular and Hematological Disorders Drug Targets 7(3): 153-162
Dasararaju, R.; Singh, N.; Mehta, A. 2013: Heparin induced thrombocytopenia: review. Expert Review of Hematology 6(4): 419-428
Royston, D. 2007: Heparin induced thrombotic thrombocytopaenia +/- thrombosis. Acta Anaesthesiologica Belgica 58(4): 243
Ueda, K.; Inoue, S.; Zhang, Y.; Kutsuna, T.; Inoue, S.; Noto, K.; Arai, N.; Noguchi, M. 2009: Heparin induces apoptosis through suppression of AKt in oral squamous cell carcinoma cells. Anticancer Research 29(4): 1079-1088
Vilasi, S.; Sarcina, R.; Maritato, R.; De Simone, A.; Irace, G.; Sirangelo, I. 2011: Heparin induces harmless fibril formation in amyloidogenic W7FW14F apomyoglobin and amyloid aggregation in wild-type protein in vitro. Plos one 6(7): E22076
Paredes-Gamero, E.J.; Medeiros, V.ír.P.; Farias, E.H.C.; Justo, G.Z.; Trindade, E.S.; Andrade-Lopes, A.L.; Godinho, R.O.; de Miranda, A.; Ferreira, A.T.; Tersariol, I.L.S.; Nader, H.B. 2010: Heparin induces rat aorta relaxation via integrin-dependent activation of muscarinic M3 receptors. Hypertension 56(4): 713-721
Zibaeenezhad, M.J.; Mazloum, Y. 2009: Heparin infusion after successful percutaneous coronary intervention: a prospective, randomized trial. Acta Cardiologica 64(1): 65-70
Bernabucci, G.; Marchetti, S.; Quarti, A.; Oggianu, A.; Pozzi, M. 2012: Heparin infusion and haemorrhagic complications in patients treated with modified Blalock-Taussig shunt: significance of a nurse and medical audit. European Journal of Cardiovascular Nursing 11(4): 419-422
Khouzam, R.N.; Soufi, M.K.; Weatherly, M. 2013: Heparin infusion through a central line misplaced in the carotid artery leading to hemorrhagic stroke. Journal of Emergency Medicine 45(3): E87-E89
Kanzaki, S.; Takahashi, T.; Kanno, T.; Ariyoshi, W.; Shinmyouzu, K.; Tujisawa, T.; Nishihara, T. 2008: Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor. Journal of Cellular Physiology 216(3): 844-850
Ozen, E.; Gozukizil, A.; Erdal, E.; Uren, A.; Bottaro, D.P.; Atabey, N. 2012: Heparin inhibits Hepatocyte Growth Factor induced motility and invasion of hepatocellular carcinoma cells through early growth response protein 1. Plos one 7(8): E42717
Wei, W.; Zuo, Y.; Hu, Y.; Wang, L.; Jia, L.; Zhang, J. 2009: Heparin inhibits P388D1 cells adherence and metastasis to peripheral lymph nodes in vitro and in vivo. Lymphology 42(1): 10-18
Spratte, J.; Meyer zu Schwabedissen, H.; Endlich, N.; Zygmunt, M.; Fluhr, H. 2013: Heparin inhibits TNF-α signaling in human endometrial stromal cells by interaction with NF-κB. Molecular Human Reproduction 19(4): 227-236
Lee, M.J. 2013: Heparin inhibits activation of latent transforming growth factor-β1. Pharmacology 92(5-6): 238-244
Xie-Zukauskas, H.; Das, J.; Short, B.L.; Gutkind, J.S.; Ray, P.E. 2013: Heparin inhibits angiotensin II-induced vasoconstriction on isolated mouse mesenteric resistance arteries through Rho-A- and PKA-dependent pathways. Vascular Pharmacology 58(4): 313-318
Zhao, S.; Zhang, X.; Zhang, X.; Shi, X.; Yu, Z.; Kan, Q. 2014: Heparin inhibits burn-induced spleen cell apoptosis by suppressing interleukin-1 expression. Chinese Medical Journal 127(13): 2463-2469
Lobov, G.I.; Pan'kova, M.N. 2010: Heparin inhibits contraction of smooth muscle cells in lymphatic vessels. Bulletin of Experimental Biology and Medicine 149(1): 4-6
Fluhr, H.; Spratte, J.; Heidrich, S.; Ehrhardt, J.; Steinmüller, F.; Zygmunt, M. 2011: Heparin inhibits interferon-γ signaling in human endometrial stromal cells by interference with the cellular binding of interferon-γ. Fertility and Sterility 95(4): 1272-1277
Makino-Okamura, C.; Niki, Y.; Takeuchi, S.; Nishigori, C.; Declercq, L.; Yaroch, D.B.; Saito, N. 2014: Heparin inhibits melanosome uptake and inflammatory response coupled with phagocytosis through blocking PI3k/Akt and MEK/ERK signaling pathways in human epidermal keratinocytes. Pigment Cell and Melanoma Research 27(6): 1063-1074
Bazar, E.; Sheynis, T.; Dorosz, J.; Jelinek, R. 2011: Heparin inhibits membrane interactions and lipid-induced fibrillation of a prion amyloidogenic determinant. Chembiochem: a European Journal of Chemical Biology 12(5): 761-767
Ogawa, T.; Shimizu, S.; Tojima, I.; Kouzaki, H.; Shimizu, T. 2011: Heparin inhibits mucus hypersecretion in airway epithelial cells. American Journal of Rhinology and Allergy 25(2): 69-74
Warzecha, Z.; Dembinski, A.; Ceranowicz, P.; Dembinski, M.; Sendur, R.; Cieszkowski, J.; Sendur, P.; Tomaszewska, R. 2012: Heparin inhibits protective effect of ischemic preconditioning in ischemia/reperfusion-induced acute pancreatitis. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 63(4): 355-365
Yu, L.; Quinn, D.A.; Garg, H.G.; Hales, C.A. 2011: Heparin inhibits pulmonary artery smooth muscle cell proliferation through guanine nucleotide exchange factor-H1/RhoA/Rho kinase/p27. American Journal of Respiratory Cell and Molecular Biology 44(4): 524-530
Guo, H.; Xu, F.; Sun, A.; Liu, L.; Shi, Y. 2010: Heparin inhibits the production of matrix metalloproteinase-2 and improves atherosclerosis in LDL receptor-deficient mice. Coronary Artery Disease 21(1): 39-45
Tan, H.; Zhou, Q.; Qi, H.; Zhu, D.; Ma, X.; Xiong, D. 2012: Heparin interacting protein mediated assembly of nano-fibrous hydrogel scaffolds for guided stem cell differentiation. Macromolecular Bioscience 12(5): 621-627
Yang, J.-Y.; Chien, T.-I.; Lu, J.-Y.; Kao, J.-T. 2009: Heparin interference in the cerebrospinal fluid protein assay measured with a pyrogallol red-molybdate complex. Clinica Chimica Acta; International Journal of Clinical Chemistry 408(1-2): 75-78
Huang, X.; Rezaie, A.R.; Broze, G.J.; Olson, S.T. 2011: Heparin is a major activator of the anticoagulant serpin, protein Z-dependent protease inhibitor. Journal of Biological Chemistry 286(11): 8740-8751
Nasu, K.; Tsuno, A.; Hirao, M.; Kobayashi, H.; Yuge, A.; Narahara, H. 2010: Heparin is a promising agent for the treatment of endometriosis-associated fibrosis. Fertility and Sterility 94(1): 46-51
Brown, K.; Tay-Uyboco, J.S.; McMillan, D.D. 1999: Heparin is not required for peripheral intravenous locks in neonates. Paediatrics and Child Health 4(1): 39-42
Smith, S.A.; Morrissey, J.H. 2008: Heparin is procoagulant in the absence of antithrombin. Thrombosis and Haemostasis 100(1): 160-162
Dreyer, G.; Lawton, P.; Jose, M. 2008: Heparin leak from a hemodialysis catheter causing major bleeding, ultimately leading to transplant rejection and death. Hemodialysis International. International Symposium on Home Hemodialysis 12(4): 431-433
Huang, C.; Wang, S.; Qiu, L.; Ke, Q.; Zhai, W.; Mo, X. 2013: Heparin loading and pre-endothelialization in enhancing the patency rate of electrospun small-diameter vascular grafts in a canine model. Acs Applied Materials and Interfaces 5(6): 2220-2226
Kaakinen, T.; Laurila, J.; Ala-Kokko, T. 2013: Heparin lock--preventing clots but causing bleeding?. Duodecim; Laaketieteellinen Aikakauskirja 129(18): 1928-1931
Wang, Y.; Zheng, Q.-C.; Kong, C.-P.; Tian, Y.; Zhan, J.; Zhang, J.-L.; Zhang, H.-X. 2015: Heparin makes differences: a molecular dynamics simulation study on the human βII-tryptase monomer. Molecular Biosystems 11(1): 252-261
Belchikov, Y.G.; Marotta, S.E. 2010: Heparin management in a patient with thyroid storm. PharmacoTherapy 30(4): 134e-138e
Xiao, Z.; Tappen, B.R.; Ly, M.; Zhao, W.; Canova, L.P.; Guan, H.; Linhardt, R.J. 2011: Heparin mapping using heparin lyases and the generation of a novel low molecular weight heparin. Journal of Medicinal Chemistry 54(2): 603-610
Hettiaratchi, M.H.; Miller, T.; Temenoff, J.S.; Guldberg, R.E.; McDevitt, T.C. 2014: Heparin microparticle effects on presentation and bioactivity of bone morphogenetic protein-2. Biomaterials 35(25): 7228-7238
Mammadov, R.; Mammadov, B.; Toksoz, S.; Aydin, B.; Yagci, R.; Tekinay, A.B.; Guler, M.O. 2011: Heparin mimetic peptide nanofibers promote angiogenesis. Biomacromolecules 12(10): 3508-3519
Coombe, D.R.; Kett, W.C. 2012: Heparin mimetics. Handbook of Experimental Pharmacology 2012(207): 361-383
Sangaj, N.; Kyriakakis, P.; Yang, D.; Chang, C.-W.; Arya, G.; Varghese, S. 2010: Heparin mimicking polymer promotes myogenic differentiation of muscle progenitor cells. Biomacromolecules 11(12): 3294-3300
Knaack, S.; Lode, A.; Hoyer, B.; Rösen-Wolff, A.; Gabrielyan, A.; Roeder, I.; Gelinsky, M. 2014: Heparin modification of a biomimetic bone matrix for controlled release of VEGF. Journal of Biomedical Materials Research. Part a 102(10): 3500-3511
Lode, A.; Reinstorf, A.; Bernhardt, A.; Wolf-Brandstetter, C.; König, U.; Gelinsky, M. 2008: Heparin modification of calcium phosphate bone cements for VEGF functionalization. Journal of Biomedical Materials Research. Part a 86(3): 749-759
Chudasama, S.L.; Espinasse, B.; Hwang, F.; Qi, R.; Joglekar, M.; Afonina, G.; Wiesner, M.R.; Welsby, I.J.; Ortel, T.L.; Arepally, G.M. 2010: Heparin modifies the immunogenicity of positively charged proteins. Blood 116(26): 6046-6053
Judice, W.A.S.; Manfredi, M.A.; Souza, G.P.; Sansevero, T.M.; Almeida, P.C.; Shida, C.áu.S.; Gesteira, T.F.; Juliano, L.; Westrop, G.D.; Sanderson, S.J.; Coombs, G.H.; Tersariol, I.L.S. 2013: Heparin modulates the endopeptidase activity of Leishmania mexicana cysteine protease cathepsin L-Like rCPB2.8. Plos one 8(11): E80153
Taha, M.O.; Ferreira, R.M.; Taha, N.S.A.ão.; Monteiro, H.P.; Caricati-Neto, A.; Fagundes, D.J.é 2014: Heparin modulates the expression of genes encoding pro and anti-apoptotic proteins in endothelial cells exposed to intestinal ischemia and reperfusion in rats. Acta Cirurgica Brasileira 29(7): 445-449
Hassanin, A.; Malek, H.A.; Saleh, D. 2014: Heparin modulation on hepatic nitric oxide synthase in experimental steatohepatitis. Experimental and Therapeutic Medicine 8(5): 1551-1558
Hellstern, P.; Bach, J.; Simon, M.; Saggau, W. 2007: Heparin monitoring during cardiopulmonary bypass surgery using the one-step point-of-care whole blood anti-factor-Xa clotting assay heptest-POC-Hi. Journal of Extra-Corporeal Technology 39(2): 81-86
Lincoff, A.M. 2014: Heparin monotherapy for percutaneous coronary intervention?. Lancet 384(9943): 564-566
Bangalore, S.; Pencina, M.J.; Kleiman, N.S.; Cohen, D.J. 2014: Heparin monotherapy or bivalirudin during percutaneous coronary intervention in patients with non-ST-segment-elevation acute coronary syndromes or stable ischemic heart disease: results from the Evaluation of Drug-Eluting Stents and Ischemic Events registry. Circulation. Cardiovascular Interventions 7(3): 365-373
Tao, Y.; Hu, T.; Wu, Z.; Tang, H.; Hu, Y.; Tan, Q.; Wu, C. 2012: Heparin nanomodification improves biocompatibility and biomechanical stability of decellularized vascular scaffolds. International Journal of Nanomedicine 7: 5847-5858
Ziarek, J.J.; Veldkamp, C.T.; Zhang, F.; Murray, N.J.; Kartz, G.A.; Liang, X.; Su, J.; Baker, J.E.; Linhardt, R.J.; Volkman, B.F. 2013: Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus. Journal of Biological Chemistry 288(1): 737-746
Schallom, M.E.; Prentice, D.; Sona, C.; Micek, S.T.; Skrupky, L.P. 2012: Heparin or 0.9% sodium chloride to maintain central venous catheter patency: a randomized trial. Critical Care Medicine 40(6): 1820-1826
Hoppe, B.; Burmester, G.-R.üd.; Dörner, T. 2011: Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome). Current Opinion in Rheumatology 23(3): 299-304
Brieger, D.; Collet, J.-P.; Silvain, J.; Landivier, A.; Barthélémy, O.; Beygui, F.; Bellemain-Appaix, A.; Mercadier, A.; Choussat, R.; Vignolles, N.; Costagliola, D.; Montalescot, G. 2011: Heparin or enoxaparin anticoagulation for primary percutaneous coronary intervention. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 77(2): 182-190
Anand, S.; Siddhartha, W.; Karnad, D.R.; Shrivastava, M.; Ghatge, S.; Limaye, U.S. 2006: Heparin or local thrombolysis in the management of cerebral venous sinus thrombosis?. Interventional Neuroradiology: Journal of Peritherapeutic Neuroradiology Surgical Procedures and Related Neurosciences 12(2): 131-140
Anonymous 2008: Heparin overdose scare in 14 babies at Texas hospital. Healthcare Benchmarks and Quality Improvement 15(9): 89-90
Junqueira, D.R.G.; Viana, T.ér.G.; Peixoto, E.R.d.M.; Barros, F.C.R.d.; Carvalho, M.d.G.ça.; Perini, E. 2011: Heparin pharmacovigilance in Brazil. Revista da Associacao Medica Brasileira 57(3): 322-326
Chalkiadaki, G.; Nikitovic, D.; Berdiaki, A.; Katonis, P.; Karamanos, N.K.; Tzanakakis, G.N. 2011: Heparin plays a key regulatory role via a p53/FAK-dependent signaling in melanoma cell adhesion and migration. Iubmb Life 63(2): 109-119
Wang, A.; Ren, J.; Wang, C.P.; Hascall, V.C. 2014: Heparin prevents intracellular hyaluronan synthesis and autophagy responses in hyperglycemic dividing mesangial cells and activates synthesis of an extensive extracellular monocyte-adhesive hyaluronan matrix after completing cell division. Journal of Biological Chemistry 289(13): 9418-9429
Gao, C.; Boylan, B.; Fang, J.; Wilcox, D.A.; Newman, D.K.; Newman, P.J. 2011: Heparin promotes platelet responsiveness by potentiating αIIbβ3-mediated outside-in signaling. Blood 117(18): 4946-4952
Gris, J-C.; Marès, P. 2012: Heparin promotes soluble vascular enothelial growth factor receptor expression in human placental villi: a rebuttal. Journal of thrombosis and haemostasis: JTH 10(3): 499-500
Li, L.; Qin, J.; Feng, Q.; Tang, H.; Liu, R.; Xu, L.; Chen, Z. 2011: Heparin promotes suspension adaptation process of CHO-TS28 cells by eliminating cell aggregation. Molecular Biotechnology 47(1): 9-17
Furue, M.K.; Na, J.; Jackson, J.P.; Okamoto, T.; Jones, M.; Baker, D.; Hata, R.-I.; Moore, H.D.; Sato, J.D.; Andrews, P.W. 2008: Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium. Proceedings of the National Academy of Sciences of the United States of America 105(36): 13409-13414
Madine, J.; Davies, H.A.; Hughes, E.; Middleton, D.A. 2013: Heparin promotes the rapid fibrillization of a peptide with low intrinsic amyloidogenicity. Biochemistry 52(50): 8984-8992
Patel, T.; Kirby, W.; Hruby, G.; Benson, M.C.; McKiernan, J.M.; Badani, K. 2011: Heparin prophylaxis and the risk of venous thromboembolism after robotic-assisted laparoscopic prostatectomy. Bju International 108(5): 729-732
Cook, D. 2008: Heparin prophylaxis did not increase mortality and was beneficial in adults with sepsis receiving drotrecogin alfa. Acp Journal Club 148(2): 32
Snee, M. 2012: Heparin prophylaxis has no benefit in medical patients. Bmj 345: E4940
Nuridsany, J.; Somos, P. 1955: Heparin protamine sulfate. A Gyogyszeresz 10(7): 128-129
Fu, L.S.; Tsai, J.J.; Chen, Y.J.; Lin, H.K.; Tsai, M.C.; Chang, M.D.T. 2013: Heparin protects BALB/c mice from mite-induced airway allergic inflammation. International Journal of Immunopathology and Pharmacology 26(2): 349-359
Melo, E.I.; Pereira, M.S.; Cunha, R.S.; Sá, M.P.L.d.; Mourão, P.A.S. 2008: Heparin quality control in the Brazilian market: implications in the cardiovascular surgery. Revista Brasileira de Cirurgia Cardiovascular: Orgao Oficial da Sociedade Brasileira de Cirurgia Cardiovascular 23(2): 169-174
Sharma, V.; Sharma, A.; Aggarwal, S. 2008: Heparin recall and India. Journal of Postgraduate Medicine 54(4): 335-336
Zayas, G.J.; Bonilla, A.M.; Saliba, M.J. 2007: Heparin reduced mortality and sepsis in severely burned children. Annals of Burns and Fire Disasters 20(1): 29-34
Chatzinikolaou, G.; Nikitovic, D.; Berdiaki, A.; Zafiropoulos, A.; Katonis, P.; Karamanos, N.K.; Tzanakakis, G.N. 2010: Heparin regulates colon cancer cell growth through p38 mitogen-activated protein kinase signalling. Cell Proliferation 43(1): 9-18
Gruber, M.; Spaeth, R.; Bechmann, V. 2008: Heparin release is insufficient in syringes with platelets as heparin source. Clinica Chimica Acta; International Journal of Clinical Chemistry 395(1-2): 187
Ma, X.; Mohammad, S.F.; Kim, S.W. 1992: Heparin removal from blood using poly(L-lysine) immobilized hollow fiber. Biotechnology and Bioengineering 40(4): 530-536
Baydemir, G.öz.; Denizli, A. 2015: Heparin removal from human plasma using molecular imprinted cryogels. Artificial Cells Nanomedicine and Biotechnology 43(6): 403-412
Zhao, D.; Ding, R.; Mao, Y.; Wang, L.; Zhang, Z.; Ma, X. 2012: Heparin rescues sepsis-associated acute lung injury and lethality through the suppression of inflammatory responses. Inflammation 35(6): 1825-1832
Maurin, N. 2009: Heparin resistance and antithrombin deficiency. Medizinische Klinik 104(6): 441-449
Koster, A.; Zittermann, A.; Schirmer, U. 2013: Heparin resistance and excessive thrombocytosis. Anesthesia and Analgesia 117(5): 1262
Kumano, N.; Ikeda, S.; Arimori, Y.; Ono, T.; Saeki, S. 2008: Heparin resistance associated with elevated factor VIIi. MASUI. Japanese Journal of Anesthesiology 57(4): 471-473
Dejardin, L.; Mascart, P. 1950: Heparin resistance test in surgical patients. Journal International de Chirurgie 10(5): 384-398
Gilotti, A.C.; Nimlamool, W.; Pugh, R.; Slee, J.B.; Barthol, T.C.; Miller, E.A.; Lowe-Krentz, L.J. 2014: Heparin responses in vascular smooth muscle cells involve cGMP-dependent protein kinase (PKG). Journal of Cellular Physiology 229(12): 2142-2152
Alexander, W. 2009: Heparin revisions: a call for heightened vigilance and monitoring. P and T: a Peer-Reviewed Journal for Formulary Management 34(11): 634-638
Boeckel, J.-N.; Thomé, C.E.; Leistner, D.; Zeiher, A.M.; Fichtlscherer, S.; Dimmeler, S. 2013: Heparin selectively affects the quantification of micro RNAs in human blood samples. Clinical Chemistry 59(7): 1125-1127
Bromfield, S.M.; Wilde, E.; Smith, D.K. 2013: Heparin sensing and binding - taking supramolecular chemistry towards clinical applications. Chemical Society Reviews 42(23): 9184-9195
Ohmori, S.; Hino, R.; Nakamura, M.; Tokura, Y. 2012: Heparin serves as a natural stimulant of the inflammasome and exacerbates the symptoms of tumor necrosis factor receptor-associated periodic syndrome (TRAPS). Journal of Dermatological Science 66(1): 82-84
Mourier, P.A.J.; Guichard, O.Y.; Herman, Féderic.; Viskov, C. 2012: Heparin sodium compliance to USP monograph: structural elucidation of an atypical 2.18 ppm NMR signal. Journal of pharmaceutical and biomedical analysis 67-68: 169-174
Mourier, P.A.J.; Guichard, O.Y.; Herman, Féderic.; Viskov, C. 2011: Heparin sodium compliance to the new proposed USP monograph: elucidation of a minor structural modification responsible for a process dependent 2.10 ppm NMR signal. Journal of pharmaceutical and biomedical analysis 54(2): 337-344
Bisogni, S.; Giusti, F.; Ciofi, D.; Festini, F. 2014: Heparin solution for maintaining peripheral venous catheter patency in children: a survey of current practice in Italian pediatric units. Issues in Comprehensive Pediatric Nursing 37(2): 122-135
Fu, L.; Li, L.; Cai, C.; Li, G.; Zhang, F.; Linhardt, R.J. 2014: Heparin stability by determining unsubstituted amino groups using hydrophilic interaction chromatography mass spectrometry. Analytical Biochemistry 461: 46-48
Relini, A.; De Stefano, S.; Torrassa, S.; Cavalleri, O.; Rolandi, R.; Gliozzi, A.; Giorgetti, S.; Raimondi, S.; Marchese, L.; Verga, L.; Rossi, A.; Stoppini, M.; Bellotti, V. 2008: Heparin strongly enhances the formation of beta2-microglobulin amyloid fibrils in the presence of type i collagen. Journal of Biological Chemistry 283(8): 4912-4920
Chu, H.-N.ü 2008: Heparin successfully improved an early onset intrauterine growth restriction accompanied by severe oligohydramnios. International Journal of General Medicine 1: 1-2
Zhang, Z.; Liu, X.; Chen, J.; Su, H.; Luo, Q.; Ye, J.; Tang, N.; Zhang, W.; Chen, W.; Ko, B.C.B.; Huang, A. 2010: Heparin sulphate D-glucosaminyl 3-O-sulfotransferase 3B1 plays a role in HBV replication. Virology 406(2): 280-285
Stavrou, P.; Murray, P.I. 1994: Heparin surface modified intraocular lenses in uveitis. Ocular Immunology and Inflammation 2(3): 161-168
Tsolaki, E.; Elpiniki, T.; Salviato, E.; Rocca, T.; Braccini, L.; Galeotti, R.; Mascoli, F. 2010: Heparin surface stent-graft for the treatment of a carotid pseudoaneurysm. Annals of Vascular Surgery 24(7): 952.E9-952.E12
Gore, S.; Andersson, J.; Biran, R.; Underwood, C.; Riesenfeld, J. 2014: Heparin surfaces: Impact of immobilization chemistry on hemocompatibility and protein adsorption. Journal of Biomedical Materials Research. Part B Applied Biomaterials 102(8): 1817-1824
Fritsma, G.A. 2013: Heparin therapeutic range. Clinical Laboratory Science: Journal of the American Society for Medical Technology 26(2): 66
Palmer, K.; Ridgway, T.; Al-Rawi, O.; Poullis, M. 2012: Heparin therapy during extracorporeal circulation: deriving an optimal activated clotting time during cardiopulmonary bypass for isolated coronary artery bypass grafting. Journal of Extra-Corporeal Technology 44(3): 145-150
Dodd, J.M.; Sahi, K.; McLeod, A.; Windrim, R.C.; Kingdom, J.P.C. 2008: Heparin therapy for complications of placental dysfunction: a systematic review of the literature. Acta Obstetricia et Gynecologica Scandinavica 87(8): 804-811
Bauer, G. 1946: Heparin therapy in acute deep venous thrombosis. Journal of the American Medical Association 131: 196-203
Wang, C.; Chi, C.; Guo, L.; Wang, X.; Guo, L.; Sun, J.; Sun, B.; Liu, S.; Chang, X.; Li, E. 2014: Heparin therapy reduces 28-day mortality in adult severe sepsis patients: a systematic review and meta-analysis. Critical Care 18(5): 563
Labarere, J.; Bosson, J-Luc. 2007: Heparin thromboprophylaxis for medical inpatients. American Journal of Medicine 120(5): E13; Author Reply E17-8
Gurjar, M. 2014: Heparin thromboprophylaxis in critically ill patients: Is it really changing outcome?. Indian Journal of Critical Care Medicine: Peer-Reviewed Official Publication of Indian Society of Critical Care Medicine 18(6): 345-347
Alhazzani, W.; Lim, W.; Jaeschke, R.Z.; Murad, M.H.; Cade, J.; Cook, D.J. 2013: Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials. Critical Care Medicine 41(9): 2088-2098
Abrahams, D.G.; Glynn, L.E.; Loewi, G. 1951: Heparin tolerance in rheumatic fever. Ii. Clinical Science 10(1): 1-11
Gurbuz, H.Alper.; Durukan, A.Baris.; Sevim, H.; Ergin, E.; Gurpinar, A.; Yorgancioglu, C. 2013: Heparin toxicity in cell culture: a critical link in translation of basic science to clinical practice. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 24(7): 742-745
Kocatürk, T.; Kocatürk, O.; Kaplan, A.; Meteoğlu, I.; Cakmak, H.; Dayanir, V. 2013: Heparin treatment for allergic conjunctivitis in the experimental BALB/c model. Ophthalmic Research 50(1): 65-71
Cole, R.P. 2009: Heparin treatment for severe hypertriglyceridemia in diabetic ketoacidosis. Archives of Internal Medicine 169(15): 1439-1441
Clark, C.A.; Spitzer, K.A.; Laskin, C.A.; Crowther, M.R.; Ginsberg, J.S. 2010: Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss. Obstetrics and Gynecology 116(4): 997-998
Ziakas, P.D.; Pavlou, M.; Voulgarelis, M. 2010: Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis. Obstetrics and Gynecology 115(6): 1256-1262
Stuckey, W.; Vainio, K. 1949: Heparin treatment of frostbite. Duodecim; Laaketieteellinen Aikakauskirja 65(3): 212-217
Blaukovitch, C.I.; Pugh, R.; Gilotti, A.C.; Kanyi, D.; Lowe-Krentz, L.J. 2010: Heparin treatment of vascular smooth muscle cells results in the synthesis of the dual-specificity phosphatase MKP-1. Journal of Cellular Biochemistry 110(2): 382-391
Lavainne, Fédéric.; Meffray, E.; Pepper, R.J.; Néel, Mélanie.; Delcroix, C.; Salama, A.D.; Fakhouri, F. 2014: Heparin use during dialysis sessions induces an increase in the antiangiogenic factor soluble Flt1. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 29(6): 1225-1231
Qin, Y.; Prescott, L.M.; Deitch, E.A.; Kaiser, V.L. 2011: Heparin use in a rat hemorrhagic shock model induces biologic activity in mesenteric lymph separate from shock. Shock 35(4): 411-421
Shen, J.I.; Mitani, A.A.; Winkelmayer, W.C. 2014: Heparin use in hemodialysis patients following gastrointestinal bleeding. American Journal of Nephrology 40(4): 300-307
López-Briz, E.; Ruiz Garcia, V.; Cabello, J.B.; Bort-Marti, S.; Carbonell Sanchis, R.; Burls, A. 2014: Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults. Cochrane Database of Systematic Reviews 2014(10): Cd008462
Stabile, E.; Sorropago, G.; Tesorio, T.; Popusoi, G.; Ambrosini, V.; Mottola, M.T.; Biamino, G.; Rubino, P. 2010: Heparin versus bivalirudin for carotid artery stenting using proximal endovascular clamping for neuroprotection: results from a prospective randomized study. Journal of Vascular Surgery 52(6): 1505-1510
Tillman, J. 2009: Heparin versus citrate for anticoagulation in critically ill patients treated with continuous renal replacement therapy. Nursing in Critical Care 14(4): 191-199
Vertolli, U. 2007: Heparin versus citrate in the extracorporeal circuitry. Giornale italiano di nefrologia: organo ufficiale della Societa italiana di nefrologia 24(4): 353; author reply 353-4
Nakase, J.; Toribatake, Y.; Mouri, Y.; Seki, H.; Kitaoka, K.; Tomita, K. 2009: Heparin versus danaproid for prevention of venous thromboembolism after hip surgery. Journal of Orthopaedic Surgery 17(1): 6-9
Robertson-Malt, S.; Malt, G.N.; Farquhar, V.; Greer, W. 2014: Heparin versus normal saline for patency of arterial lines. Cochrane Database of Systematic Reviews 5: Cd007364
Magee, K.D.; Campbell, S.G.; Moher, D.; Rowe, B.H. 2008: Heparin versus placebo for acute coronary syndromes. Cochrane Database of Systematic Reviews 2: Cd003462
Andrade-Castellanos, C.A.; Colunga-Lozano, L.E.; Delgado-Figueroa, N.; Magee, K. 2014: Heparin versus placebo for non-ST elevation acute coronary syndromes. Cochrane Database of Systematic Reviews 6: Cd003462
Arcangeli, A.; Rocca, B.; Salvatori, G.; Ciancia, M.; De Cristofaro, R.; Antonelli, M. 2010: Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter. Thrombosis Research 126(1): 24-31
Singh, P.; Fu Zhu, L.; Dziegielewski, P.; Harris, J.; Seikaly, H. 2011: Heparin versus tirofiban in microvascular anastomosis: randomized controlled trial in a rat model. Journal of Otolaryngology - Head and Neck Surgery 40(Suppl 1): S59-S64
Ricci, G.; Giolo, E.; Simeone, R. 2010: Heparin's 'potential to improve pregnancy rates and outcomes' is not evidence-based. Human reproduction update 16(2): 225-7; author reply 227-8
Hughes, G.R.V. 2012: Heparin, antiphospholipid antibodies and the brain. Lupus 21(10): 1039-1040
Li, J.-P.; Vlodavsky, I. 2009: Heparin, heparan sulfate and heparanase in inflammatory reactions. Thrombosis and Haemostasis 102(5): 823-828
Borawski, J.; Naumnik, B.; Mysliwiec, M. 2007: Heparin, myeloperoxidase, and atherosclerosis: a new focus on an old drug. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 13(2): 219-220
Crotty, R.; Nazarian, R.M.; Song, P.I.; Van Cott, E.M. 2014: Heparin, warfarin, or calciphylaxis?. American Journal of Hematology 89(7): 785-786
Zhang, G.Wei.; Liu, X.C.; Mphil, Y.Luan.; Zhao, J.; Shi, R.Fang.; Zhao, X.Bin.; Liu, T.J.; Lü, F.; Yang, Q.; He, G.W. 2011: Heparin- and basic fibroblast growth factor-incorporated degradable stent: comparison with traditional transmyocardial revascularization. Journal of Cardiovascular Surgery 52(2): 261-270
Liu, X-Cheng.; Zhao, J.; Wang, Y.; Liu, T-Jun.; Lü, F.; He, G-Wei. 2010: Heparin- and basic fibroblast growth factor-incorporated stent: a new promising method for myocardial revascularization. Journal of Surgical Research 164(2): 204-213
Chatzinikolaou, G.; Nikitovic, D.; Asimakopoulou, A.; Tsatsakis, A.; Karamanos, N.K.; Tzanakakis, G.N. 2008: Heparin--a unique stimulator of human colon cancer cells' growth. Iubmb Life 60(5): 333-340
Drewlo, S. 2013: Heparin--not only thinning the blood. Blood 121(11): 1932-1933
Pomin, V.H. 2014: Heparin-Binding Proteins (Chemokines and Defensins) and their complexes with glycosaminoglycans from the solution NMR perspective. Current Protein and Peptide Science 15(7): 738-744
Ye, L.; Wu, X.; Mu, Q.; Chen, B.; Duan, Y.; Geng, X.; Gu, Y.; Zhang, A.; Zhang, J.; Feng, Z-guo. 2011: Heparin-Conjugated PCL Scaffolds Fabricated by Electrospinning and Loaded with Fibroblast Growth Factor 2. Journal of Biomaterials Science. Polymer Edition 22(1-3): 389-406
Newkirk, C.E. 2010: Heparin-Induced thrombocytopenia (HIT): a case study. Clinical Laboratory Science: Journal of the American Society for Medical Technology 23(1): 5-11
Brandan, E.; Llona, I.; Inestrosa, N.C. 1986: Heparin-acetylcholinesterase interaction: Specific detachment of class I-A forms and binding of class i and II-A forms to heparin-agarose. Neurochemistry International 9(1): 75-84
Durdureanu-Angheluta, A.; Uritu, C.M.; Coroaba, A.; Minea, B.; Doroftei, F.; Calin, M.; Maier, S.Sergiu.; Pinteala, M.; Simionescu, M.; Simionescu, B.C. 2014: Heparin-anthranoid conjugates associated with nanomagnetite particles and their cytotoxic effect on cancer cells. Journal of Biomedical Nanotechnology 10(1): 131-142
Becker, R.C.; Mahaffey, K.W.; Yang, H.; Marian, A.J.; Furman, M.I.; Michael Lincoff, A.; Hazen, S.L.; Petersen, J.L.; Reist, C.J.; Kleiman, N.S. 2011: Heparin-associated anti-Xa activity and platelet-derived prothrombotic and proinflammatory biomarkers in moderate to high-risk patients with acute coronary syndrome. Journal of Thrombosis and Thrombolysis 31(2): 146-153
Falvo, N.; Bonithon-Kopp, C.; Rivron Guillot, K.; Todoli, J.A.; Jiménez-Gil, M.; Di Micco, P.; Monreal, M.; Monreal, M.; Decousus, H.; Prandoni, P.; Brenner, B.; Barba, R.; Di Micco, P.; Rivron-Guillot, K.; Bosevski, M. 2011: Heparin-associated thrombocytopenia in 24,401 patients with venous thromboembolism: findings from the RIETE Registry. Journal of Thrombosis and Haemostasis: Jth 9(9): 1761-1768
Kim, M.; Lee, J.Y.; Jones, C.N.; Revzin, A.; Tae, G. 2010: Heparin-based hydrogel as a matrix for encapsulation and cultivation of primary hepatocytes. Biomaterials 31(13): 3596-3603
Kemp, M.M.; Linhardt, R.J. 2010: Heparin-based nanoparticles. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology 2(1): 77-87
Spencer, A.; Cawood, T.; Frampton, C.; Jardine, D. 2014: Heparin-based treatment to prevent symptomatic deep venous thrombosis, pulmonary embolism or death in general medical inpatients is not supported by best evidence. Internal Medicine Journal 44(11): 1054-1065
Al-Akeel, R.A.; El-Kersh, T.A.; Al-Sheikh, Y.A.; Al-Ahmadey, Z.Z. 2013: Heparin-benzyl alcohol enhancement of biofilms formation and antifungal susceptibility of vaginal Candida species isolated from pregnant and nonpregnant Saudi women. Bioinformation 9(7): 357-362
Rahman, F.B.; Ishihara, S.; Aziz, M.M.; Mishima, Y.; Oshima, N.; Li, Y.-Y.; Sanchez-Siles, A.A.; Otani, A.; Oka, A.; Kusunoki, R.; Tada, Y.; Moriyama, I.; Ishimura, N.; Yuki, T.; Kazumori, H.; Amano, Y.; Sato, S.; Ansary, M.U.; Kinoshita, Y. 2010: Heparin-binding EGF-like factor augments esophageal epithelial cell proliferation, migration and inhibits TRAIL-mediated apoptosis via EGFR/MAPK signaling. Scandinavian Journal of Gastroenterology 45(11): 1350-1359
Su, Y.; Besner, G.E. 2014: Heparin-binding EGF-like growth factor (HB-EGF) promotes cell migration and adhesion via focal adhesion kinase. Journal of Surgical Research 189(2): 222-231
Yang, J.; Su, Y.; Zhou, Y.; Besner, G.E. 2014: Heparin-binding EGF-like growth factor (HB-EGF) therapy for intestinal injury: Application and future prospects. Pathophysiology: the Official Journal of the International Society for Pathophysiology 21(1): 95-104
Ota, I.; Higashiyama, S.; Masui, T.; Yane, K.; Hosoi, H.; Matsuura, N. 2013: Heparin-binding EGF-like growth factor enhances the activity of invasion and metastasis in thyroid cancer cells. Oncology Reports 30(4): 1593-1600
Sánchez-Vizcaíno, E.; Vehí, C.; Campreciós, Gís.; Morcillo, César.; Soley, M.; Ramírez, I. 2010: Heparin-binding EGF-like growth factor in human serum. Association with high blood cholesterol and heart hypertrophy. Growth Factors 28(2): 98-103
Yu, X.; Radulescu, A.; Zorko, N.; Besner, G.E. 2009: Heparin-binding EGF-like growth factor increases intestinal microvascular blood flow in necrotizing enterocolitis. Gastroenterology 137(1): 221-230
Lian, H.; Ma, Y.; Feng, J.; Dong, W.; Yang, Q.; Lu, D.; Zhang, L. 2012: Heparin-binding EGF-like growth factor induces heart interstitial fibrosis via an Akt/mTor/p70s6k pathway. Plos one 7(9): E44946
El-Assal, O.N.; Radulescu, A.; Besner, G.E. 2007: Heparin-binding EGF-like growth factor preserves mesenteric microcirculatory blood flow and protects against intestinal injury in rats subjected to hemorrhagic shock and resuscitation. Surgery 142(2): 234-242
Radulescu, A.; Zhang, H.-Y.; Chen, C.-L.; Chen, Y.; Zhou, Y.; Yu, X.; Otabor, I.; Olson, J.K.; Besner, G.E. 2011: Heparin-binding EGF-like growth factor promotes intestinal anastomotic healing. Journal of Surgical Research 171(2): 540-550
Yu, X.; Radulescu, A.; Chen, C.-L.; James, I.O.; Besner, G.E. 2012: Heparin-binding EGF-like growth factor protects pericytes from injury. Journal of Surgical Research 172(1): 165-176
Piltonen, M.; Bespalov, M.M.; Ervasti, D.; Matilainen, T.; Sidorova, Y.A.; Rauvala, H.; Saarma, M.; Männistö, P.T. 2009: Heparin-binding determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons. Experimental Neurology 219(2): 499-506
Martino, Mël.M.; Briquez, P.S.; Ranga, A.; Lutolf, M.P.; Hubbell, J.A. 2013: Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix. Proceedings of the National Academy of Sciences of the United States of America 110(12): 4563-4568
Scuderi, R.; Failla, A. 2008: Heparin-binding epidermal growth factor (HB-EGF): myth or reality?. La Clinica Terapeutica 159(2): 111-116
Hofbauer, R.; Pasching, E.; Moser, D.; Frass, M. 2010: Heparin-binding epidermal growth factor expression in KATO-IIi cells after Helicobacter pylori stimulation under the influence of strychnos Nux vomica and Calendula officinalis. Homeopathy: the Journal of the Faculty of Homeopathy 99(3): 177-182
Taylor, S.R.; Markesbery, M.G.; Harding, P.A. 2014: Heparin-binding epidermal growth factor-like growth factor (HB-EGF) and proteolytic processing by a disintegrin and metalloproteinases (ADAM): a regulator of several pathways. Seminars in Cell and Developmental Biology 28: 22-30
Zhang, X.-H.; Liang, X.; Wang, T.-S.; Liang, X.-H.; Zuo, R.-J.; Deng, W.-B.; Zhang, Z.-R.; Qin, F.-N.; Zhao, Z.-A.; Yang, Z.-M. 2013: Heparin-binding epidermal growth factor-like growth factor (HB-EGF) induction on Snail expression during mouse decidualization. Molecular and Cellular Endocrinology 381(1-2): 272-279
Miyamoto, S.; Yagi, H.; Yotsumoto, F.; Kawarabayashi, T.; Mekada, E. 2008: Heparin-binding epidermal growth factor-like growth factor as a new target molecule for cancer therapy. Advances in Experimental Medicine and Biology 622: 281-295
Lutmer, J.; Watkins, D.; Chen, C.-L.; Velten, M.; Besner, G. 2013: Heparin-binding epidermal growth factor-like growth factor attenuates acute lung injury and multiorgan dysfunction after scald burn. Journal of Surgical Research 185(1): 329-337
Luo, C.-C.; Ming, Y.-C.; Chao, H.-C.; Chu, S.-M.; Pang, S.-T. 2011: Heparin-binding epidermal growth factor-like growth factor downregulates expression of activator protein-1 transcription factor after intestinal ischemia-reperfusion injury. Neonatology 99(4): 241-246
Kim, J.; Keay, S.K.; Freeman, M.R. 2009: Heparin-binding epidermal growth factor-like growth factor functionally antagonizes interstitial cystitis antiproliferative factor via mitogen-activated protein kinase pathway activation. Bju International 103(4): 541-546
El-Assal, O.N.; Paddock, H.; Marquez, A.; Besner, G.E. 2008: Heparin-binding epidermal growth factor-like growth factor gene disruption is associated with delayed intestinal restitution, impaired angiogenesis, and poor survival after intestinal ischemia in mice. Journal of Pediatric Surgery 43(6): 1182-1190
Zhou, Y.; Besner, G.E. 2010: Heparin-binding epidermal growth factor-like growth factor is a potent neurotrophic factor for PC12 cells. Neuro-Signals 18(3): 141-151
Ohnishi, Y.; Inoue, H.; Furukawa, M.; Kakudo, K.; Nozaki, M. 2012: Heparin-binding epidermal growth factor-like growth factor is a potent regulator of invasion activity in oral squamous cell carcinoma. Oncology Reports 27(4): 954-958
Zhang, H-Yi.; Radulescu, A.; Besner, G.E. 2009: Heparin-binding epidermal growth factor-like growth factor is essential for preservation of gut barrier function after hemorrhagic shock and resuscitation in mice. Surgery 146(2): 334-339
Radulescu, A.; Zhang, H.-Y.; Yu, X.; Olson, J.K.; Darbyshire, A.K.; Chen, Y.; Besner, G.E. 2010: Heparin-binding epidermal growth factor-like growth factor overexpression in transgenic mice increases resistance to necrotizing enterocolitis. Journal of Pediatric Surgery 45(10): 1933-1939
Yagi, H.; Yotsumoto, F.; Miyamoto, S. 2008: Heparin-binding epidermal growth factor-like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition. Molecular Cancer Therapeutics 7(10): 3441-3451
Liao, X.; Chen, L.; Fu, W.; Zhou, J. 2013: Heparin-binding epidermal growth factor-like growth factor protects rat intestine after portal triad clamping. Growth Factors 31(2): 74-80
Chen, C.-L.; Yang, J.; James, I.O.A.; Zhang, H.-Y.; Besner, G.E. 2014: Heparin-binding epidermal growth factor-like growth factor restores Wnt/β-catenin signaling in intestinal stem cells exposed to ischemia/reperfusion injury. Surgery 155(6): 1069-1080
Zhang, D.; Zhang, J.; Jiang, X.; Li, X.; Wang, Y.; Ma, J.; Jiang, H. 2014: Heparin-binding epidermal growth factor-like growth factor: a hepatic stellate cell proliferation inducer via ErbB receptors. Journal of Gastroenterology and Hepatology 29(3): 623-632
Olwin, B.B. 1989: Heparin-binding growth factors and their receptors. Cytotechnology 2(4): 351-365
Dessein, R.; Corbière, V.ér.; Nortier, J.ël.; Dratwa, M.; Gastaldello, K.; Pozdzik, A.; Lecher, S.; Grandbastien, B.; Locht, C.; Mascart, F.ço. 2013: Heparin-binding haemagglutinin, a new tool for the detection of latent Mycobacterium tuberculosis infection in hemodialysis patients. Plos one 8(8): E71088
Esposito, C.; Marasco, D.; Delogu, G.; Pedone, E.; Berisio, R. 2011: Heparin-binding hemagglutinin HBHA from Mycobacterium tuberculosis affects actin polymerisation. Biochemical and Biophysical Research Communications 410(2): 339-344
Zheng, Q.; Yang, L.; Yang, J.; Zhou, S.; Zhou, L.; Han, R.; Hao, X.; Ma, Y. 2014: Heparin-binding hemagglutinin enhances Mycobacterium smegmatis infection by inhibiting autophagy in A549 cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 30(7): 696-699; 703
Loxton, A.é G.; Black, G.F.; Stanley, K.; Walzl, G. 2012: Heparin-binding hemagglutinin induces IFN-γ(+) IL-2(+) IL-17(+) multifunctional CD4(+) T cells during latent but not active tuberculosis disease. Clinical and Vaccine Immunology: Cvi 19(5): 746-751
Lund, J.; Søndergaard, M.T.; Conover, C.A.; Overgaard, M.T. 2014: Heparin-binding mechanism of the IGF2/IGF-binding protein 2 complex. Journal of Molecular Endocrinology 52(3): 345-355
Green, J.V.; Orsborn, K.I.; Zhang, M.; Tan, Q.K.G.; Greis, K.D.; Porollo, A.; Andes, D.R.; Long Lu, J.; Hostetter, M.K. 2013: Heparin-binding motifs and biofilm formation by Candida albicans. Journal of Infectious Diseases 208(10): 1695-1704
Kaukonen, K.-M.; Linko, R.; Herwald, H.; Lindbom, L.; Ruokonen, E.; Ala-Kokko, T.; Pettilä, V. 2013: Heparin-binding protein (HBP) in critically ill patients with influenza A(H1N1) infection. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 19(12): 1122-1128
Persson, B.P.; Halldorsdottir, H.; Lindbom, L.; Rossi, P.; Herwald, H.; Weitzberg, E.; Oldner, A. 2014: Heparin-binding protein (HBP/CAP37) - a link to endothelin-1 in endotoxemia-induced pulmonary oedema?. Acta Anaesthesiologica Scandinavica 58(5): 549-559
Beran, O.; Herwald, H.; Dzupová, O.; Chalupa, P.; Holub, M. 2010: Heparin-binding protein as a biomarker of circulatory failure during severe infections: a report of three cases. Scandinavian Journal of Infectious Diseases 42(8): 634-636
Linder, A.; Akesson, P.; Brink, M.; Studahl, M.; Björck, L.; Christensson, B. 2011: Heparin-binding protein: a diagnostic marker of acute bacterial meningitis. Critical Care Medicine 39(4): 812-817
Huttunen, R.; Syrjänen, J. 2010: Heparin-binding protein: a potential biomarker in sepsis?. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 50(2): 283-4; author reply 284-5
Dankiewicz, J.; Linder, A.; Annborn, M.; Rundgren, M.; Friberg, H. 2013: Heparin-binding protein: an early indicator of critical illness and predictor of outcome in cardiac arrest. Resuscitation 84(7): 935-939
Linder, A.; Christensson, B.; Herwald, H.; Björck, L.; Akesson, P. 2009: Heparin-binding protein: an early marker of circulatory failure in sepsis. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 49(7): 1044-1050
Mariscalco, M.M. 2011: Heparin-binding protein: another neutrophil granule protein ... another new biomarker?. Critical Care Medicine 39(4): 910-911
Place, S.; Verscheure, V.; de San, N.; Hougardy, J.-M.; Schepers, K.; Dirix, V.; Dediste, A.; Michel, O.; Drowart, A.; Allard, S.D.; Doherty, T.M.; Lecher, S.; Locht, C.; Mascart, F.ço. 2010: Heparin-binding, hemagglutinin-specific IFN-gamma synthesis at the site of infection during active tuberculosis in humans. American Journal of Respiratory and Critical Care Medicine 182(6): 848-854
Wood, M.D.; Hunter, D.; Mackinnon, S.E.; Sakiyama-Elbert, S.E. 2010: Heparin-binding-affinity-based delivery systems releasing nerve growth factor enhance sciatic nerve regeneration. Journal of Biomaterials Science. Polymer Edition 21(6-7): 771-787
Hougardy, J.-M.; Schepers, K.; Place, S.; Drowart, A.; Lechevin, V.ér.; Verscheure, V.; Debrie, A.-S.; Doherty, T.M.; Van Vooren, J.-P.; Locht, C.; Mascart, F.ço. 2007: Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis. Plos one 2(10): E926
Shah, P.S.; Shah, N. 2014: Heparin-bonded catheters for prolonging the patency of central venous catheters in children. Cochrane Database of Systematic Reviews 2: Cd005983
Anton, N.; Cox, P.N.; Massicotte, M.P.; Chait, P.; Yasui, Y.; Dinyari, P.M.; Marzinotto, V.; Mitchell, L.G. 2009: Heparin-bonded central venous catheters do not reduce thrombosis in infants with congenital heart disease: a blinded randomized, controlled trial. Pediatrics 123(3): E453-E458
Lammer, J.; Zeller, T.; Hausegger, K.A.; Schaefer, P.J.; Gschwendtner, M.; Mueller-Huelsbeck, S.; Rand, T.; Funovics, M.; Wolf, F.; Rastan, A.; Gschwandtner, M.; Puchner, S.; Ristl, R.; Schoder, M. 2013: Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease). Journal of the American College of Cardiology 62(15): 1320-1327
Daenens, K.; Schepers, S.; Fourneau, I.; Houthoofd, S.; Nevelsteen, A.é 2009: Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results. Journal of Vascular Surgery 49(5): 1210-1216
Lösel-Sadée, H.; Alefelder, C. 2009: Heparin-bonded expanded polytetrafluoroethylene graft for infragenicular bypass: five-year results. Journal of Cardiovascular Surgery 50(3): 339-343
Dorrucci, V.; Griselli, F.; Petralia, G.; Spinamano, L.; Adornetto, R. 2008: Heparin-bonded expanded polytetrafluoroethylene grafts for infragenicular bypass in patients with critical limb ischemia: 2-year results. Journal of Cardiovascular Surgery 49(2): 145-149
Saxon, R.R.; Chervu, A.; Jones, P.A.; Bajwa, T.K.; Gable, D.R.; Soukas, P.A.; Begg, R.J.; Adams, J.G.; Ansel, G.M.; Schneider, D.B.; Eichler, C.M.; Rush, M.J. 2013: Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) trial. Journal of Vascular and Interventional Radiology: Jvir 24(2): 165-173; Quiz 174
Park, T.-J.; Lee, S.-H.; Simmons, T.J.; Martin, J.G.; Mousa, S.A.; Snezhkova, E.A.; Sarnatskaya, V.V.; Nikolaev, V.G.; Linhardt, R.J. 2008: Heparin-cellulose-charcoal composites for drug detoxification prepared using room temperature ionic liquids. Chemical Communications 40: 5022-5024
Thomas, A.M.; Gomez, A.J.; Palma, J.L.; Yap, W.Teck.; Shea, L.D. 2014: Heparin-chitosan nanoparticle functionalization of porous poly(ethylene glycol) hydrogels for localized lentivirus delivery of angiogenic factors. Biomaterials 35(30): 8687-8693
Sun, X.-j.; Peng, W.; Yang, Z.-l.; Ren, M.-l.; Zhang, S.-c.; Zhang, W.-g.; Zhang, L.-y.; Xiao, K.; Wang, Z.-g.; Zhang, B.; Wang, J. 2011: Heparin-chitosan-coated acellular bone matrix enhances perfusion of blood and vascularization in bone tissue engineering scaffolds. Tissue Engineering. Part a 17(19-20): 2369-2378
Hein, E.; Munthe-Fog, L.; Thiara, A.S.; Fiane, A.E.; Mollnes, T.E.; Garred, P. 2015: Heparin-coated cardiopulmonary bypass circuits selectively deplete the pattern recognition molecule ficolin-2 of the lectin complement pathway in vivo. Clinical and Experimental Immunology 179(2): 294-299
Argyo, C.; Cauda, V.; Engelke, H.; Rädler, J.; Bein, G.; Bein, T. 2012: Heparin-coated colloidal mesoporous silica nanoparticles efficiently bind to antithrombin as an anticoagulant drug-delivery system. Chemistry 18(2): 428-432
Mirow, N.; Zittermann, A.; Koertke, H.; Maleszka, A.; Knobl, H.; Coskun, T.; Kleesiek, K.; Koerfer, R. 2008: Heparin-coated extracorporeal circulation in combination with low dose systemic heparinization reduces early postoperative blood loss in cardiac surgery. Journal of Cardiovascular Surgery 49(2): 277-284
Tagarakis, G.I.; Tsilimingas, N.B. 2009: Heparin-coated extracorporeal circulation systems in heart surgery. Recent Patents on Cardiovascular Drug Discovery 4(3): 177-179
Sun, I-Cheol.; Eun, D-Kyung.; Na, J.Hee.; Lee, S.; Kim, I-Jin.; Youn, I-Chan.; Ko, C-Yong.; Kim, H-Sung.; Lim, D.; Choi, K.; Messersmith, P.B.; Park, T.Gwan.; Kim, S.Yoon.; Kwon, I.Chan.; Kim, K.; Ahn, C-Hee. 2009: Heparin-coated gold nanoparticles for liver-specific CT imaging. Chemistry 15(48): 13341-13347
Evenepoel, P.; Dejagere, T.; Verhamme, P.; Claes, K.; Kuypers, D.; Bammens, B.; Vanrenterghem, Y. 2007: Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 49(5): 642-649
Sherman, K.L.; Obi, S.H.; Aranha, G.V.; Yao, K.A.; Shoup, M.C. 2009: Heparin-coated stents do not protect cancer patients from cardiac complications after noncardiac surgery. American Surgeon 75(1): 61-65
Lee, J.-h.; Jung, M.J.; Hwang, Y.H.; Lee, Y.J.; Lee, S.; Lee, D.Y.; Shin, H. 2012: Heparin-coated superparamagnetic iron oxide for in vivo MR imaging of human MSCs. Biomaterials 33(19): 4861-4871
Jung, M.Jin.; Ha, Y.Eun.; Lee, D.Yun. 2011: Heparin-coated superparamagnetic iron oxide nanoparticles as highly effective MRI contrast agent for cell labeling. Journal of Controlled Release: Official Journal of the Controlled Release Society 152 Suppl. 1: E214-E215
Yang, H.S.; La, W.-G.; Bhang, S.H.; Jeon, J.-Y.; Lee, J.H.; Kim, B.-S. 2010: Heparin-conjugated fibrin as an injectable system for sustained delivery of bone morphogenetic protein-2. Tissue Engineering. Part a 16(4): 1225-1233
Joung, Y.K.; Jang, J.Y.; Choi, J.H.; Han, D.K.; Park, K.D. 2013: Heparin-conjugated pluronic nanogels as multi-drug nanocarriers for combination chemotherapy. Molecular Pharmaceutics 10(2): 685-693
La, W.-G.; Yang, H.S. 2015: Heparin-conjugated poly(lactic-co-glycolic acid) nanospheres enhance large-wound healing by delivering growth factors in platelet-rich plasma. Artificial Organs 39(4): 388-394
Jeon, O.; Yang, H.S.; Lee, T.-J.; Kim, B.-S. 2008: Heparin-conjugated polyethylenimine for gene delivery. Journal of Controlled Release: Official Journal of the Controlled Release Society 132(3): 236-242
Kuo, Y.-C.; Tsai, Y.-T. 2011: Heparin-conjugated scaffolds with pore structure of inverted colloidal crystals for cartilage regeneration. Colloids and Surfaces. B Biointerfaces 82(2): 616-623
Go, D.H.; Joung, Y.K.; Park, S.Y.; Park, Y.D.; Park, K.D. 2008: Heparin-conjugated star-shaped PLA for improved biocompatibility. Journal of Biomedical Materials Research. Part a 86(3): 842-848
Xu, X.; Jha, A.K.; Duncan, R.L.; Jia, X. 2011: Heparin-decorated, hyaluronic acid-based hydrogel particles for the controlled release of bone morphogenetic protein 2. Acta Biomaterialia 7(8): 3050-3059
Lai, J.-P.; Thompson, J.R.; Sandhu, D.S.; Roberts, L.R. 2008: Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets. Future Oncology 4(6): 803-814
Bream-Rouwenhorst, H.R.; Hobbs, R.A. 2008: Heparin-dependent antibodies and thrombosis without heparin-induced thrombocytopenia. PharmacoTherapy 28(11): 1401-1407
Parker, R.I. 2007: Heparin-dependent platelet antibodies in children: problem or merely problematic?. Pediatric Critical Care Medicine: a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 8(4): 404-405
Perry, S.L.; Whitlatch, N.L.; Ortel, T.L. 2009: Heparin-dependent platelet factor 4 antibodies and the impact of renal function on clinical outcomes: a retrospective study in hospitalized patients. Journal of Thrombosis and Thrombolysis 28(2): 146-150
Hubbard, B.; Buczek-Thomas, J.A.; Nugent, M.A.; Smith, M.L. 2014: Heparin-dependent regulation of fibronectin matrix conformation. Matrix Biology: Journal of the International Society for Matrix Biology 34: 124-131
Casu, B.; Naggi, A.; Torri, G. 2010: Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer. Matrix Biology: Journal of the International Society for Matrix Biology 29(6): 442-452
Hughes, E.; Edwards, R.; Middleton, D.A. 2010: Heparin-derived oligosaccharides interact with the phospholamban cytoplasmic domain and stimulate SERCA function. Biochemical and Biophysical Research Communications 401(3): 370-375
Ahmed, T.; Smith, G.; Abraham, W.M. 2014: Heparin-derived supersulfated disaccharide inhibits allergic airway responses in sheep. Pulmonary Pharmacology and Therapeutics 28(1): 77-86
Golembiewski, J. 2008: Heparin-focus on safety. Journal of Perianesthesia Nursing: Official Journal of the American Society of Perianesthesia Nurses 23(4): 276-278
Tran, T.H.; Bae, B.-c.; Lee, Y.-k.; Na, K.; Huh, K.M. 2013: Heparin-folate-retinoic acid bioconjugates for targeted delivery of hydrophobic photosensitizers. Carbohydrate Polymers 92(2): 1615-1624
Gümüşderelioğlu, M.şe.; Aday, S. 2011: Heparin-functionalized chitosan scaffolds for bone tissue engineering. Carbohydrate Research 346(5): 606-613
Ho, Y.-C.; Mi, F.-L.; Sung, H.-W.; Kuo, P.-L. 2009: Heparin-functionalized chitosan-alginate scaffolds for controlled release of growth factor. International Journal of Pharmaceutics 376(1-2): 69-75
Wu, J.M.; Xu, Y.Y.; Li, Z.H.; Yuan, X.Y.; Wang, P.F.; Zhang, X.Z.; Liu, Y.Q.; Guan, J.; Guo, Y.; Li, R.X.; Zhang, H. 2011: Heparin-functionalized collagen matrices with controlled release of basic fibroblast growth factor. Journal of Materials Science. Materials in Medicine 22(1): 107-114
Fernàndez-Busquets, X. 2013: Heparin-functionalized nanocapsules: enabling targeted delivery of antimalarial drugs. Future Medicinal Chemistry 5(7): 737-739
Liang, Y.; Kiick, K.L. 2014: Heparin-functionalized polymeric biomaterials in tissue engineering and drug delivery applications. Acta Biomaterialia 10(4): 1588-1600
Arisaka, Y.; Kobayashi, J.; Yamato, M.; Akiyama, Y.; Okano, T. 2013: Heparin-functionalized thermoresponsive surface: a versatile cell culture substrate for regulating multivalent affinity binding with heparin-binding proteins by temperature changes. Organogenesis 9(3): 125-127
Duo, J.; Stenken, J.A. 2011: Heparin-immobilized microspheres for the capture of cytokines. Analytical and Bioanalytical Chemistry 399(2): 773-782
Gong, F.; Cheng, X.; Wang, S.; Zhao, Y.; Gao, Y.; Cai, H. 2010: Heparin-immobilized polymers as non-inflammatory and non-thrombogenic coating materials for arsenic trioxide eluting stents. Acta Biomaterialia 6(2): 534-546
Socher, I.; Kroll, H.; Jorks, S.; Santoso, S.; Sachs, U.J.H. 2008: Heparin-independent activation of platelets by heparin-induced thrombocytopenia antibodies: a common occurrence. Journal of Thrombosis and Haemostasis: Jth 6(1): 197-200
Padmanabhan, A.; Jones, C.G.; Bougie, D.W.; Curtis, B.R.; McFarland, J.G.; Wang, D.; Aster, R.H. 2015: Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis. Blood 125(1): 155-161
Leone, S.; Zuccoli, M.L.; Fucile, C.; Storace, S.; Martelli, A.; Mattioli, F. 2012: Heparin-induced acute adverse reaction--case report of a patient with acute trauma and a genetic predisposition to thrombotic events: a concurrence of events. Journal of Clinical Pharmacy and Therapeutics 37(6): 733-735
Warkentin, T.E.; Greinacher, A. 2009: Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes. Expert Opinion on Drug Safety 8(2): 129-144
Foreman, J.S.; Daniels, L.M.; Stettner, E.A. 2014: Heparin-induced anaphylactoid reaction associated with heparin-induced thrombocytopenia in the ED. American Journal of Emergency Medicine 32(12): 1559.E5-6
Asmis, L.M.; Segal, J.B.; Plantinga, L.C.; Fink, N.E.; Kerman, J.S.; Kickler, T.S.; Coresh, J.; Gardner, L.B. 2008: Heparin-induced antibodies and cardiovascular risk in patients on dialysis. Thrombosis and Haemostasis 100(3): 498-504
Choudhry, S.; Fishman, P.M.; Hernandez, C. 2013: Heparin-induced bullous hemorrhagic dermatosis. Cutis 91(2): 93-98
Stanley, F.E.; Warner, A.M.; McWilliams, K.M.; Stalcup, A.M. 2011: Heparin-induced circular dichroism of an achiral, bicyclic species. Chirality 23(1): 84-92
Stanley, F.E.; Warner, A.M.; Gutierrez, S.M.; Stalcup, A.M. 2009: Heparin-induced circular dichroism of chloroquine. Biochemical and Biophysical Research Communications 388(1): 28-30
Roux, J.; Duong, T.A.; Ingen-Housz-Oro, S.; Valeyrie-Allanore, L.; Ortonne, N.; Chosidow, O.; Wolkenstein, P. 2013: Heparin-induced hemorrhagic blisters. European Journal of Dermatology: Ejd 23(1): 105-107
Thomas, C.M.; Thomas, J.; Smeeton, F.; Leatherdale, B.A. 2008: Heparin-induced hyperkalemia. Diabetes Research and Clinical Practice 80(2): E7-E8
Cho, R.; Leclaire, M.; Kempainen, R. 2013: Heparin-induced hyperkalemia in a patient diagnosed with thyroid storm. Annals of PharmacoTherapy 47(9): 1213-1217
Shimokaze, T.; Akaba, K.; Saito, E. 2014: Heparin-induced hyperkalemia in an extremely-low-birth-weight infant: a case report. Journal of Clinical Research in Pediatric Endocrinology 6(2): 125-128
Zhang, S.; Condac, E.; Qiu, H.; Jiang, J.; Gutierrez-Sanchez, G.; Bergmann, C.; Handel, T.; Wang, L. 2012: Heparin-induced leukocytosis requires 6-O-sulfation and is caused by blockade of selectin- and CXCL12 protein-mediated leukocyte trafficking in mice. Journal of Biological Chemistry 287(8): 5542-5553
Galea, V.; Khaterchi, A.; Robert, F.; Gerotziafas, G.; Hatmi, M.; Elalamy, I. 2013: Heparin-induced multiple electrode aggregometry is a promising and useful functional tool for heparin-induced thrombocytopenia diagnosis: confirmation in a prospective study. Platelets 24(6): 441-447
Elalamy, I.; Galea, V.; Hatmi, M.; Gerotziafas, G.T. 2009: Heparin-induced multiple electrode aggregometry: a potential tool for improvement of heparin-induced thrombocytopenia diagnosis. Journal of Thrombosis and Haemostasis: Jth 7(11): 1932-1934
Schindewolf, M.; Kroll, H.; Ackermann, H.; Garbaraviciene, J.; Kaufmann, R.; Boehncke, W.-H.; Ludwig, R.J.; Lindhoff-Last, E. 2010: Heparin-induced non-necrotizing skin lesions: rarely associated with heparin-induced thrombocytopenia. Journal of Thrombosis and Haemostasis: Jth 8(7): 1486-1491
Le Templier, G.; Rodger, M.A. 2008: Heparin-induced osteoporosis and pregnancy. Current Opinion in Pulmonary Medicine 14(5): 403-407
Sator, P.; Kiprov, A.; Feldmann, R.; Breier, F.; Steiner, A. 2016: Heparin-induced skin necrosis. Journal of the European Academy of Dermatology and Venereology: Jeadv 30(1): 161-163
Bertrand, P.-M.; Perbet, S.éb.; Sapin, A.-F.ço.; Salavert, M.; Constantin, J.-M.; Elalamy, I.; Bazin, J.-E. 2011: Heparin-induced skin necrosis: HIT-2 without thrombocytopenia. Intensive Care Medicine 37(1): 172-173
Nowicka, A.; Kandziora, M.; Szymanowska, K.; Michalski, M.; Piatkowska, A.; Biegalski, W.; Dankowski, Rł.; Poprawski, K.; Wierzchowiecki, Mł. 2008: Heparin-induced thrombocythopenia in a patient with massive pulmonary embolism and dilated cardiomyopathy, successfuly treated with fondaparinux - a case report. Kardiologia Polska 66(12): 1306-1308
Gounden, R.; Blockman, M. 2008: Heparin-induced thrombocytopaenia. Cardiovascular Journal of Africa 19(6): 325-327
Dave, P.A. 2009: Heparin-induced thrombocytopaenia/thrombosis: a clinicopathologic review. East African Medical Journal 86(12 Suppl): S62-S70
Warkentin, T.E. 2007: Heparin-induced thrombocytopenia. Hematology/Oncology Clinics of North America 21(4): 589-607 V
Unkle, D.W. 2007: Heparin-induced thrombocytopenia. Orthopedic Nursing 26(6): 383-385; Quiz: 386-387
Greinacher, A. 2009: Heparin-induced thrombocytopenia. Journal of Thrombosis and Haemostasis: Jth 7(Suppl 1): 9-12
Arepally, G.M.; Ortel, T.L. 2010: Heparin-induced thrombocytopenia. Annual Review of Medicine 61: 77-90
Szokol, J.W. 2010: Heparin-induced thrombocytopenia. Seminars in Cardiothoracic and Vascular Anesthesia 14(1): 73-74
Shaikh, N. 2011: Heparin-induced thrombocytopenia. Journal of Emergencies Trauma and Shock 4(1): 97-102
Greinacher, A.; Fürll, B.; Selleng, S. 2013: Heparin-induced thrombocytopenia. Methods in Molecular Biology 992: 301-318
Lovecchio, F. 2014: Heparin-induced thrombocytopenia. Clinical Toxicology 52(6): 579-583
Nowak, G.öt. 2009: Heparin-induced thrombocytopenia (HIT II) - a drug-associated autoimmune disease. Thrombosis and Haemostasis 102(5): 887-891
Al-Lamee, R.K.; Gerber, R.T.; Kooner, J.S. 2010: Heparin-induced thrombocytopenia (HIT) as an unusual cause of acute stent thrombosis. European Heart Journal 31(5): 613
Lammering, J.C.; Wang, D.S.; Shin, L.K. 2012: Heparin-induced thrombocytopenia (HIT) causing portosplenic, superior mesenteric, and splenic vein thrombosis resulting in splenic rupture and pulmonary emboli formation. Clinical Imaging 36(6): 865-868
Jiji, R.S.; Michaels, A.D. 2008: Heparin-induced thrombocytopenia (HIT) causing pulmonary emboli during coronary intervention. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 72(6): 819-822
Wang, J.-Y.; Jin, X.; Zhang, X.; Li, X.-F. 2018: CC-223 inhibits human head and neck squamous cell carcinoma cell growth. Biochemical and Biophysical Research Communications 496(4): 1191-1196
Cuker, A. 2011: Heparin-induced thrombocytopenia (HIT) in 2011: an epidemic of overdiagnosis. Thrombosis and Haemostasis 106(6): 993-994
Szromba, C. 2010: Heparin-induced thrombocytopenia (HIT) in patients on hemodialysis: an update. Nephrology Nursing Journal: Journal of the American Nephrology Nurses' Association 37(2): 185-187
Baroletti, S.; Piovella, C.; Fanikos, J.; Labreche, M.; Lin, J.; Goldhaber, S.Z. 2008: Heparin-induced thrombocytopenia (HIT): clinical and economic outcomes. Thrombosis and Haemostasis 100(6): 1130-1135
Beyer, J.; Halbritter, K.; Weise, M.; Leonhard, J.; Schellong, S. 2007: Heparin-induced thrombocytopenia II-induced critical limb ischaemia treated with urokinase and argatroban. Thrombosis and Haemostasis 98(2): 470-472
de Bree, L.Charlotte.J.; Alings, A.Marco.W.; van Wijngaarden, P. 2014: Heparin-induced thrombocytopenia after ICD-lead flushing. Acta Cardiologica 69(2): 197-199
Thakur, S.; Pigott, J.P.; Comerota, A.J. 2009: Heparin-induced thrombocytopenia after implantation of a heparin-bonded polytetrafluoroethylene lower extremity bypass graft: A case report and plan for management. Journal of Vascular Surgery 49(4): 1037-1040
Kigawa, I.; Okamura, Y.; Fukuda, S.; Miyairi, T. 2010: Heparin-induced thrombocytopenia after on-pump coronary artery bypass grafting. Kyobu Geka. Japanese Journal of Thoracic Surgery 63(6): 442-445
Ma, Y.-t.; Ma, X.; Yang, Y.-n. 2008: Heparin-induced thrombocytopenia after percutaneous balloon mitral valvuloplasty. Zhonghua Xin Xue Guan Bing Za Zhi 36(7): 617
Levy, J.H.; Winkler, A.M. 2010: Heparin-induced thrombocytopenia and cardiac surgery. Current Opinion in Anaesthesiology 23(1): 74-79
Durand, M.; Lecompte, T.; Hacquard, M.; Carteaux, J.-P. 2008: Heparin-induced thrombocytopenia and cardiopulmonary bypass: anticoagulation with unfractionated heparin and the GPIIb/IIIa inhibitor tirofiban and successful use of rFVIIa for post-protamine bleeding due to persistent platelet blockade. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 34(3): 687-689
Fesler, M.J.; Creer, M.H.; Richart, J.M.; Edgell, R.; Havlioglu, N.; Norfleet, G.; Cruz-Flores, S. 2011: Heparin-induced thrombocytopenia and cerebral venous sinus thrombosis: case report and literature review. Neurocritical Care 15(1): 161-165
Shah, S.D.; Shah, C.; Vora, R. 2010: Heparin-induced thrombocytopenia and cerebral venous thrombosis after low-molecular weight heparin. Neurology India 58(4): 669-670
Wang, J.-h.; Wang, C.-y.; Chen, X. 2012: Heparin-induced thrombocytopenia and crossreactivity study between anti-heparin/platelet factor 4 -antibody and low molecular weight heparin. Zhonghua Xue Ye Xue Za Zhi 33(7): 584-586
Okamura, K.; Kitajima, K.; Maeyama, T.; Fukuyama, S.; Inoue, H.; Nakanishi, Y. 2010: Heparin-induced thrombocytopenia and disseminated intravascular coagulation in a patient with drug-induced pneumonia. Nihon Kokyuki Gakkai Zasshi 48(2): 157-161
Pollak, U.; Yacobobich, J.; Tamary, H.; Dagan, O.; Manor-Shulman, O. 2011: Heparin-induced thrombocytopenia and extracorporeal membrane oxygenation: a case report and review of the literature. Journal of Extra-Corporeal Technology 43(1): 5-12
Liodakis, E.; Hildebrand, F.; Frink, M.; Mommsen, P.; Krettek, C.; Probst, C. 2009: Heparin-induced thrombocytopenia and liver hemorrhage following polytrauma. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 80(9): 872-874
Filis, K.; Lagoudianakis, E.E.; Pappas, A.; Kotzadimitriou, K.; Genetzakis, M.; Sigala, F.; Theodorou, D.; Manouras, A. 2008: Heparin-induced thrombocytopenia and phlegmasia cerulea dolens of the upper limb successfully treated with fondaparinux. Acta Haematologica 120(3): 190-191
Coventry, D.A.; Webster, N.R. 2014: Heparin-induced thrombocytopenia and the health economic analysis of argatroban. British Journal of Anaesthesia 112(6): 964-967
Khan, M.M.; Noble, D.W.; Watson, H.G. 2011: Heparin-induced thrombocytopenia and the utility of the 4Ts score in the Intensive Care Unit. British Journal of Haematology 152(5): 672-674
Tessler, O.; Vorstenbosch, J.; Jones, D.; Lalonde, S.; Zadeh, T. 2014: Heparin-induced thrombocytopenia and thrombosis as an under-diagnosed cause of flap failure in heparin-naive patients: a case report and systematic review of the literature. Microsurgery 34(2): 157-163
Kaiber, Fávia.Larissa.; Malucelli, T.Osternack.; Baroni, Eína.do.Rocio.Valenga.; Schafranski, M.Derbly.; Akamatsu, Hélcio.Takeshi.; Schmidt, C.Cecília.Finkler. 2010: Heparin-induced thrombocytopenia and warfarin-induced skin necrosis: case report. Anais Brasileiros de Dermatologia 85(6): 915-918
Pannicke, N.; Pollok, J.-M.; Kluge, S.; Petzoldt, M. 2012: Heparin-induced thrombocytopenia associated with acute liver graft failure. BMJ Case Reports
Chong, B.H.; Chong, J.J.H. 2010: Heparin-induced thrombocytopenia associated with fondaparinux. Clinical Advances in Hematology and Oncology: H&o 8(1): 63-65
Tsai, H.C.; Yen, H.C.; Hsu, J.C.; Lin, C.L. 2009: Heparin-induced thrombocytopenia associated with intra-tumour haemorrhage in cavernous sinus after cardiac myxoma surgery. British Journal of Neurosurgery 23(1): 95-96
Ahmed, A.; Al-Mondhiry, H.; Milling, T.J.; Campbell, D. 2012: Heparin-induced thrombocytopenia associated with massive intracardiac thrombosis: a case report. Case Reports in Hematology 2012: 257023
Mumoli, N.; Cei, M. 2010: Heparin-induced thrombocytopenia associated with pulmonary embolism. Clinical Cardiology 33(2): E65-E67
Studt, J.-D.; Binet, I.; Nair, G.; Schanz, U. 2013: Heparin-induced thrombocytopenia associated with thrombotic microangiopathy. Hamostaseologie 33(2): 160-163
Altoijry, A.; MacKenzie, K.S.; Corriveau, M.-M.; Obrand, D.I.; Abraham, C.Z.; Steinmetz, O.K. 2015: Heparin-induced thrombocytopenia causing graft thrombosis and bowel ischemia postendovascular aneurysm repair. Journal of Vascular Surgery 61(1): 234-236
Howard-Thompson, A.; Usery, J.B.; Lobo, B.L.; Finch, C.K. 2008: Heparin-induced thrombocytopenia complicated by warfarin-induced skin necrosis. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 65(12): 1144-1147
Barginear, M.F.; Donahue, L.; Allen, S.L.; Budman, D.R.; Bradley, T.; Bhaskaran, M.; Shapira, I. 2008: Heparin-induced thrombocytopenia complicating hemodialysis. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 14(1): 105-107
Chan, K.Ming.; Cheung, C.Yuen.; Chau, K.Foon. 2014: Heparin-induced thrombocytopenia due to heparin lock in a hemodialysis patient: a case report. Hemodialysis International. International Symposium on Home Hemodialysis 18(2): 555-558
Welp, H.; Ellger, B.ör.; Scherer, M.; Lanckohr, C.; Martens, S.; Gottschalk, A. 2014: Heparin-induced thrombocytopenia during extracorporeal membrane oxygenation. Journal of Cardiothoracic and Vascular Anesthesia 28(2): 342-344
Davenport, A. 2004: Heparin-induced thrombocytopenia during renal replacement therapy. Hemodialysis International. International Symposium on Home Hemodialysis 8(3): 295-303
Davenport, A. 2008: Heparin-induced thrombocytopenia during renal replacement therapy in the intensive care unit. Critical Care 12(3): 158
Wang, J.; Dong, X.; Xin, Y.; Xu, P.; Xue, Y.; Wang, L.; Wang, Y.; Wang, C.; Chen, X.; Guan, Y.; Liu, J.; Chang, Y.; Gao, X.; Jin, Y.; Zhang, Y.; Li, X.; Dai, H. 2013: Heparin-Induced Thrombocytopenia in Chinese Patients: 240 Patients Study in One Center. Clinical Laboratory 2013(7-8): 10.7754/Clin.Lab.2012.120701
Nitta, N.; Shitara, S.; Nozaki, K. 2011: Heparin-induced thrombocytopenia in a glioblastoma multiforme patient with inferior vena cava filter placement for deep venous thrombosis. Neurologia Medico-Chirurgica 51(6): 445-448
Busche, M.N.; Peters, T.; Knobloch, K.; Vogt, P.M.; Rennekampff, H.-O. 2009: Heparin-induced thrombocytopenia in a nonthrombocytopenic patient with toxic epidermal necrolysis causing fatal outcome: is HIT still a HIT?. Journal of Burn Care and Research: Official Publication of the American Burn Association 30(4): 747-751
Ratuapli, S.K.; Bobba, B.; Zafar, H. 2010: Heparin-induced thrombocytopenia in a patient treated with fondaparinux. Clinical Advances in Hematology and Oncology: H&o 8(1): 61-65
Koul, A.N.; Ahad, R. 2013: Heparin-induced thrombocytopenia in a patient with colon cancer. Indian Journal of Medical and Paediatric Oncology: Official Journal of Indian Society of Medical and Paediatric Oncology 34(4): 336-337
Doboszyńska, A.; Rozek, M.; Swietlik, E.; Tomaszewska, I. 2007: Heparin-induced thrombocytopenia in a patient with lung embolism and left-sided pneumonia: a case report. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 58 Suppl. 5(Pt 1): 135-139
Matsuo, T.; Kusano, H.; Wanaka, K.; Ishihara, M.; Oyama, A. 2007: Heparin-induced thrombocytopenia in a uremic patient requiring hemodialysis: an alternative treatment and reexposure to heparin. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 13(2): 182-187
Peteja, M.; Chmelo, J.; Zuchnická, J.; Zonča, P.; Mazur, M. 2013: Heparin-induced thrombocytopenia in a patient with acute thrombosis, acute aortic dissection and acute lower limb ischaemia. Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 92(11): 650-653
Miriovsky, B.J.; Ortel, T.L. 2011: Heparin-induced thrombocytopenia in cancer. Journal of the National Comprehensive Cancer Network: Jnccn 9(7): 781-787
Yoon, J.H.; Jang, I.-K. 2011: Heparin-induced thrombocytopenia in cardiovascular patients: pathophysiology, diagnosis, and treatment. Cardiology in Review 19(3): 143-153
Murawaki, A.; Nakayasu, H.; Doi, M.; Suzuki-Kinoshita, K.; Asai, Y.; Omura, H.; Nakashima, K. 2012: Heparin-induced thrombocytopenia in essential thrombocytosis. Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association 21(8): 916.E1
Quiñones-Ortiz, L.; Suárez-Laurés, A.; Pablos-de Pablo, M.; Robles, V.ón.; Calzón-Blanco, C.; Quiñones-Pérez, S.; Ayausty-Ruiz, A. 2014: Heparin-induced thrombocytopenia in haemodialysis treated with argatroban. Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 34(5): 670-674
Schroder, J.N.; Daneshmand, M.A.; Villamizar, N.R.; Petersen, R.P.; Blue, L.J.; Welsby, I.J.; Lodge, A.J.; Ortel, T.L.; Rogers, J.G.; Milano, C.A. 2007: Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients. Annals of Thoracic Surgery 84(3): 841
Warkentin, T.E.; Sheppard, J.-A.I.; Heels-Ansdell, D.; Marshall, J.C.; McIntyre, L.; Rocha, M.G.; Mehta, S.; Davies, A.R.; Bersten, A.D.; Crozier, T.M.; Ernest, D.; Vlahakis, N.E.; Hall, R.I.; Wood, G.G.; Poirier, G.; Crowther, M.A.; Cook, D.J. 2013: Heparin-induced thrombocytopenia in medical surgical critical illness. Chest 144(3): 848-858
Limaye, K.; Ravilla, R.; Boye, B.; Sahaya, K.; Motwani, P. 2014: Heparin-induced thrombocytopenia in patients receiving plasma exchange. American Journal of Medicine 127(12): E3-E4
Selleng, S.; Selleng, K.; Wollert, H.-G.; Muellejans, B.; Lietz, T.; Warkentin, T.E.; Greinacher, A. 2008: Heparin-induced thrombocytopenia in patients requiring prolonged intensive care unit treatment after cardiopulmonary bypass. Journal of Thrombosis and Haemostasis: Jth 6(3): 428-435
Randi, M.L.; Tezza, F.; Scapin, M.; Duner, E.; Scarparo, P.; Scandellari, R.; Fabris, F. 2010: Heparin-induced thrombocytopenia in patients with Philadelphia-negative myeloproliferative disorders and unusual splanchnic or cerebral vein thrombosis. Acta Haematologica 123(3): 140-145
Warkentin, T.E.; Greinacher, A.; Koster, A. 2009: Heparin-induced thrombocytopenia in patients with ventricular assist devices: are new prevention strategies required?. Annals of Thoracic Surgery 87(5): 1633-1640
Knobloch, K.; Gohritz, A.; Redeker, J.; Vogt, P.M. 2008: Heparin-induced thrombocytopenia in plastic surgery: do we take care enough?. Plastic and Reconstructive Surgery 122(5): 1592-1593
Battistelli, S.; Genovese, A.; Gori, T. 2010: Heparin-induced thrombocytopenia in surgical patients. American Journal of Surgery 199(1): 43-51
Warkentin, T.E. 2012: Heparin-induced thrombocytopenia in the ICU: a transatlantic perspective. Chest 142(4): 815-816
Sakr, Y. 2011: Heparin-induced thrombocytopenia in the ICU: an overview. Critical Care 15(2): 211
Rice, L. 2011: Heparin-induced thrombocytopenia in the cardiac patient: 10 points to help the physician. Methodist Debakey Cardiovascular Journal 7(4): 6-9
Crowther, M.; Cook, D.; Guyatt, G.; Zytaruk, N.; McDonald, E.; Williamson, D.; Albert, M.; Dodek, P.; Finfer, S.; Vallance, S.; Heels-Ansdell, D.; McIntyre, L.; Mehta, S.; Lamontagne, F.; Muscedere, J.; Jacka, M.; Lesur, O.; Kutsiogiannis, J.; Friedrich, J.; Klinger, J.R.; Qushmaq, I.; Burry, L.; Khwaja, K.; Sheppard, J.-A.; Warkentin, T.E.; Cook, D.; McDonald, E.; Tkaczyk, A.; Clarke, F.; Wallace, C.; Hall, R.; Rocker, G.; Julien, L.; Wright, D.; Roy, C.; Theriault, J.; Pleasance, S.; Snow, D.; Herbert, S.; Meade, M.; Hand, L.; Biljan, M.; Freitag, A.; Wynne, C.; Duffett, M.; Kho, M.; Zytaruk, N.; Currie, K.; Granton, J.; Matte, A.; Farias, P.; Chu, L.; Brockest, N.; Go, S.; McGrath-Chong, M.; Dennis, M.; Lipkus, M.; Stern, E.; Albert, R.; 2014: Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trial. Journal of Critical Care 29(3): 470.E7
Argudín, M.A.; Deplano, A.; Vandendriessche, S.; Dodémont, M.; Nonhoff, C.; Denis, O.; Roisin, S. 2018: CC398 Staphylococcus aureus subpopulations in Belgian patients. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 37(5): 911-916
Wheatcroft, M.D.; Greco, E.; Tse, L.; Roche-Nagle, G. 2011: Heparin-induced thrombocytopenia in the presence of a heparin-bonded bypass graft. Vascular 19(6): 338-341
Frykberg, R.G.; Gordon, S.; Tierney, E.; Tallis, A. 2013: Heparin-induced thrombocytopenia in the setting of perioperative bridging for podiatric surgery: a case report. Journal of the American Podiatric Medical Association 103(1): 67-72
Sugimoto, T.; Matsuo, T.; Wanaka, K. 2010: Heparin-induced thrombocytopenia in two patients undergoing abdominal aortic aneurysm surgery. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 16(1): 110-114
Medina, N.D.; Mehan, V.; Schmidt, S.T. 2010: Heparin-induced thrombocytopenia leading to flap failure: Hirudo medicinalis and implications. Plastic and Reconstructive Surgery 125(5): 217e-219e
Nazliel, B.; Batur Caglayan, H.Z.; Yildirim Capraz, I.; Irkec, C.; Yagci, M.; Gesoglu, T. 2014: Heparin-induced thrombocytopenia leading to stroke, lower extremity arterial occlusive disease, and skin necrosis: a case report. Platelets 25(2): 129-131
Djunić, I.; Tomin, D.; Antonijević, N.; Gradinac, S.; Kovac, M.; Vidović, A.; Djurasinović, V.; Elezović, I. 2009: Heparin-induced thrombocytopenia occurring after surgical treatment of atrial myxoma--a case report. Srpski Arhiv Za Celokupno Lekarstvo 137(9-10): 540-544
Marinella, M.A. 2007: Heparin-induced thrombocytopenia presenting as otalgia. Southern Medical Journal 100(10): 1057
Takemoto, C.M.; Streiff, M.B. 2011: Heparin-induced thrombocytopenia screening and management in pediatric patients. HEMATOLOGY. American Society of Hematology. Education Program 2011: 162-169
Seldrum, S.; Lambert, M.; Hainaut, P. 2009: Heparin-induced thrombocytopenia successfully treated with fondaparinux. Acta Clinica Belgica 64(2): 144-146
Lasocki, S.; Ajzenberg, N.; Quintard, H.é; Plantefève, G.; Desmonts, J.-M.; Montravers, P. 2007: Heparin-induced thrombocytopenia suspected because of repeated hemofiltration filter clotting. Intensive Care Medicine 33(7): 1305-1307
Tremblay, D.M.; Harris, P.G.; Gagnon, A.R.; Cordoba, C.; Brutus, J.Paul.; Nikolis, A. 2008: Heparin-induced thrombocytopenia syndrome as a cause of flap failure: a report of two cases. Journal of Plastic Reconstructive and Aesthetic Surgery: Jpras 61(1): 78-83
Martin, K.; Kia, L.; Parikh, N.D.; Kulik, L.; McMahon, B. 2014: Heparin-induced thrombocytopenia testing is over-utilized in cirrhosis and correlates with poor clinical outcomes. Annals of Hepatology 13(5): 548-554
Heil, S. 2009: Heparin-induced thrombocytopenia type Ii with thrombosis in an intensive care patient: therapy management using the direct thrombin inhibitor argatroban. Der Anaesthesist 58(11): 1119-1122
Dracopoulos, S.; Vougas, V.; Kassimatis, T.I.; Theodoridis, T.; Ali, M.E.; Apostolou, T. 2007: Heparin-induced thrombocytopenia type II: a serious hazard in preemptive renal transplantation: a case report. Transplantation Proceedings 39(10): 3481-3484
Vucelić, D.; Antonijević, N.; Galun, D.; Bulajić, P.; Basarić, D.; Milićević, M. 2011: Heparin-induced thrombocytopenia with iliacofemoropopliteal thrombosis in a patient operated for colorectal carcinoma liver metastases. Acta Chirurgica Iugoslavica 58(4): 93-96
Ichinoe, M.; Mikami, T.; Ujiie, S.; Suzuki, K.; Okayasu, I. 2009: Heparin-induced thrombocytopenia with multiple organized thrombi accompanied by unusual cholesterin deposition: autopsy case after long-term follow up. Pathology International 59(10): 757-761
Kolluri, R.; Rocha-Singh, K.; Sarac, T.; Bartholomew, J.R. 2009: Heparin-induced thrombocytopenia with thrombosis after endovascular aneurysm repair. Vascular and Endovascular Surgery 43(1): 89-92
Kramer, R.; Oberg-Higgins, P.; Russo, L.; Braxton, J.H. 2009: Heparin-induced thrombocytopenia with thrombosis syndrome managed with plasmapheresis. Interactive Cardiovascular and Thoracic Surgery 8(4): 439-441
Benyounes, N.; Engrand, N.; Bartolini, B.; Taylor, G.; Devys, J.-M. 2013: Heparin-induced thrombocytopenia without thrombocytopenia in an intensive care unit. Presse Medicale 42(7-8): 1140-1142
Krauel, K.; Fürll, B.; Warkentin, T.E.; Weitschies, W.; Kohlmann, T.; Sheppard, J.I.; Greinacher, A. 2008: Heparin-induced thrombocytopenia--therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4-heparin complexes. Journal of Thrombosis and Haemostasis: Jth 6(12): 2160-2167
Shantsila, E.; Lip, G.Y.H.; Chong, B.H. 2009: Heparin-induced thrombocytopenia. a contemporary clinical approach to diagnosis and management. Chest 135(6): 1651-1664
Bartholomew, J.R. 2008: Heparin-induced thrombocytopenia: 2008 update. Current Treatment Options in Cardiovascular Medicine 10(2): 117-127
Miyata, S. 2012: Heparin-induced thrombocytopenia: HIT. Japanese Journal of Clinical Hematology 53(10): 1709-1719
Prisco, D. 2007: Heparin-induced thrombocytopenia: a brief update in an Italian perspective. Recenti Progressi in Medicina 98(9): 452-456
Jourdain, M.; Ennezat, P.-V.; Darchis, J.; Aubert, J.-M.; Bauchart, J.-J.; Auffray, J.-L.; Asseman, P. 2007: Heparin-induced thrombocytopenia: a case of persistent thrombocytopenia. Archives des Maladies du Coeur et des Vaisseaux 100(11): 959-962
Pouplard, C.; Regina, S.; May, M.-A.; Gruel, Y. 2007: Heparin-induced thrombocytopenia: a frequent complication after cardiac surgery. Archives des Maladies du Coeur et des Vaisseaux 100(6-7): 563-568
Swanson, J.M. 2007: Heparin-induced thrombocytopenia: a general review. Journal of Infusion Nursing: the Official Publication of the Infusion Nurses Society 30(4): 232-240
Kelton, J.G.; Warkentin, T.E. 2008: Heparin-induced thrombocytopenia: a historical perspective. Blood 112(7): 2607-2616
Hong, M.S.; Amanullah, A.M. 2010: Heparin-induced thrombocytopenia: a practical review. Reviews in Cardiovascular Medicine 11(1): 13-25
Greinacher, A.; Juhl, D.; Strobel, U.; Wessel, A.; Lubenow, N.; Selleng, K.; Eichler, P.; Warkentin, T.E. 2007: Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes. Journal of Thrombosis and Haemostasis: Jth 5(8): 1666-1673
Junqueira, D.R.G.; Carvalho, M.d.G.ça.; Perini, E. 2013: Heparin-induced thrombocytopenia: a review of concepts regarding a dangerous adverse drug reaction. Revista da Associacao Medica Brasileira 59(2): 161-166
Talati, R.; Colemen, C.I.; White, C.M. 2008: Heparin-induced thrombocytopenia: a review of current pharmacologic treatment. Connecticut Medicine 72(5): 275-279
Kawano, H.; Toyoda, K.; Miyata, S.; Yamamoto, H.; Okamoto, A.; Kakutani, I.; Walenga, J.M.; Naritomi, H.; Minematsu, K. 2008: Heparin-induced thrombocytopenia: a serious complication of heparin therapy for acute stroke. Cerebrovascular Diseases 26(6): 641-649
Greinacher, A.; Alban, S.; Omer-Adam, M.A.; Weitschies, W.; Warkentin, T.E. 2008: Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings. Thrombosis Research 122(2): 211-220
Elalamy, I.; Le Gal, G.; Nachit-Ouinekh, F.; Lafuma, A.; Emery, C.; Le-Fur, C.; Chapuis, F.ço. 2009: Heparin-induced thrombocytopenia: an estimate of the average cost in the hospital setting in France. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 15(4): 428-434
Rosenberger, L.H.; Smith, P.W.; Sawyer, R.G. 2011: Heparin-induced thrombocytopenia: an increasingly common cause of bilateral adrenal hemorrhage. Journal of the American Geriatrics Society 59(6): 1157-8; author reply 1158
Kato, S.; Takahashi, K.; Ayabe, K.; Samad, R.; Fukaya, E.; Friedmann, P.; Varma, M.; Bergmann, S.R. 2011: Heparin-induced thrombocytopenia: analysis of risk factors in medical inpatients. British Journal of Haematology 154(3): 373-377
Al-Rossaies, A.; Alkharfy, K.M.; Al-Ayoubi, F.; Al-Momen, A. 2011: Heparin-induced thrombocytopenia: comparison between response to fondaparinux and lepirudin. International Journal of Clinical Pharmacy 33(6): 997-1001
Otis, S.A.; Zehnder, J.L. 2010: Heparin-induced thrombocytopenia: current status and diagnostic challenges. American Journal of Hematology 85(9): 700-706
Liebman, H.A. 2008: Heparin-induced thrombocytopenia: diagnosis and management. Vascular 16(Suppl 1): S71-S76
Morel-Kopp, M.-C.; Aboud, M.; Tan, C.W.; Kulathilake, C.; Ward, C. 2011: Heparin-induced thrombocytopenia: evaluation of IgG and IgGAM ELISA assays. International Journal of Laboratory Hematology 33(3): 245-250
Pötschke, C.; Selleng, S.; Bröker, B.M.; Greinacher, A. 2012: Heparin-induced thrombocytopenia: further evidence for a unique immune response. Blood 120(20): 4238-4245
Koposova, N.; Eriksen, H.M.; Widström, E.; Handegård, B.ør.H.; Pastbin, M.; Koposov, R. 2013: Caries prevalence and determinants among 12-year-olds in North-West Russia and Northern Norway. Stomatologija 15(1): 3-11
Zinkovsky, D.A.; Antonopoulos, M.S. 2008: Heparin-induced thrombocytopenia: overview and treatment. P and T: a Peer-Reviewed Journal for Formulary Management 33(11): 642-651
Cuker, A. 2011: Heparin-induced thrombocytopenia: present and future. Journal of Thrombosis and Thrombolysis 31(3): 353-366
Gruel, Y.; Rollin, J.; Leroux, D.; Pouplard, C. 2014: Heparin-induced thrombocytopenia: recent data. La Revue de Medecine Interne 35(3): 174-182
Lubenow, N.; Greinacher, A. 2000: Heparin-induced thrombocytopenia: recommendations for optimal use of recombinant hirudin. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 14(2): 109-125
Alberio, L. 2008: Heparin-induced thrombocytopenia: some working hypotheses on pathogenesis, diagnostic strategies and treatment. Current Opinion in Hematology 15(5): 456-464
Desconclois, C.él.; Ract, C.; Boutekedjiret, T.; Alhenc-Gelas, M.; Duranteau, J.; Dreyfus, M.; Proulle, V. 2011: Heparin-induced thrombocytopenia: successful biological and clinical management with lepirudin despite severe renal impairment. Thrombosis and Haemostasis 105(3): 568-569
Pamela, S.; Anna Maria, L.; Elena, D.; Giovanni, M.; Emanuele, A.; Silvia, V.; Carmen, B.; Andreas, G.; Fabrizio, F. 2013: Heparin-induced thrombocytopenia: the role of platelets genetic polymorphisms. Platelets 24(5): 362-368
Gur'ianov, V.A.; Tolmachev, G.N. 2013: Heparin-induced thrombocytopenia: theory and practice. Anesteziologiia i Reanimatologiia 6: 60-62
Greinacher, A.; Ittermann, T.; Bagemühl, J.; Althaus, K.; Fürll, B.; Selleng, S.; Lubenow, N.; Schellong, S.; Sheppard, J.I.; Warkentin, T.E. 2010: Heparin-induced thrombocytopenia: towards standardization of platelet factor 4/heparin antigen tests. Journal of Thrombosis and Haemostasis: Jth 8(9): 2025-2031
Dalainas, I.; Avgerinos, E.D.; Liapis, C.D. 2011: Heparin-induced thrombocytopenia: what a vascular surgeon needs to know. Journal of Cardiovascular Surgery 52(1): 81-88
Chong, B.H.; Isaacs, A. 2009: Heparin-induced thrombocytopenia: what clinicians need to know. Thrombosis and Haemostasis 101(2): 279-283
Ortel, T.L. 2009: Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation. HEMATOLOGY. American Society of Hematology. Education Program 2009: 225-232
Glass, M.; Spitrey, J. 2009: Heparin-induced thrombocytopenia: your questions answered. AACN Advanced Critical Care 20(1): 5-9; Quiz 10-1
Tibayan, F.A.; Leung, L.L.; Burdon, T.A.; Fann, J.I. 2010: Heparin-induced thrombosis without thrombocytopenia. Journal of Thoracic and Cardiovascular Surgery 139(2): E6-E7
Bigdeli, A.K.; Schmitz, C.; Bruegger, D.; Weis, F.; Weis, M.; Michel, S.; Schmauss, D.; Reichart, D.; Reichart, B.; Sodian, R. 2009: Heparin-induced thrombosis without thrombocytopenia causing fulminant pulmonary embolism after off-pump coronary artery bypass grafting. Heart Surgery Forum 12(6): E368-E370
Esposito, P.; Libetta, C.; Borettaz, I.; Barone, M.; Canevari, M.; Martinelli, C.; Montagna, F.; Romeo, S.; Margiotta, E.; Calatroni, M.; La Porta, E.; Dal Canton, A. 2014: Heparin-induced trombocytopenia: pathogenesis, clinical manifestations and management in hemodialysis. Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 31(3)
Madhugiri, V.S.; Mahadevan, A.; Gundamaneni, S.K.; Singh, M. 2012: Heparin-induced tumour bleed. BMJ Case Reports
Medeiros, V.ír.P.; Paredes-Gamero, E.J.; Monteiro, H.P.; Rocha, H.A.O.; Trindade, E.S.; Nader, H.B. 2012: Heparin-integrin interaction in endothelial cells: downstream signaling and heparan sulfate expression. Journal of Cellular Physiology 227(6): 2740-2749
Tao, Y.; Hu, T.; Wu, Z.; Tang, H.; Hu, Y.; Tan, Q. 2012: Heparin-iron complex multilayer nanomodification improves hemocompatibility of decellular xenograft. Zhong Nan da Xue Xue Bao. Yi Xue Ban 37(3): 260-266
Senzolo, M.; Agarwal, S.; Zappoli, P.; Vibhakorn, S.; Mallett, S.; Burroughs, A.K. 2009: Heparin-like effect contributes to the coagulopathy in patients with acute liver failure undergoing liver transplantation. Liver International: Official Journal of the International Association for the Study of the Liver 29(5): 754-759
Senzolo, M.; Cholongitas, E.; Thalheimer, U.; Riddell, A.; Agarwal, S.; Mallett, S.; Ferronato, C.; Burroughs, A.K. 2009: Heparin-like effect in liver disease and liver transplantation. Clinics in Liver Disease 13(1): 43-53
Ranucci, M.; Baryshnikova, E.; Isgrò, G.; Carlucci, C.; Cotza, M.; Carboni, G.; Ballotta, A. 2014: Heparin-like effect in postcardiotomy extracorporeal membrane oxygenation patients. Critical Care 18(5): 504
Colliec-Jouault, S.; Bavington, C.; Delbarre-Ladrat, C. 2012: Heparin-like entities from marine organisms. Handbook of Experimental Pharmacology 207: 423-449
Ran, F.; Nie, S.; Li, J.; Su, B.; Sun, S.; Zhao, C. 2012: Heparin-like macromolecules for the modification of anticoagulant biomaterials. Macromolecular Bioscience 12(1): 116-125
Pollari, S.; Käkönen, R.S.; Mohammad, K.S.; Rissanen, J.P.; Halleen, J.M.; Wärri, A.; Nissinen, L.; Pihlavisto, M.; Marjamäki, A.; Perälä, M.; Guise, T.A.; Kallioniemi, O.; Käkönen, S.-M. 2012: Heparin-like polysaccharides reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasis. Molecular Cancer Research: Mcr 10(5): 597-604
Arlov, Øy.; Aachmann, F.L.; Sundan, A.; Espevik, T.; Skjåk-Bræk, G. 2014: Heparin-like properties of sulfated alginates with defined sequences and sulfation degrees. Biomacromolecules 15(7): 2744-2750
Tang, M.; Xue, J.; Yan, K.; Xiang, T.; Sun, S.; Zhao, C. 2012: Heparin-like surface modification of polyethersulfone membrane and its biocompatibility. Journal of Colloid and Interface Science 386(1): 428-440
Shao, M.; Wang, H.-F. 2013: Heparin-mediated fluorescence anisotropy assay of antithrombin based on polyethyleneimine capped Mn-doped ZnS quantum dots. Analyst 138(16): 4618-4623
Satoh, Y.; Masuda, A.; Jona, M.; Nannya, Y.; Yokota, H.; Kurokawa, M.; Yatomi, Y. 2014: Heparin-mediated inhibition of PCR in the accelerated phase of chronic myeloid leukaemia characterised by abundant basophilia. European Journal of Haematology 92(5): 456-457
Deng, J.; Liu, X.; Ma, L.; Cheng, C.; Shi, W.; Nie, C.; Zhao, C. 2014: Heparin-mimicking multilayer coating on polymeric membrane via LbL assembly of cyclodextrin-based supramolecules. Acs Applied Materials and Interfaces 6(23): 21603-21614
Princz, M.A.; Sheardown, H. 2008: Heparin-modified dendrimer cross-linked collagen matrices for the delivery of basic fibroblast growth factor (FGF-2). Journal of Biomaterials Science. Polymer Edition 19(9): 1201-1218
Princz, M.A.; Sheardown, H. 2012: Heparin-modified dendrimer crosslinked collagen matrices for the delivery of heparin-binding epidermal growth factor. Journal of Biomedical Materials Research. Part a 100(8): 1929-1937
Niu, G.; Choi, J.-S.; Wang, Z.; Skardal, A.; Giegengack, M.; Soker, S. 2014: Heparin-modified gelatin scaffolds for human corneal endothelial cell transplantation. Biomaterials 35(13): 4005-4014
Janairo, R.R.R.; Henry, J.J.D.; Lee, B.L.-P.; Hashi, C.K.; Derugin, N.; Lee, R.; Li, S. 2012: Heparin-modified small-diameter nanofibrous vascular grafts. IEEE Transactions on Nanobioscience 11(1): 22-27
Wang, Y.; Xin, D.; Liu, K.; Zhu, M.; Xiang, J. 2009: Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity. Bioconjugate Chemistry 20(12): 2214-2221
Wang, Y.; Xin, D.; Liu, K.; Xiang, J. 2009: Heparin-paclitaxel conjugates using mixed anhydride as intermediate: synthesis, influence of polymer structure on drug release, anticoagulant activity and in vitro efficiency. Pharmaceutical Research 26(4): 785-793
Levine, R.L.; Hergenroeder, G.W.; Francis, J.L.; Miller, C.C.; Hursting, M.J. 2010: Heparin-platelet factor 4 antibodies in intensive care patients: an observational seroprevalence study. Journal of Thrombosis and Thrombolysis 30(2): 142-148
Kleschyov, A.L.; Sen', V.D. 2013: Heparin-polynitroxide derivatives: a platform for new diagnostic and therapeutic agents in cardiovascular disease?. Future Medicinal Chemistry 5(4): 385-388
Kleschyov, A.L.; Sen', V.; Golubev, V.; Münnemann, K.; Hinderberger, D.; Lackner, K.J.; Weber, S.; Terekhov, M.; Schreiber, L.M.; Münzel, T. 2012: Heparin-polynitroxides: synthesis and preliminary evaluation as cardiovascular EPR/MR imaging probes and extracellular space-targeted antioxidants. European Journal of Medicinal Chemistry 58: 265-271
Peysselon, F.; Ricard-Blum, S. 2014: Heparin-protein interactions: from affinity and kinetics to biological roles. Application to an interaction network regulating angiogenesis. Matrix Biology: Journal of the International Society for Matrix Biology 35: 73-81
McGonigle, J.S.; Tae, G.; Stayton, P.S.; Hoffman, A.S.; Scatena, M. 2008: Heparin-regulated delivery of osteoprotegerin promotes vascularization of implanted hydrogels. Journal of Biomaterials Science. Polymer Edition 19(8): 1021-1034
Spadaccio, C.; Rainer, A.; Centola, M.; Trombetta, M.; Chello, M.; Lusini, M.; Covino, E.; Toyoda, Y.; Genovese, J.A. 2010: Heparin-releasing scaffold for stem cells: a differentiating device for vascular aims. Regenerative Medicine 5(4): 645-657
Absar, S.; Choi, S.; Yang, V.C.; Kwon, Y.M. 2012: Heparin-triggered release of camouflaged tissue plasminogen activator for targeted thrombolysis. Journal of Controlled Release: Official Journal of the Controlled Release Society 157(1): 46-54
Elsharnouby, N.M.; Eid, H.E.A.; Abou Elezz, N.F.; Aboelatta, Y.A. 2014: Heparin/N-acetylcysteine: an adjuvant in the management of burn inhalation injury: a study of different doses. Journal of Critical Care 29(1): 182.E1-4
Selleng, S.; Greinacher, A.; Ittermann, T.; Wollert, H.-G. 2009: Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up. American Heart Journal 158(1): E15
Lin, Q.; Yan, J.; Qiu, F.; Song, X.; Fu, G.; Ji, J. 2011: Heparin/collagen multilayer as a thromboresistant and endothelial favorable coating for intravascular stent. Journal of Biomedical Materials Research. Part a 96(1): 132-141
Myette, J.R.; Soundararajan, V.; Shriver, Z.; Raman, R.; Sasisekharan, R. 2009: Heparin/heparan sulfate 6-O-sulfatase from Flavobacterium heparinum: integrated structural and biochemical investigation of enzyme active site and substrate specificity. Journal of Biological Chemistry 284(50): 35177-35188
Myette, J.R.; Soundararajan, V.; Behr, J.; Shriver, Z.; Raman, R.; Sasisekharan, R. 2009: Heparin/heparan sulfate N-sulfamidase from Flavobacterium heparinum: structural and biochemical investigation of catalytic nitrogen-sulfur bond cleavage. Journal of Biological Chemistry 284(50): 35189-35200
Carlsson, P.; Presto, J.; Spillmann, D.; Lindahl, U.; Kjellén, L. 2008: Heparin/heparan sulfate biosynthesis: processive formation of N-sulfated domains. Journal of Biological Chemistry 283(29): 20008-20014
Sabatier, L.; Djokic, J.; Hubmacher, D.; Dzafik, D.; Nelea, V.; Reinhardt, D.P. 2014: Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. Febs Letters 588(17): 2890-2897
Gandhi, N.S.; Mancera, R.L. 2010: Heparin/heparan sulphate-based drugs. Drug Discovery Today 15(23-24): 1058-1069
Poli, M.; Girelli, D.; Campostrini, N.; Maccarinelli, F.; Finazzi, D.; Luscieti, S.; Nai, A.; Arosio, P. 2011: Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo. Blood 117(3): 997-1004
Xu, X.; Dai, Y. 2010: Heparin: an intervenor in cell communication. Journal of Cellular and Molecular Medicine 14(1-2): 175-180
Middeldorp, S. 2008: Heparin: from animal organ extract to designer drug. Thrombosis Research 122(6): 753-762
Kotwal, J.; Chaudhary, S.; Manoj, M.G.; Hasnain, S.; Nair, V.; Luthra, M. 2014: Heparin: induced thrombocytopenia: incidence and laboratory approach to diagnosis in Indians. Indian Journal of Pathology and Microbiology 57(1): 31-38
Xiao, Z.; Zhao, W.; Yang, B.; Zhang, Z.; Guan, H.; Linhardt, R.J. 2011: Heparinase 1 selectivity for the 3,6-di-O-sulfo-2-deoxy-2-sulfamido-alpha-D-glucopyranose (1,4) 2-O-sulfo-alpha-L-idopyranosyluronic acid (GlcNS3S6S-IdoA2S) linkages. Glycobiology 21(1): 13-22
Levin, A.I.; Heine, A.M.; Coetzee, J.F.; Coetzee, A.é 2014: Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia 28(2): 224-229
Cvirn, G.; Tafeit, E.; Hoerl, G.; Janschitz, M.; Wagner, T.; Juergens, G.; Koestenberger, M. 2010: Heparinase-Modified Thrombelastometry: Inactivation of Heparin in Plasma Samples. Clinical Laboratory 56(11-12): 585-589
Durila, M.; Kalincik, T.; Cvachovec, K.; Filho, R. 2010: Heparinase-modified thromboelastography can result in a fibrinolytic pattern. Anaesthesia 65(8): 864-865
Trethewie, E.R.; Melvin, P.A. 1945: Heparine evaluation. Australian journal of experimental biology and medical science 23: 241
Tocantins, L.M. 1948: Heparinemia. Blood 3(11): 1304-1306
Emile, C. 2007: Heparinemia (anti-factor Xa activity. Revue de l'Infirmiere 135: 49-50
Kannan, A. 2008: Heparinised saline or normal saline?. Journal of Perioperative Practice 18(10): 440-441
König, U.; Lode, A.; Welzel, P.B.; Ueda, Y.; Knaack, S.; Henß, A.; Hauswald, A.; Gelinsky, M. 2014: Heparinization of a biomimetic bone matrix: integration of heparin during matrix synthesis versus adsorptive post surface modification. Journal of Materials Science. Materials in Medicine 25(3): 607-621
Wang, W.; Hu, J.; He, C.; Nie, W.; Feng, W.; Qiu, K.; Zhou, X.; Gao, Y.; Wang, G. 2015: Heparinized PLLA/PLCL nanofibrous scaffold for potential engineering of small-diameter blood vessel: tunable elasticity and anticoagulation property. Journal of Biomedical Materials Research. Part a 103(5): 1784-1797
Wilbring, M.; Ebner, A.; Schoenemann, K.; Knaut, M.; Tugtekin, S.M.; Zatschler, B.; Waldow, T.; Alexiou, K.; Matschke, K.; Deussen, A. 2013: Heparinized blood better preserves cellular energy charge and vascular functions of intraoperatively stored saphenous vein grafts in comparison to isotonic sodium-chloride-solution. Clinical Hemorheology and Microcirculation 55(4): 445-455
Øvrum, E.; Tangen, G.; Tølløfsrud, S.; Skeie, B.ør.; Ringdal, M.A.L.; Istad, R.; Øystese, R. 2011: Heparinized cardiopulmonary bypass circuits and low systemic anticoagulation: an analysis of nearly 6000 patients undergoing coronary artery bypass grafting. Journal of Thoracic and Cardiovascular Surgery 141(5): 1145-1149
Tang, D-Wei.; Yu, S-Huei.; Ho, Y-Cheng.; Mi, F-Long.; Kuo, P-Li.; Sung, H-Wen. 2010: Heparinized chitosan/poly(γ-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin. Biomaterials 31(35): 9320-9332
Brouwer, K.M.; Wijnen, R.é M.; Reijnen, D.; Hafmans, T.G.; Daamen, W.F.; van Kuppevelt, T.H. 2013: Heparinized collagen scaffolds with and without growth factors for the repair of diaphragmatic hernia: construction and in vivo evaluation. Organogenesis 9(3): 161-167
Teixeira, S.; Yang, L.; Dijkstra, P.J.; Ferraz, M.P.; Monteiro, F.J. 2010: Heparinized hydroxyapatite/collagen three-dimensional scaffolds for tissue engineering. Journal of Materials Science. Materials in Medicine 21(8): 2385-2392
Wu, Q.; Liu, C.; Fan, L.; Shi, J.; Liu, Z.; Li, R.; Sun, L. 2012: Heparinized magnetic mesoporous silica nanoparticles as multifunctional growth factor delivery carriers. Nanotechnology 23(48): 485703
Jiang, T.; Wang, G.; Qiu, J.; Luo, L.; Zhang, G. 2009: Heparinized poly(vinyl alcohol)--small intestinal submucosa composite membrane for coronary covered stents. Biomedical Materials 4(2): 025012
Ma, K.-w.; Dai, X.-z.; Feng, S.-y.; Jing, A.-h.; Yang, J.-y. 2011: Heparinized polyvinyl alcohol to specifically adsorb low-density lipoprotein from plasma. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 44(1): 3-9
Cook, L.; Bellini, S.; Cusson, R.M. 2011: Heparinized saline vs normal saline for maintenance of intravenous access in neonates: an evidence-based practice change. Advances in Neonatal Care: Official Journal of the National Association of Neonatal Nurses 11(3): 208-215
Del Cotillo, M.; Grané, N.úr.; Llavoré, M.; Quintana, S. 2008: Heparinized solution vs. saline solution in the maintenance of arterial catheters: a double blind randomized clinical trial. Intensive Care Medicine 34(2): 339-343
Fulcher, Y.G.; Sanganna Gari, R.Reddy.; Frey, N.C.; Zhang, F.; Linhardt, R.J.; King, G.M.; Van Doren, S.R. 2014: Heparinoids activate a protease, secreted by mucosa and tumors, via tethering supplemented by allostery. Acs Chemical Biology 9(4): 957-966
De Azevedo, T.C.G.; Bezerra, M.E.íl.B.; Santos, M.d.G.ór.d.L.; Souza, L.A.; Marques, C.T.; Benevides, N.M.B.; Leite, E.L. 2009: Heparinoids algal and their anticoagulant, hemorrhagic activities and platelet aggregation. Biomedicine and PharmacoTherapy 63(7): 477-483
Cavalheiro Filho, C.; Chamone, D.d.A.F.; Rached, R.A.; Maffei, F.H. 2008: Heparins - current status. Revista da Associacao Medica Brasileira 54(6): 471-472
Stiefelhagen, P. 2013: Heparins after thrombosis and during bridging. MMW Fortschritte der Medizin 155(11): 22
Noble, S. 2014: Heparins and cancer survival: where do we stand?. Thrombosis Research 133(Suppl 2): S133-S138
Barouti, N.; Masouyé, I.; Boehncke, W.-H.; Prins, C. 2013: Heparins and skin reactions: from diagnostic to management. Revue Medicale Suisse 9(380): 705
Laubli, H.; Borsig, L. 2009: Heparins attenuate cancer metastasis: are selectins the link?. Cancer Investigation 27(5): 474-481
Sciahbasi, A.; Rigattieri, S.; Calcagno, S.; Mancone, M.; Pendenza, G.; Cera, M.; Danza, A.I.; Di Russo, C.; Bruno, P.; Fedele, S.; Pugliese, F.R.; Sardella, G. 2015: Heparins crossover in percutaneous coronary interventions: a real issue with increasing rate of transradial procedures?. Journal of Cardiovascular Medicine 16(7): 507-511
Gallus, A.S. 2014: Heparins for preventing venous thromboembolism in general medical wards: evidence and guidelines. Internal Medicine Journal 44(11): 1051-1054
Hitzeman, N.; Rafii, F. 2009: Heparins for unstable angina and non-ST segment elevation myocardial infarction. American Family Physician 79(7): 560-562
Aquino, R.S.; Pereira, M.S.; Vairo, B.C.; Cinelli, L.P.; Santos, G.R.C.; Fonseca, R.J.C.; Mourão, P.A.S. 2010: Heparins from porcine and bovine intestinal mucosa: Are they similar drugs?. Thrombosis and Haemostasis 103(5): 1005-1015
Dinwoodey, D.L.; Ansell, J.E. 2008: Heparins, low-molecular-weight heparins, and pentasaccharides: use in the older patient. Cardiology Clinics 26(2): 145-155 V
Liverani, L.; Mascellani, G.; Spelta, F. 2009: Heparins: process-related physico-chemical and compositional characteristics, fingerprints and impurities. Thrombosis and Haemostasis 102(5): 846-853
Chen, J.-X.; Liu, W.; Zhang, M.; Chen, J.-H. 2014: Heparosan based negatively charged nanocarrier for rapid intracellular drug delivery. International Journal of Pharmaceutics 473(1-2): 493-500
DeAngelis, P.L. 2015: Heparosan, a promising 'naturally good' polymeric conjugating vehicle for delivery of injectable therapeutics. Expert Opinion on Drug Delivery 12(3): 349-352
Gao, M.; Zhan, Y.-Q.; Yu, M.; Ge, C.-H.; Li, C.-Y.; Zhang, J.-H.; Wang, X.-H.; Ge, Z.-Q.; Yang, X.-M. 2014: Hepassocin activates the EGFR/ERK cascade and induces proliferation of L02 cells through the Src-dependent pathway. Cellular Signalling 26(10): 2161-2166
Calvaruso, V. 2010: Hepassocin as a treatment for fulminant hepatic failure: will it translate from rats to human?. Gut 59(6): 709-710
Cao, M.-M.; Xu, W.-X.; Li, C.-Y.; Cao, C.-Z.; Wang, Z.-D.; Yao, J.-W.; Yu, M.; Zhan, Y.-Q.; Wang, X.-H.; Tang, L.-J.; Chen, H.; Li, W.; Ge, C.-H.; Yang, X.-M. 2011: Hepassocin regulates cell proliferation of the human hepatic cells L02 and hepatocarcinoma cells through different mechanisms. Journal of Cellular Biochemistry 112(10): 2882-2890
Aller, M.-A.; Lorente, L.; Prieto, I.; Moquillaza, L.M.; Arias, J. 2009: Hepatectomies in the rat: a look at the caudate process through microsurgery. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 41(10): 695-699
Xing, Q.; Luo, Y.; Gao, Y.; Zhang, S.; Zhu, Z.; Wang, Y.; Yuan, Q.; Shu, G.; Lou, C.; Wang, J.; Wang, P.; Du, Z. 2014: Hepatectomised patient sera promote hepatocyte differentiation of human-induced pluripotent stem cells. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 46(8): 731-737
Hobsley, M. 1964: Hepatectomy [Abridged. Proceedings of the Royal Society of Medicine 57(7): 550-551
Brown, R.E.; Bower, M.R.; Metzger, T.L.; Scoggins, C.R.; McMasters, K.M.; Hahl, M.J.; Tatum, C.; Martin, R.C.G. 2011: Hepatectomy after hepatic arterial therapy with either yttrium-90 or drug-eluting bead chemotherapy: is it safe?. Hpb: the Official Journal of the International Hepato Pancreato Biliary Association 13(2): 91-95
Li, A.-J.; Zhou, W.-P.; Wu, M.-C.; Luo, X.-J. 2007: Hepatectomy after primary repair of ruptured liver cancer. Hepatobiliary and Pancreatic Diseases International: Hbpd Int 6(3): 267-270
Petillon, S.; Vibert, E.; Gorden, D.-L.; de la Serna, S.; Salloum, C.; Azoulay, D. 2010: Hepatectomy and intrahepatic biliary enteric anastomosis: a rescue surgery for obstructed metallic biliary stents in chronic pancreatitis. Gastroenterologie Clinique et Biologique 34(4-5): 310-313
Yan, T.D.; King, J.; Ebrahimi, A.; Sjarif, A.; Glenn, D.; Steinke, K.; Morris, D.L. 2007: Hepatectomy and lung radiofrequency ablation for hepatic and subsequent pulmonary metastases from colorectal carcinoma. Journal of Surgical Oncology 96(5): 367-373
Nanashima, A.; Yamaguchi, H.; Sumida, Y.; Abo, T.; Tobinaga, S.; Tanaka, K.; Takeshita, H.; Hidaka, S.; Sawai, T.; Yasutake, T.; Nagayasu, T. 2008: Hepatectomy and pancreatectomy with combined vascular resection in patients with hepato-biliary and pancreas diseases at a single cancer institute. Hepato-Gastroenterology 55(84): 873-878
Chua, T.C.; Saxena, A.; Liauw, W.; Chu, F.; Morris, D.L. 2012: Hepatectomy and resection of concomitant extrahepatic disease for colorectal liver metastases--a systematic review. European Journal of Cancer 48(12): 1757-1765
Lu, W.-q.; Yu, N.-r.; Liu, H.-y. 2012: Hepatectomy combined with cryoablation and ethanol injection for unresectable multiple liver metastases from colorectal cancer. Zhonghua Wei Chang Wai Ke Za Zhi 15(4): 370-372
Shellenberger, M.J.; Smith, R.; Varma, C.; Kotru, A.; Maloo, M.; Gerst, H. 2010: Hepatectomy cures a cough: giant cavernous hemangioma in a patient with persistent cough. Journal of the American Osteopathic Association 110(11): 675-677
Prieto-Puga Arjona, T.; Sánchez Pérez, B.; Suárez Muñoz, M.Án.; Fernández Aguilar, J.é L.; Santoyo Santoyo, J. 2014: Hepatectomy due to a saphenous vein leiomyosarcoma metastasis. Cirugia Espanola 92(3): 217-218
Yang, T.; Lau, W.Y.; Lai, E.C.H.; Yang, L.-Q.; Zhang, J.; Yang, G.-S.; Lu, J.-H.; Wu, M.-C. 2010: Hepatectomy for bilateral primary hepatolithiasis: a cohort study. Annals of Surgery 251(1): 84-90
Jabłońska, B. 2013: Hepatectomy for bile duct injuries: when is it necessary?. World Journal of Gastroenterology 19(38): 6348-6352
Brouquet, A.; Benoist, S.ép. 2011: Hepatectomy for colorectal liver metastases after neoadjuvant chemotherapy. Bulletin du Cancer 98(1): 11-18
Jaeck, D.; Oussoultzoglou, E.; Rosso, E. 2007: Hepatectomy for colorectal metastases in the presence of extrahepatic disease. Surgical Oncology Clinics of North America 16(3): 507
Fan, J.; Wang, Z. 2010: Hepatectomy for hepatocellular carcinoma. Zhonghua Wai Ke Za Zhi 48(3): 167-168
Abdi, Z.; Krasnokutsky, S.; Rapkiewicz, A.; Saxena, A.; Villanueva, G.; Sarpel, U. 2010: Hepatectomy for hepatocellular carcinoma complicated by vasculitis flare. Hpb Surgery: a World Journal of Hepatic Pancreatic and Biliary Surgery 2010: 841754
Oishi, K.; Itamoto, T.; Kobayashi, T.; Oshita, A.; Amano, H.; Ohdan, H.; Tashiro, H.; Asahara, T. 2009: Hepatectomy for hepatocellular carcinoma in elderly patients aged 75 years or more. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 13(4): 695-701
Inokawa, Y.; Sugimoto, H.; Kanda, M.; Yamada, S.; Fujii, T.; Nomoto, S.; Takeda, S.; Suzuki, N.; Matsushita, T.; Kodera, Y. 2014: Hepatectomy for hepatocellular carcinoma in patients with hemophilia. Journal of Hepato-Biliary-Pancreatic Sciences 21(11): 824-828
Tanaka, S.; Ishihara, K.; Watanabe, C.; Ohno, K.; Yamamoto, T. 2011: Hepatectomy for hepatocellular carcinoma in patients with severe thrombocytopenia. Hepato-Gastroenterology 58(109): 1316-1320
Lu, W.-P.; Dong, J.-H. 2014: Hepatectomy for hepatocellular carcinoma in the era of liver transplantation. World Journal of Gastroenterology 20(28): 9237-9244
Zeng, Q.-a.; Qiu, J.; Hong, J.; Li, Y.; Li, S.; Zou, R.; Huang, P.; Li, B.; Zheng, Y.; Lao, X.; Yuan, Y. 2012: Hepatectomy for hepatocellular carcinoma patients with macronodular cirrhosis. European Journal of Gastroenterology and Hepatology 24(5): 575-582
Yang, L.; Xu, J.; Ou, D.; Wu, W.; Zeng, Z. 2013: Hepatectomy for huge hepatocellular carcinoma: single institute's experience. World Journal of Surgery 37(9): 2189-2196
Hashimoto, M.; Sasaki, K.; Matsuda, M.; Watanabe, G. 2014: Hepatectomy for liver abscess caused by stones spilled during laparoscopic cholecystectomy. Asian Journal of Endoscopic Surgery 7(1): 60-62
Nakatake, R.; Kaibori, M.; Ishizaki, M.; Matsui, K.; Tsuda, T.; Matsushima, H.; Kwon, A-Hon. 2012: Hepatectomy for liver metastasis in malignant melanoma of ocular choroid origin-a case report. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(12): 2009-2011
Xu, J.; Wei, Y.; Zhong, Y.; Fan, J.; Zhou, J.; Qin, L.; Ren, L.; Qin, X. 2009: Hepatectomy for liver metastasis of colorectal cancer. International Journal of Colorectal Disease 24(4): 419-425
Sawada, T.; Kita, J.; Nagata, H.; Shimoda, M.; Kubota, K. 2007: Hepatectomy for metastatic liver tumor in patients with liver dysfunction. Hepato-Gastroenterology 54(80): 2306-2309
Sakaguchi, T.; Suzuki, S.; Morita, Y.; Oishi, K.; Suzuki, A.; Fukumoto, K.; Inaba, K.; Takehara, Y.; Baba, S.; Nakamura, S.; Konno, H. 2011: Hepatectomy for metastatic liver tumors complicated with right umbilical portion. Hepato-Gastroenterology 58: 107-108
Groeschl, R.T.; Nachmany, I.; Steel, J.L.; Reddy, S.K.; Glazer, E.S.; de Jong, M.C.; Pawlik, T.M.; Geller, D.A.; Tsung, A.; Marsh, J.Wallis.; Clary, B.M.; Curley, S.A.; Gamblin, T.Clark. 2012: Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis. Journal of the American College of Surgeons 214(5): 769-777
Strong, R.W.; Fawcett, J.; Lynch, S.V.; Wall, D.R. 2003: Hepatectomy for pyogenic liver abscess. Hpb: the Official Journal of the International Hepato Pancreato Biliary Association 5(2): 86-90
Lupinacci, R.; Penna, C.; Nordlinger, B. 2007: Hepatectomy for resectable colorectal cancer metastases--indicators of prognosis, definition of resectability, techniques and outcomes. Surgical Oncology Clinics of North America 16(3): 493-506 Vii-Viii
Torzilli, G.; Donadon, M.; Marconi, M.; Palmisano, A.; Del Fabbro, D.; Spinelli, A.; Botea, F.; Montorsi, M. 2008: Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis. Archives of Surgery 143(11): 1082-1090
Zhou, Y.; Zhang, X.; Zhang, Z.; Liu, X.; Wu, L.; Li, Y.; Li, B. 2013: Hepatectomy in elderly patients: does age matter?. World Journal of Surgery 37(12): 2899-2910
Schiffman, S.C.; Bower, M.; Brown, R.E.; Martin, R.C.G.; McMasters, K.M.; Scoggins, C.R. 2010: Hepatectomy is superior to thermal ablation for patients with a solitary colorectal liver metastasis. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 14(12): 1881-1886; Discussion: 1886-1887
Soares Júnior, Aônio.Wellington.Lima.; Tajra, C.Eduardo.Feitosa.; Soares, V.Yamashiro.Rocha.; Soares, J.Lemos.; Costa, J.Alexandre. 2011: Hepatectomy of lymphangioma in situs inversus totalis--case report. Revista do Colegio Brasileiro de Cirurgioes 38(6): 450-451
Kohya, N.; Miyazaki, K. 2008: Hepatectomy of segment 4a and 5 combined with extra-hepatic bile duct resection for T2 and T3 gallbladder carcinoma. Journal of Surgical Oncology 97(6): 498-502
Paes-Barbosa, Fábio.Colagrossi.; Ferreira, F.Gonçalves.; Szutan, L.Arnaldo. 2010: Hepatectomy preoperative planning. Revista do Colegio Brasileiro de Cirurgioes 37(5): 370-375
Shimizu, A.; Kobayashi, A.; Yokoyama, T.; Nakata, T.; Motoyama, H.; Kubota, K.; Furusawa, N.; Kitahara, H.; Kitagawa, N.; Fukushima, K.; Shirota, T.; Miyagawa, S. 2012: Hepatectomy preserving drainage veins of the posterior section for liver malignancy invading the right hepatic vein: an alternative to right hepatectomy. American Journal of Surgery 204(5): 717-723
Ishizaki, Y.; Yoshimoto, J.; Sugo, H.; Miwa, K.; Kawasaki, S. 2008: Hepatectomy using traditional Péan clamp-crushing technique under intermittent Pringle maneuver. American Journal of Surgery 196(3): 353-357
Fujita, T. 2009: Hepatectomy versus radiofrequency ablation for early hepatocellular carcinoma. Journal of hepatology 50(5): 1051-2; author reply 1052-3
Fujita, T. 2011: Hepatectomy versus radiofrequency ablation for early-stage hepatocellular carcinoma. Hepatology 53(1): 374
Belghiti, J.; Durand, F.ço. 2007: Hepatectomy vs. liver transplantation: a combination rather than an opposition. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 13(5): 636-638
Manzanet, G.; Pellicer, V.; Suelves, C.; Calabuig, Jé.P.; Morón, Rón. 2009: Hepatectomy with inferior vena cava resection. Is veno-venous bypass necessary?. Cirugia Espanola 85(2): 117-118
Hashimoto, K.; Sasaki, Y.; Yokoyama, S.; Naitou, A.; Hiraki, M.; Matsumoto, S.; Matsuyama, J.; Morita, S.; Morimoto, T.; Fukushima, Y.; Nishisho, I.; Nomura, T.; Takeda, M. 2009: Hepatectomy with microwave coagulation therapy for multiple liver metastases of rectal carcinoid--a case report. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(12): 2198-2200
Han, F.; Zhou, J-xue.; Zhang, L.; Han, Y-zhi. 2007: Hepatectomy with portal vein resection and reconstruction in the treatment of hilar cholangiocarcinoma. Zhonghua Wai Ke Za Zhi 45(11): 763-765
Nagino, M.; Nimura, Y.; Nishio, H.; Ebata, T.; Igami, T.; Matsushita, M.; Nishikimi, N.; Kamei, Y. 2010: Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases. Annals of Surgery 252(1): 115-123
Hovaguimian, F.; Beck-Schimmer, B.; Clavien, P.-A.; Schwartz, D.E. 2014: Hepatectomy without endotracheal general anesthesia: a safe procedure?. Journal of the American College of Surgeons 218(3): 499-500
Yuan, D.; Wei, Y.G.; Chen, K.; Li, B.; Yan, L.; Wen, T.; Zhao, J.; Yang, J. 2010: Hepatectomy-related hypophosphatemia may predict donor liver dysfunction in live-donor liver transplantation. Transplantation Proceedings 42(10): 4548-4551
Nomura, K.; Tatsumi, S.; Miyagawa, A.; Shiozaki, Y.; Sasaki, S.; Kaneko, I.; Ito, M.; Kido, S.; Segawa, H.; Sano, M.; Fukuwatari, T.; Shibata, K.; Miyamoto, K.-i. 2014: Hepatectomy-related hypophosphatemia: a novel phosphaturic factor in the liver-kidney axis. Journal of the American Society of Nephrology: Jasn 25(4): 761-772
Lopes-Junior, A.ên.G.; Belebecha, V.; Jacob, C.E. 2014: Hepatectomy: a critical analysis on expansion of the indications. Arquivos Brasileiros de Cirurgia Digestiva: Abcd 27(1): 47-52
Altuna, M.E.; Mazzetti, M.B.; Rago, L.F.; San Martín de Viale, L.C.; Damasco, M.C. 2009: Hepatic 11 beta-hydroxysteroid dehydrogenase 1 involvement in alterations of glucose metabolism produced by acidotic stress in rat. Journal of Physiology and Biochemistry 65(4): 329-337
Konopelska, S.; Kienitz, T.; Hughes, B.; Pirlich, M.; Bauditz, J.ür.; Lochs, H.; Strasburger, C.J.; Stewart, P.M.; Quinkler, M. 2009: Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis. Clinical Endocrinology 70(4): 554-560
Dube, S.; Norby, B.; Pattan, V.; Lingineni, R.K.; Singh, R.J.; Carter, R.E.; Basu, A.; Basu, R. 2014: Hepatic 11β-hydroxysteroid dehydrogenase type 1 activity in obesity and type 2 diabetes using a novel triple tracer cortisol technique. Diabetologia 57(7): 1446-1455
Leatherland, J.F.; Reddy, P.K.; Yong, A.N.; Leatherland, A.; Lam, T.J. 1990: Hepatic 5'-monodeiodinase activity in teleosts in vitro: a survey of thirty-three species. Fish Physiology and Biochemistry 8(1): 1-10
Parks, J.S.; Chung, S.; Shelness, G.S. 2012: Hepatic ABC transporters and triglyceride metabolism. Current Opinion in Lipidology 23(3): 196-200
Liu, M.; Chung, S.; Shelness, G.S.; Parks, J.S. 2012: Hepatic ABCA1 and VLDL triglyceride production. Biochimica et Biophysica Acta 1821(5): 770-777
De Haan, W.; Karasinska, J.M.; Ruddle, P.; Hayden, M.R. 2014: Hepatic ABCA1 expression improves β-cell function and glucose tolerance. Diabetes 63(12): 4076-4082
Pedrelli, M.; Davoodpour, P.; Degirolamo, C.; Gomaraschi, M.; Graham, M.; Ossoli, A.; Larsson, L.; Calabresi, L.; Gustafsson, J.-Åk.; Steffensen, K.R.; Eriksson, M.; Parini, P. 2014: Hepatic ACAT2 knock down increases ABCA1 and modifies HDL metabolism in mice. Plos one 9(4): E93552
Mo, Y.H.; Jaw, F.S.; Ho, M.C.; Wang, Y.C.; Peng, S.S.F. 2011: Hepatic ADC value correlates with cirrhotic severity of patients with biliary atresia. European Journal of Radiology 80(3): E253-E257
Damlaj, M.; Amre, R.; Wong, P.; How, J. 2014: Hepatic ALECT-2 amyloidosis causing portal hypertension and recurrent variceal bleeding: a case report and review of the literature. American Journal of Clinical Pathology 141(2): 288-291
Ong, K.Teong.; Mashek, M.T.; Bu, S.Young.; Mashek, D.G. 2013: Hepatic ATGL knockdown uncouples glucose intolerance from liver TAG accumulation. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 27(1): 313-321
Ong, K.Teong.; Mashek, M.T.; Davidson, N.O.; Mashek, D.G. 2014: Hepatic ATGL mediates PPAR-α signaling and fatty acid channeling through an L-FABP independent mechanism. Journal of lipid research 55(5): 808-815
Bidwell, L.A. 1910: Hepatic Abscess following Acute Appendicitis. British Medical Journal 2(2591): 507-508
Macleod, N. 1880: Hepatic Abscess Opened Antiseptically: Death. British Medical Journal 2(1039): 843-844
Wear, A.T. 1881: Hepatic Abscess Opened Antiseptically: Recovery. British Medical Journal 1(1046): 86
Boyce, F.F. 1939: Hepatic and Biliary Tract Disease: a Review of Recent Significant Advances. Annals of Surgery 109(3): 351-372
Banshodani, M.; Ishiyama, K.; Amano, H.; Tashiro, H.; Arihiro, K.; Itamoto, T.; Ohdan, H. 2009: Hepatic Angiomyolipoma with Minimal Intratumoral Fat Content. Case Reports in Gastroenterology 3(3): 324-331
Sergeant, G.; Schadde, E.; Maleux, G.; Aerts, R. 2013: Hepatic Artery Embolization prior to En Bloc Resection of an Encased Common Hepatic Artery in Adenocarcinoma of the Head of the Pancreas. Case Reports in Medicine 2013: 205475
Tarzamni, M.Kazem.; Khoshbaten, M.; Sadrarhami, S.; Daneshpajouhnejad, P.; Jalili, J.; Gholamian, M.; Shahmoradi, Z. 2014: Hepatic Artery and Portal Vein Doppler Indexes in Non-alcoholic Fatty Liver Disease Before and After Treatment to Prevent Unnecessary Health Care Costs. International Journal of Preventive Medicine 5(4): 472-477
Zhang, H.; Stolz, D.B.; Chalasani, G.; Thomson, A.W. 2013: Hepatic B cells are readily activated by Toll-like receptor-4 ligation and secrete less interleukin-10 than lymphoid tissue B cells. Clinical and Experimental Immunology 173(3): 473-479
Ueki, S.; Castellaneta, A.; Yoshida, O.; Ozaki, K.; Zhang, M.; Kimura, S.; Isse, K.; Ross, M.; Shao, L.; Stolz, D.B.; Thomson, A.W.; Demetris, A.J.; Geller, D.A.; Murase, N. 2011: Hepatic B7 homolog 1 expression is essential for controlling cold ischemia/reperfusion injury after mouse liver transplantation. Hepatology 54(1): 216-228
Bailly-Maitre, B.éa.; Belgardt, B.F.; Jordan, S.D.; Coornaert, B.; von Freyend, M.J.; Kleinridders, A.; Mauer, J.; Cuddy, M.; Kress, C.L.; Willmes, D.; Essig, M.; Hampel, B.; Protzer, U.; Reed, J.C.; Brüning, J.C. 2010: Hepatic Bax inhibitor-1 inhibits IRE1alpha and protects from obesity-associated insulin resistance and glucose intolerance. Journal of Biological Chemistry 285(9): 6198-6207
Osei-Hyiaman, D.; Liu, J.; Zhou, L.; Godlewski, G.; Harvey-White, J.; Jeong, W.-i.; Bátkai, S.án.; Marsicano, G.; Lutz, B.; Buettner, C.; Kunos, G. 2008: Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. Journal of Clinical Investigation 118(9): 3160-3169
Wegscheid, C.; Karimi, K.; Tiegs, G. 2014: Hepatic CD141⁺IFNλ⁺ DC subset: one against all?. Journal of Hepatology 60(1): 9-11
Nakagawa, Y.; Satoh, A.; Yabe, S.; Furusawa, M.; Tokushige, N.; Tezuka, H.; Mikami, M.; Iwata, W.; Shingyouchi, A.; Matsuzaka, T.; Kiwata, S.; Fujimoto, Y.; Shimizu, H.; Danno, H.; Yamamoto, T.; Ishii, K.; Karasawa, T.; Takeuchi, Y.; Iwasaki, H.; Shimada, M.; Kawakami, Y.; Urayama, O.; Sone, H.; Takekoshi, K.; Kobayashi, K.; Yatoh, S.; Takahashi, A.; Yahagi, N.; Suzuki, H.; Yamada, N.; Shimano, H. 2014: Hepatic CREB3L3 controls whole-body energy homeostasis and improves obesity and diabetes. Endocrinology 155(12): 4706-4719
Jacobs, R.é L.; Lingrell, S.; Zhao, Y.; Francis, G.A.; Vance, D.E. 2008: Hepatic CTP:phosphocholine cytidylyltransferase-alpha is a critical predictor of plasma high density lipoprotein and very low density lipoprotein. Journal of Biological Chemistry 283(4): 2147-2155
Kubota, A.; Watanabe, M.; Kunisue, T.; Kim, E.-Y.; Tanabe, S.; Iwata, H. 2010: Hepatic CYP1A induction by chlorinated dioxins and related compounds in the endangered black-footed albatross from the North Pacific. Environmental Science and Technology 44(9): 3559-3565
Morten Sandvik Tor Einar Horsberg Janneche Utne Skaare And Kristian Ingebrigtsen 1997: Hepatic CYP1A induction in rainbow trout (Oncorhynchus mykiss) after exposure to benzo[a]pyrene in water. Biomarkers: Biochemical Indicators of Exposure Response and Susceptibility to Chemicals 2(3): 175-180
Al Koudsi, N.; Hoffmann, E.B.; Assadzadeh, A.; Tyndale, R.F. 2010: Hepatic CYP2A6 levels and nicotine metabolism: impact of genetic, physiological, environmental, and epigenetic factors. European Journal of Clinical Pharmacology 66(3): 239-251
Al Koudsi, N.; Tyndale, R.F. 2010: Hepatic CYP2B6 is altered by genetic, physiologic, and environmental factors but plays little role in nicotine metabolism. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 40(6): 381-392
Acharya, P.; Engel, J.C.; Correia, M.Almira. 2009: Hepatic CYP3A suppression by high concentrations of proteasomal inhibitors: a consequence of endoplasmic reticulum (ER) stress induction, activation of RNA-dependent protein kinase-like ER-bound eukaryotic initiation factor 2alpha (eIF2alpha)-kinase (PERK) and general control nonderepressible-2 eIF2alpha kinase (GCN2), and global translational shutoff. Molecular Pharmacology 76(3): 503-515
Kimura, T.; Nakajima, T.; Kamijo, Y.; Tanaka, N.; Wang, L.; Hara, A.; Sugiyama, E.; Tanaka, E.; Gonzalez, F.J.; Aoyama, T. 2012: Hepatic Cerebroside Sulfotransferase Is Induced by PPARα Activation in Mice. PPAR research 2012: 174932
Jollye, F.W. 1892: Hepatic Cirrhosis Occurring in two Children of the Same Family. British Medical Journal 1(1634): 858-859
Noble, C.A.; Perry, I.H.; Marquis, H.H. 1936: Hepatic Cirrhosis With Encapsulated Peritonitis: Report of Case. California and Western Medicine 45(2): 172-174
Tidey, S. 1892: Hepatic Cirrhosis in Children. British Medical Journal 2(1646): 125
Poynton, F.J.; Wyllie, W.G. 1926: Hepatic Cirrhosis in Children: With special reference to the Biliary Forms. Archives of Disease in Childhood 1(1): 1-20
Powell, C.M. 1897: Hepatic Cirrhosis of Childhood: Intercurrent Typhoid Fever: Death from Acute Yellow Atrophy. British Medical Journal 2(1920): 1086-1087
Dal Palù, C.; Spandri, P.; Zuin, R. 1965: Hepatic Clearance and Lm of Galactose in Normal and Cirrhotic Subjects. Postgraduate Medical Journal 41(475): 261-267
Topletz, A.R.; Le, H.N.; Lee, N.; Chapman, J.D.; Kelly, E.J.; Wang, J.; Isoherranen, N. 2013: Hepatic Cyp2d and Cyp26a1 mRNAs and activities are increased during mouse pregnancy. Drug Metabolism and Disposition: the Biological Fate of Chemicals 41(2): 312-319
Marques, P.E.; Oliveira, A.é G.; Pereira, R.V.; David, B.A.új.; Gomides, L.F.; Saraiva, A.M.; Pires, D.A.új.; Novaes, J.úl.T.; Patricio, D.O.; Cisalpino, D.; Menezes-Garcia, Z.él.; Leevy, W.M.; Chapman, S.E.; Mahecha, G.án.; Marques, R.E.; Guabiraba, R.; Martins, V.P.; Souza, D.G.; Mansur, D.S.; Teixeira, M.M.; Leite, M.F.; Menezes, G.B. 2015: Hepatic DNA deposition drives drug-induced liver injury and inflammation in mice. Hepatology 61(1): 348-360
Ma, Y.; Xia, W.; Wang, D.Q.; Wan, Y.J.; Xu, B.; Chen, X.; Li, Y.Y.; Xu, S.Q. 2013: Hepatic DNA methylation modifications in early development of rats resulting from perinatal BPA exposure contribute to insulin resistance in adulthood. Diabetologia 56(9): 2059-2067
Umeda, K.; Shiraki, N.; Kume, S. 2016: Hepatic Differentiation from Human Ips Cells Using M15 Cells. Methods in Molecular Biology 1357: 375-381
Yamazoe, T.; Shiraki, N.; Kume, S. 2016: Hepatic Differentiation from Murine and Human iPS Cells Using Nanofiber Scaffolds. Methods in Molecular Biology 1357: 475-483
Penn, I.; Hammond, W.; Bell, P.; McGuire, R.; Hutt, M.; Starzl, T. 1969: Hepatic Disorders in Renal Homograft Recipients. Current Topics in Surgical Research 1: 67-76
Ward, G.R. 1911: Hepatic Distomiasis (Sheep Rot) in man. British Medical Journal 1(2625): 931-935
Brown, M.J. 1928: Hepatic Efficiency: the Value of the Hæmoclastic and the Lævulose Tests in Childhood. Archives of Disease in Childhood 3(14): 81-95
Chen, A.; Guo, Z.; Zhou, L.; Yang, H. 2010: Hepatic Endosome Protein Profiling in Apolipoprotein e Deficient Mice Expressing Apolipoprotein B48 but not B100. Journal of Bioanalysis and Biomedicine 2(5): 100-106
Demuynck, F.; Morvan, J.; Brochart, C.; Blanpain, S.; Brasseur, A.; Boukadoum, N.; Herlin, C.; Fuks, D.; Chatelain, D.; Yzet, T.; Deramond, A. 2009: Hepatic Epithelioid hemangioendothelioma: a rare liver tumor. Journal de Radiologie 90(7-8 Pt 1: 845-848
Pak, K.; Kim, S-Jang.; Kim, I.Joo.; Kim, K.; Kim, H.; Kim, S.Jung. 2012: Hepatic FDG Uptake is not Associated with Hepatic Steatosis but with Visceral Fat Volume in Cancer Screening. Nuclear Medicine and Molecular Imaging 46(3): 176-181
Abdolazimi, Y.; Zhao, Z.; Lee, S.; Xu, H.; Allegretti, P.; Horton, T.M.; Yeh, B.; Moeller, H.P.; Nichols, R.J.; McCutcheon, D.; Shalizi, A.; Smith, M.; Armstrong, N.A.; Annes, J.P. 2018: CC-401 Promotes β-Cell Replication via Pleiotropic Consequences of DYRK1A/B Inhibition. Endocrinology 159(9): 3143-3157
Cui, Y.; Giesy, S.L.; Hassan, M.; Davis, K.; Zhao, S.; Boisclair, Y.R. 2014: Hepatic FGF21 production is increased in late pregnancy in the mouse. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 307(3): R290-R298
You, C.Ran.; Jang, J.Won.; Choi, J.Ki.; Bae, S.Hyun.; Yoon, S.Kew.; Kay, C.Seung.; Choi, J.Young. 2010: Hepatic Failure Caused by Reactivation of YMDD Mutants Occurring during Preemptive Lamivudine Therapy. Gut and Liver 4(2): 262-265
Anonymous 1955: Hepatic Fibrosis. British Medical Journal 1(4908): 274-275
Kang, K.-H.; Qian, Z.-J.; Ryu, B.; Karadeniz, F.; Kim, D.; Kim, S.-K. 2013: Hepatic Fibrosis Inhibitory Effect of Peptides Isolated from Navicula incerta on TGF-β1 Induced Activation of LX-2 Human Hepatic Stellate Cells. Preventive Nutrition and Food Science 18(2): 124-132
Gonnert, F.A.; Kunisch, E.; Gajda, M.; Lambeck, S.; Weber, M.; Claus, R.A.; Bauer, M.; Kinne, R.W. 2012: Hepatic Fibrosis in a Long-term Murine Model of Sepsis. Shock 37(4): 399-407
Haeusler, R.A.; Han, S.; Accili, D. 2010: Hepatic FoxO1 ablation exacerbates lipid abnormalities during hyperglycemia. Journal of Biological Chemistry 285(35): 26861-26868
Zhou, X.; Zeng, X.-Y.; Wang, H.; Li, S.; Jo, E.; Xue, C.C.L.; Tan, M.; Molero, J.C.; Ye, J.-M. 2014: Hepatic FoxO1 acetylation is involved in oleanolic acid-induced memory of glycemic control: novel findings from Study 2. Plos one 9(9): E107231
Ido-Kitamura, Y.; Sasaki, T.; Kobayashi, M.; Kim, H.-J.; Lee, Y.-S.; Kikuchi, O.; Yokota-Hashimoto, H.; Iizuka, K.; Accili, D.; Kitamura, T. 2012: Hepatic FoxO1 integrates glucose utilization and lipid synthesis through regulation of Chrebp O-glycosylation. Plos one 7(10): E47231
Tao, R.; Wei, D.; Gao, H.; Liu, Y.; DePinho, R.A.; Dong, X.C. 2011: Hepatic FoxOs regulate lipid metabolism via modulation of expression of the nicotinamide phosphoribosyltransferase gene. Journal of Biological Chemistry 286(16): 14681-14690
Wang, H.; Feng, M.; Frey, K.; Balter, J.; Haken, R.T.; Lawrence, T.; Cao, Y. 2013: Hepatic Function Model Based Upon HIDA SPECT and Dose for Physiological Adaptive RT. Practical Radiation Oncology 3(2 Suppl 1: S2
Anonymous 1897: Hepatic Glycogenesis. British Medical Journal 2(1924): 1433-1434
Kapitsinou, P.P.; Liu, Q.; Unger, T.L.; Rha, J.; Davidoff, O.; Keith, B.; Epstein, J.A.; Moores, S.L.; Erickson-Miller, C.L.; Haase, V.H. 2010: Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia. Blood 116(16): 3039-3048
Jabłonowska, E.żb.; Wójcik, K.; Szymańska, B.że.; Omulecka, A.; Cwiklińska, H.; Piekarska, A. 2014: Hepatic HMOX1 expression positively correlates with Bach-1 and miR-122 in patients with HCV mono and HIV/HCV coinfection. Plos one 9(4): E95564
Matz-Soja, M.; Aleithe, S.; Marbach, E.; Böttger, J.; Arnold, K.; Schmidt-Heck, W.; Kratzsch, Jürgen.; Gebhardt, R. 2014: Hepatic Hedgehog signaling contributes to the regulation of IGF1 and IGFBP1 serum levels. Cell Communication and Signaling: Ccs 12: 11
Zitelli, B.J.; Gartner, J.C.; Malatack, J.J.; Shaw, B.W.; Iwatsuki, S.; Starzl, T.E. 1983: Hepatic Homograft Survival in Pediatric Orthotopic Liver Transplantation with Cyclosporine and Steroids. Transplantation Proceedings 15(4 Suppl 1: 2592-2596
Ilmakunnas, M.; Höckerstedt, K.; Mäkisalo, H.; Siitonen, S.; Repo, H.; Pesonen, E.J. 2010: Hepatic IL-8 release during graft procurement is associated with impaired graft function after human liver transplantation. Clinical Transplantation 24(1): 29-35
Honda, M.; Sakai, A.; Yamashita, T.; Nakamoto, Y.; Mizukoshi, E.; Sakai, Y.; Yamashita, T.; Nakamura, M.; Shirasaki, T.; Horimoto, K.; Tanaka, Y.; Tokunaga, K.; Mizokami, M.; Kaneko, S.; Kagaya, T.; Arai, K.; Kakinoki, K.; Kawaguchi, K.; Takatori, H.; Sunakosaka, H.; Nakahama, T.; Kamiyamamoto, S.; Takemori, Y.; Oguri, H.; Noda, Y.; Ogino, H.; Hinoue, Y.; Minouchi, K.; Hirai, N.; Sugimoto, T.; Adachi, K.; Nakamura, Y.; Unoura, M.; Nishino, R.; Morimoto, H.; Ohta, H.; Tsuji, H.; Iwata, A.; Terasaki, S.; Wakabayashi, T.; Shirota, Y.; Urabe, T.; Kawai, H.; Mizuno, Y.; Kameda, S.; Miyamori, H.; Fuchizaki, U.; Shyugo, H.; Osaka, H.; Matsushita, E.; Katou, Y.; Tanaka, N.; Notsumata, K.; Kumagai, M.; Yoneshima, M. 2010: Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. Gastroenterology 139(2): 499-509
Carslaw, R.W. 1939: Hepatic Insufficiency in Scarlet Fever. British Medical Journal 2(4100): 278-279
Solari, P.R.; Jones, C.; Wallace, M.R. 2014: Hepatic Lesions with Secondary Syphilis in an HIV-Infected Patient. Case Reports in Medicine 2014: 604794
Beljaars, L.; Schippers, M.; Reker-Smit, C.; Martinez, F.O.; Helming, L.; Poelstra, K.; Melgert, B.N. 2014: Hepatic Localization of Macrophage Phenotypes during Fibrogenesis and Resolution of Fibrosis in Mice and Humans. Frontiers in Immunology 5: 430
Bashir, M.R.; Merkle, E.M.; Smith, A.D.; Boll, D.T. 2012: Hepatic MR imaging for in vivo differentiation of steatosis, iron deposition and combined storage disorder: single-ratio in/opposed phase analysis vs. dual-ratio Dixon discrimination. European Journal of Radiology 81(2): E101-E109
Guglielmo, F.F.; Mitchell, D.G.; Roth, C.G.; Deshmukh, S. 2014: Hepatic MR imaging techniques, optimization, and artifacts. Magnetic Resonance Imaging Clinics of North America 22(3): 263-282
Li, J.; Viswanadha, S.; Loor, J.J. 2012: Hepatic Metabolic, Inflammatory, and Stress-Related Gene Expression in Growing Mice Consuming a Low Dose of Trans-10, cis-12-Conjugated Linoleic Acid. Journal of Lipids 2012: 571281
Radhi, J.; Ara, S.; Ruo, L. 2012: Hepatic Metastasis of Composite Adenocarcinoma and Neuroendocrine Carcinoma. Journal of Gastrointestinal Cancer 43(Suppl 1): S25-S27
Moir, J.A.G.; Haugk, B.; French, J.J. 2010: Hepatic Metastasis via a Ventriculo-Peritoneal Shunt from an Intracranial Meningioma: Case Report and Review of the Literature. Case Reports in Gastroenterology 4(2): 267-272
Floreani, A.; Antoniazzi, S.; Mescoli, C.; Bergasa, N.V. 2012: Hepatic Methionine-enkephalin may interfere with response to antiviral therapy in chronic hepatitis C. European Journal of Gastroenterology and Hepatology 24(4): 427-430
Quist, E.M.; Filgo, A.J.; Cummings, C.A.; Kissling, G.E.; Hoenerhoff, M.J.; Fenton, S.E. 2015: Hepatic Mitochondrial Alteration in CD-1 Mice Associated with Prenatal Exposures to Low Doses of Perfluorooctanoic Acid (PFOA). Toxicologic Pathology 43(4): 546-557
Campion, S.N.; Johnson, R.; Aleksunes, L.M.; Goedken, M.J.; van Rooijen, N.; Scheffer, G.L.; Cherrington, N.J.; Manautou, J.é E. 2008: Hepatic Mrp4 induction following acetaminophen exposure is dependent on Kupffer cell function. American Journal of Physiology. Gastrointestinal and Liver Physiology 295(2): G294-G304
Xie, Y.; Fung, H.Y.J.; Newberry, E.P.; Kennedy, S.; Luo, J.; Crooke, R.M.; Graham, M.J.; Davidson, N.O. 2014: Hepatic Mttp deletion reverses gallstone susceptibility in L-Fabp knockout mice. Journal of Lipid Research 55(3): 540-548
Suzuki, T.; Uetsuka, K.; Kusanagi, K.; Hirai, T.; Nunoya, T.; Doi, K. 2010: Hepatic Myelolipoma with systemic amyloidosis in a goose (Anser cygnoides domesticus). Journal of Veterinary Medical Science 72(5): 669-671
McCarthy, C.F.; Sheridan, M.R. 1960: Hepatic Necrosis Due to Marsilid. Gut 1(2): 169-170
Pramfalk, C.; Jiang, Z.-Y.; Parini, P. 2011: Hepatic Niemann-Pick C1-like 1. Current Opinion in Lipidology 22(3): 225-230
Temel, R.E.; Tang, W.; Ma, Y.; Rudel, L.L.; Willingham, M.C.; Ioannou, Y.A.; Davies, J.P.; Nilsson, L-Mari.; Yu, L. 2007: Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. Journal of Clinical Investigation 117(7): 1968-1978
Petruzzelli, M.; Moschetta, A. 2007: Hepatic Niemann-Pick C1-like 1: the canalicular side of the coin. Hepatology 46(6): 2040-2042
Marina, R.; González, P.; Ferreras, M.Carmen.; Costilla, Sín.; Barrio, J-Pablo. 2015: Hepatic Nrf2 expression is altered by quercetin supplementation in X-irradiated rats. Molecular Medicine Reports 11(1): 539-546
Fahrmayr, C.; Fromm, M.F.; König, J.ör. 2010: Hepatic OATP and OCT uptake transporters: their role for drug-drug interactions and pharmacogenetic aspects. Drug Metabolism Reviews 42(3): 380-401
Meyer zu Schwabedissen, H.E.; Kim, R.B. 2009: Hepatic OATP1B transporters and nuclear receptors PXR and CAR: interplay, regulation of drug disposition genes, and single nucleotide polymorphisms. Molecular Pharmaceutics 6(6): 1644-1661
Moore, J.N.; Newsted, J.L.; Hecker, M.; Zwiernik, M.J.; Fitzgerald, S.D.; Kay, D.P.; Zhang, X.; Higley, E.B.; Aylward, L.L.; Beckett, K.J.; Budinsky, R.A.; Bursian, S.J.; Giesy, J.P. 2009: Hepatic P450 enzyme activity, tissue morphology and histology of mink (Mustela vison) exposed to polychlorinated dibenzofurans. Archives of Environmental Contamination and Toxicology 57(2): 416-425
Khan, H.M.; Katz, S.C.; Libbey, N.P.; Somasundar, P.S. 2014: Hepatic PEComa: a potential pitfall in the evaluation of hepatic neoplasms. BMJ Case Reports
Garcia-Manero, G.; Scott, B.L.; Cogle, C.R.; Boyd, T.E.; Kambhampati, S.; Hetzer, J.; Dong, Q.; Kumar, K.; Ukrainskyj, S.M.; Beach, C.L.; Skikne, B.S. 2018: CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia. Leukemia Research 72: 79-85
Zardi, E.M.; Navarini, L.; Sambataro, G.; Piccinni, P.; Sambataro, F.M.; Spina, C.; Dobrina, A. 2013: Hepatic PPARs: their role in liver physiology, fibrosis and treatment. Current medicinal chemistry 20(27): 3370-3396
Matsusue, K.; Aibara, D.; Hayafuchi, R.; Matsuo, K.; Takiguchi, S.; Gonzalez, F.J.; Yamano, S. 2014: Hepatic PPARγ and LXRα independently regulate lipid accumulation in the livers of genetically obese mice. FEBS letters 588(14): 2277-2281
Peyrou, M.; Bourgoin, L.; Poher, A.-L.; Altirriba, J.; Maeder, C.; Caillon, A.él.; Fournier, M.; Montet, X.; Rohner-Jeanrenaud, F.ço.; Foti, M. 2015: Hepatic PTEN deficiency improves muscle insulin sensitivity and decreases adiposity in mice. Journal of Hepatology 62(2): 421-429
Bence, K.K. 2010: Hepatic PTP1B Deficiency: the Promise of a Treatment for Metabolic Syndrome?. Journal of Clinical Metabolism and Diabetes 1(1): 27-33
Li, M.; Chang, B.; Zhen, Z.; Qin, P.-J.; Liu, W.-K.; Tong, X.-L. 2011: Hepatic PTP1B expression involvement in the effects of Chinese medicine formula xiao-gao-jiang-zhuo using an obese rat model. American Journal of Chinese Medicine 39(2): 301-313
Hou, J.; Zhou, Y.; Zheng, Y.; Fan, J.; Zhou, W.; Ng, I.O.L.; Sun, H.; Qin, L.; Qiu, S.; Lee, J.M.F.; Lo, C.-M.; Man, K.; Yang, Y.; Yang, Y.; Yang, Y.; Zhang, Q.; Zhu, X.; Li, N.; Wang, Z.; Ding, G.; Zhuang, S.-M.; Zheng, L.; Luo, X.; Xie, Y.; Liang, A.; Wang, Z.; Zhang, M.; Xia, Q.; Liang, T.; Yu, Y.; Cao, X. 2014: Hepatic RIG-i predicts survival and interferon-α therapeutic response in hepatocellular carcinoma. Cancer Cell 25(1): 49-63
Terblanche, J.; Starzl, T.E. 1979: Hepatic Regeneration. Viewpoints on Digestive Diseases 11(4): 40182
Niu, G-Cai.; Shen, C-Ming.; Cui, W.; Li, Q. 2012: Hepatic Resection is Safe for Metachronous Hepatic Metastases from Ovarian Cancer. Cancer Biology and Medicine 9(3): 182-187
Miyazaki, M.; Shimizu, H.; Ohtsuka, M.; Yoshidome, H.; Kato, A.; Yoshitomi, H.; Furukawa, K.; Kimura, F. 2012: Hepatic S4a + S5 and bile duct resection for gallbladder carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 19(3): 225-229
Sheng, L.; Liu, Y.; Jiang, L.; Chen, Z.; Zhou, Y.; Cho, K.W.; Rui, L. 2013: Hepatic SH2B1 and SH2B2 regulate liver lipid metabolism and VLDL secretion in mice. Plos one 8(12): E83269
Xu, J.; Li, N.; Wang, J.; Zhang, C.; Ding, S.; Jiao, Y. 2012: Hepatic SIRT1 and UCP2 expressions in rats with type 2 diabetes mellitus and nonalcoholic fatty liver. Nan Fang Yi Ke da Xue Xue Bao 32(5): 726-729
Li, Y.; Wong, K.; Giles, A.; Jiang, J.; Lee, J.W.; Adams, A.C.; Kharitonenkov, A.; Yang, Q.; Gao, B.; Guarente, L.; Zang, M. 2014: Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21. Gastroenterology 146(2): 539-49.E7
De Lima, M.; Oran, B.; Champlin, R.E.; Papadopoulos, E.B.; Giralt, S.A.; Scott, B.L.; William, B.M.; Hetzer, J.; Laille, E.; Hubbell, B.; Skikne, B.S.; Craddock, C. 2018: CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 24(10): 2017-2024
Wiersma, H.; Gatti, A.; Nijstad, N.; Kuipers, F.; Tietge, U.J.F. 2009: Hepatic SR-BI, not endothelial lipase, expression determines biliary cholesterol secretion in mice. Journal of Lipid Research 50(8): 1571-1580
Tannour-Louet, M.; York, B.; Tang, K.; Stashi, E.; Bouguerra, H.; Zhou, S.; Yu, H.; Wong, L.-J.C.; Stevens, R.D.; Xu, J.; Newgard, C.B.; O'Malley, B.W.; Louet, J.-F. 2014: Hepatic SRC-1 activity orchestrates transcriptional circuitries of amino acid pathways with potential relevance for human metabolic pathogenesis. Molecular Endocrinology 28(10): 1707-1718
Tao, R.; Xiong, X.; DePinho, R.A.; Deng, C.-X.; Dong, X.C. 2013: Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6. Journal of Lipid Research 54(10): 2745-2753
Kim, H.Y.; Cho, H.K.; Yoo, S.K.; Cheong, J.H. 2012: Hepatic STAMP2 decreases hepatitis B virus X protein-associated metabolic deregulation. Experimental and Molecular Medicine 44(10): 622-632
Miyamura, T.; Kanda, T.; Nakamoto, S.; Wu, S.; Fujiwara, K.; Imazeki, F.; Yokosuka, O. 2011: Hepatic STAT1-nuclear translocation and interleukin 28B polymorphisms predict treatment outcomes in hepatitis C virus genotype 1-infected patients. Plos one 6(12): E28617
Ishaqi, M.K.; Jamil, A.; Khanani, M.; Baroudi, M.; Trad, O.; El-Hayek, M.; Bouffet, E. 2010: Hepatic Sinusoidal Obstruction Syndrome in a child after chemotherapy for medulloblastoma. Journal of Neuro-Oncology 97(1): 137-141
Wang, R.-H.; Kim, H.-S.; Xiao, C.; Xu, X.; Gavrilova, O.; Deng, C.-X. 2011: Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance. Journal of Clinical Investigation 121(11): 4477-4490
Berzsenyi, M.D.; Roberts, S.K.; Preiss, S.; Woollard, D.J.; Beard, M.R.; Skinner, N.A.; Bowden, D.S.; Visvanathan, K. 2011: Hepatic TLR2 and TLR4 expression correlates with hepatic inflammation and TNF-α in HCV and HCV/HIV infection. Journal of Viral Hepatitis 18(12): 852-860
Chen, Z.; Sheng, L.; Shen, H.; Zhao, Y.; Wang, S.; Brink, R.; Rui, L. 2012: Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses. Diabetes 61(3): 566-573
Yuki, N.; Matsumoto, S.; Kato, M.; Yamaguchi, T. 2010: Hepatic Toll-Like Receptor 3 expression in chronic hepatitis C genotype 1 correlates with treatment response to peginterferon plus ribavirin. Journal of Viral Hepatitis 17(2): 130-138
Hennenberg, M.; Trebicka, J.; Fischer, H.-P.; Heller, J.ör.; Sauerbruch, T. 2009: Hepatic VASP upregulation in rats with secondary biliary cirrhosis by expression in the peribiliary vascular plexus. Microvascular Research 78(2): 235-240
Cano, A.; Ciaffoni, F.; Safwat, G.M.; Aspichueta, P.; Ochoa, B.ña.; Bravo, E.; Botham, K.M. 2009: Hepatic VLDL assembly is disturbed in a rat model of nonalcoholic fatty liver disease: is there a role for dietary coenzyme Q?. Journal of Applied Physiology 107(3): 707-717
Gill, J.M.R.; Sattar, N. 2011: Hepatic VLDL overproduction: is hyperinsulinemia or insulin resistance the culprit?. Journal of Clinical Endocrinology and Metabolism 96(7): 2032-2034
Inoue, Y.; Saiura, A.; Arita, J.; Takahashi, Y. 2015: Hepatic Vein-Oriented Liver Resection Using Fusion Indocyanine Green Fluorescence Imaging. Annals of Surgery 262(6): E98-E99
Maithel, S.K.; Fong, Y. 2009: Hepatic ablation for neuroendocrine tumor metastases. Journal of Surgical Oncology 100(8): 635-638
Tang, W.; Zhang, X.-M.; Zhai, Z.-H.; Zeng, N.-L. 2013: Hepatic abnormal perfusion visible by magnetic resonance imaging in acute pancreatitis. World Journal of Radiology 5(12): 491-497
Feinstein, E.G.; Marr, B.P.; Winston, C.B.; Abramson, D.H. 2010: Hepatic abnormalities identified on abdominal computed tomography at diagnosis of uveal melanoma. Archives of Ophthalmology 128(3): 319-323
Deshayes, S.; Galateau-Sallé, F.; de La Blanchardière, A. 2015: Hepatic abnormality. La Revue de Medecine Interne 36(5): 363-364
Tallón-Aguilar, L.; Gutiérrez-Moreno, M.; Flores-Cortés, M.; Pareja-Ciuró, F. 2008: Hepatic abscess after scrape for natural abortion. Medicina Clinica 131(17): 679
Mascarenhas, N.B.; Mulcahy, M.F.; Lewandowski, R.J.; Salem, R.; Ryu, R.K. 2010: Hepatic abscess after yttrium-90 radioembolization for islet-cell tumor hepatic metastasis. Cardiovascular and Interventional Radiology 33(3): 650-653
Soares, J.ão.-B.; Ferreira, A.íb.; Gonçalves, R. 2011: Hepatic abscess and colonic stenosis: two complications of an unlikely cause. Gastroenterology 141(3): E9
Ballardini, P.; Gamberini, S.; Margutti, G.; Manfredini, R. 2008: Hepatic abscess and silent underlying colon cancer: an emerging association?. Tumori 94(4): 624
Fusaro, F.; Lo Piccolo, R.; Scarpa, M.G.; Orzali, A.; Trafojer, U.; Zanon, G.F. 2003: Hepatic abscess and umbilical venous catheter: one cannot be cavalier about proper position. Journal of Vascular Access 4(1): 32-34
Gilardi, L.; Eugenia Dellepiane, M.ía. 2011: Hepatic abscess as first manifestation of pneumococcal invasive disease. Revista Chilena de Infectologia: Organo Oficial de la Sociedad Chilena de Infectologia 28(4): 381
Székely, A.ár.; Péter, M.óz.; Erdos, M.; Maródi, L.ás.ó 2012: Hepatic abscess as the single manifestation of X-linked chronic granulomatous disease. Pediatric Blood and Cancer 58(5): 828-829
Tulachan, S.S.; Wilkins, C.E.; Cutrona, A.F.; Gemmel, D.; Marnejon, T.P. 2013: Hepatic abscess associated with Salmonella serotype B in a chronic alcoholic patient. Hepatobiliary and Pancreatic Diseases International: Hbpd Int 12(4): 440-442
Cardoso, C.áu.; Freire, R.; Mangualde, J.; Oliveira, A.P. 2013: Hepatic abscess caused by an ingested chicken bone. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 105(1): 44-45
Morelli, L.; Morelli, J.N.; Rosati, C.M.; Guadagni, S.; Doria, R.; Pisano, R.; Crocetti, L.; Tagliaferri, E.; Mosca, F. 2015: Hepatic abscess caused by trans-gastric migration of a fishbone. Surgical Infections 16(2): 206-208
Price, S.; Chang, T. 1946: Hepatic abscess complicating atresia of the small intestine of a newborn infant. Archives of Pathology 41: 450-453
Chatzipetrou, M.; Avgerinos, E.; Christianakis, E.; Barmparas, G.; Pashalidis, N.; Stathoulopoulos, A.; Tsatsoulis, P.; Smailis, D.; Filippou, D. 2008: Hepatic abscess in a pre-existed simple hepatic cyst as a late complication of sigmoid colon ruptured diverticula: a case report. Journal of Medical Case Reports 2: 83
Sharma, S.; Mohta, A.; Sharma, P. 2007: Hepatic abscess in a preterm neonate. Indian Pediatrics 44(3): 226-228
Santos, S.A.; Alberto, S.C.F.; Cruz, E.; Pires, E.; Figueira, Tás.; Coimbra, E.; Estevez, Jé.; Oliveira, Mário.; Novais, Lís.; Deus, Jão.R. 2007: Hepatic abscess induced by foreign body: case report and literature review. World Journal of Gastroenterology 13(9): 1466-1470
Kim, J.W.; Shin, S.S.; Heo, S.H.; Lim, H.S.; Hur, Y.H.; Kim, J.H. 2013: Hepatic abscess mimicking hepatocellular carcinoma in a patient with alcoholic liver disease. Clinical and Molecular Hepatology 19(4): 431-434
Staines, E. 1952: Hepatic abscess ruptured into the bronchi. Revista Mexicana de Tuberculosis y Enfermedades del Aparato Respiratorio 13(63): 61-67
Kark, W. 1945: Hepatic abscess secondarily infected; penicillin treatment. Indian Medical Gazette 80: 451
Karamarkovic, A.-R.; Djuranovic, S.-P.; Popovic, N.-P.; Bumbasirevic, V.-D.; Sijacki, A.-D.; Blazic, I.-V. 2007: Hepatic abscess secondary to a rosemary twig migrating from the stomach into the liver. World Journal of Gastroenterology 13(41): 5530-5532
Beaver, M.G.; Davis, P.B.; Smith, R.S. 1946: Hepatic abscess secondary to perforated duodenal ulcer. Northwest Medicine 45: 94-96
Huang, R.J.; Ambrosy, A.P.; Triadafilopoulos, G. 2013: Hepatic abscess with biliary communication following transarterial chemoembolization of hepatocellular carcinoma. Digestive Diseases and Sciences 58(9): 2463-2465
McKaigney, C. 2013: Hepatic abscess: case report and review. Western Journal of Emergency Medicine 14(2): 154-157
Hegarty, R.Mark.; Sanka, S.; Bansal, S. 2013: Hepatic abscess: presentation in a previously healthy teenager. Archives of Disease in Childhood 98(2): 145
Fantuzzi S, Aés.; Albertz A, Nás.; Valenzuela V, A.; Estuardo A, N.; Castro L, A. 2009: Hepatic abscess: series of 107 cases and literature review. Revista Chilena de Infectologia: Organo Oficial de la Sociedad Chilena de Infectologia 26(1): 49-53
Kinney, T.D.; Ferrebee, J.W. 1948: Hepatic abscess; factors determining its localization. Archives of Pathology 45(1): 41-47
Nikeghbalian, S.; Salahi, R.; Salahi, H.; Bahador, A.; Kakaie, F.; Kazemi, K.; Malek-Hosseini, S.Ali.; Janghorban, P. 2009: Hepatic abscesses after liver transplant: 1997-2008. Experimental and clinical transplantation: official journal of the Middle East Society for Organ Transplantation 7(4): 256-260
Campoamor Serrano, M.ía.T.; Galiana Martín, D.; Noval Menéndez, J.; de la Fuente García, B.én. 2007: Hepatic abscesses and hepatic venous thrombosis due to Fusobacterium necrophorum septicemia: Lemierre syndrome variant. Medicina Clinica 129(5): 197-198
Raposeiras Roubín, S.; Cabarcos Ortiz De Barrón, A.; Maldonado Bakovic, A.M.; Barreiro Pardal, C. 2010: Hepatic abscesses in a sepsis context due to Gemella morbillorum: base for gastric adenocarcinoma diagnosis. Revista Clinica Espanola 210(3): 146-147
Johnson, A.L.; Ducore, R.M.; Colgin, L.M.; Lewis, A.D. 2014: Hepatic abscesses in five outdoor-housed rhesus macaques (Macaca mulatta). Journal of Medical Primatology 43(6): 503-506
Sellon, D.C.; Spaulding, K.; Breuhaus, B.A.; Katz, L.; Mealey, R. 2000: Hepatic abscesses in three horses. Journal of the American Veterinary Medical Association 216(6): 882
Koral, K.F.; Huberty, J.P.; Frame, B.; Matthay, K.K.; Maris, J.M.; Regan, D.; Normolle, D.; Yanik, G.A. 2008: Hepatic absorbed radiation dosimetry during I-131 metaiodobenzylguanidine (MIBG) therapy for refractory neuroblastoma. European Journal of Nuclear Medicine and Molecular Imaging 35(11): 2105-2112
Minet, J.; Warembourg, H.; Niquet 1950: Hepatic accidents during streptomycin therapy and their treatment by vitamin C in massive doses. La Revue du Foie 9(2): 69-72
Kamili, A.; Wat, E.; Chung, R.Ws.; Tandy, S.; Weir, J.M.; Meikle, P.J.; Cohn, J.S. 2010: Hepatic accumulation of intestinal cholesterol is decreased and fecal cholesterol excretion is increased in mice fed a high-fat diet supplemented with milk phospholipids. Nutrition and Metabolism 7: 90
Martínez-Vázquez, M.A.; Garza-Galindo, A.A.; Barboza-Quintana, O.; Garza-Guajardo, R.; Navar-Vizcarra, S.; Rodríguez-Leal, M.C.; Maldonado-Garza, H.J. 2010: Hepatic actinomycosis ; presentation a case in a diabetic patient. Revista de Gastroenterologia de Mexico 75(3): 344-347
Ding, N.; Liddle, C.; Evans, R.M.; Downes, M. 2013: Hepatic actions of vitamin D receptor ligands: a sunshine option for chronic liver disease?. Expert Review of Clinical Pharmacology 6(6): 597-599
Jones, R.P.; Sutton, P.; Greensmith, R.M.D.; Santoyo-Castelazo, A.; Carr, D.F.; Jenkins, R.; Rowe, C.; Hamlett, J.; Park, B.K.; Terlizzo, M.; O'Grady, E.; Ghaneh, P.; Fenwick, S.W.; Malik, H.Z.; Poston, G.J.; Kitteringham, N.R. 2013: Hepatic activation of irinotecan predicts tumour response in patients with colorectal liver metastases treated with DEBIRI: exploratory findings from a phase II study. Cancer ChemoTherapy and Pharmacology 72(2): 359-368
Bode, J.G.; Albrecht, U.; Häussinger, D.; Heinrich, P.C.; Schaper, F. 2012: Hepatic acute phase proteins--regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-κB-dependent signaling. European Journal of Cell Biology 91(6-7): 496-505
Sander, L.E.; Sackett, S.D.; Dierssen, U.; Beraza, N.; Linke, R.P.; Müller, M.; Blander, J.M.; Tacke, F.; Trautwein, C. 2010: Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. Journal of Experimental Medicine 207(7): 1453-1464
Monetti, M.; Levin, M.C.; Watt, M.J.; Hubbard, B.K.; Newgard, C.; Farese, R.V.; Hevener, A.L.; Farese, R.V. 2011: Hepatic acyl-CoA:diacylglcyerol acyltransferase (DGAT) overexpression, diacylglycerol, and insulin sensitivity. Proceedings of the National Academy of Sciences of the United States of America 108(34): E523; Author Reply E524
Marion, V.; Sankaranarayanan, S.; de Theije, C.; van Dijk, P.; Hakvoort, T.B.M.; Lamers, W.H.; Köhler, E.S. 2013: Hepatic adaptation compensates inactivation of intestinal arginine biosynthesis in suckling mice. Plos one 8(6): E67021
Lim, D.; Lee, S.Y.; Lim, K.H.; Chan, C.Y. 2013: Hepatic adenoma mimicking a metastatic lesion on computed tomography-positron emission tomography scan. World Journal of Gastroenterology 19(27): 4432-4436
Allmark, E. 2007: Hepatic adenoma: an unusual cause of abdominal pain. Emergency Nurse: the Journal of the Rcn Accident and Emergency Nursing Association 15(3): 18-22
Lee, P.U.Y.; Roberts, L.R.; Kaiya, J.K.; Lee, C.U. 2010: Hepatic adenomas associated with anti-epileptic drugs: a case series and imaging review. Abdominal Imaging 35(2): 208-211
Holter, S.; Pollett, A.; Zogopoulos, G.; Kim, H.; Schwenter, F.; Asai, K.; Gallinger, S.; Clendenning, M.; Steinbach, G.; Jacobson, A.; Boycott, K.M. 2011: Hepatic adenomas caused by somatic HNF1A mutations in children with biallelic mismatch repair gene mutations. Gastroenterology 140(2): 735-736
Ronald, M.; Woodfield, J.; McCall, J.; Koea, J. 2004: Hepatic adenomas in male patients. Hpb: the Official Journal of the International Hepato Pancreato Biliary Association 6(1): 25-27
Lorenzo Garrido, H.; Rotaetxe Vacas, O.; García Barcina, M.J.; Muñoz García, G.; Martín Bejarano, E. 2008: Hepatic adenomatosis. Anales de Pediatria 68(5): 526-527
Babaoglu, K.; Binnetoglu, F.K.ök.; Aydoğan, A.şe.; Altun, G.ür.; Gürbüz, Y.şi.; Inan, N.; Corapçioğlu, F. 2010: Hepatic adenomatosis in a 7-year-old child treated earlier with a Fontan procedure. Pediatric Cardiology 31(6): 861-864
Kwon, J.E.; Park, Y.N. 2008: Hepatic adenomatosis in glycogen storage disease. Korean Journal of Hepatology 14(1): 108-112
Sanli, Y.; Bakir, B.; Kuyumcu, S.; Ozkan, Z.Gozde.; Gulluoglu, M.; Bilge, O.; Turkmen, C.; Mudun, A. 2012: Hepatic adenomatosis may mimic metastatic lesions of liver with 18F-FDG PET/CT. Clinical Nuclear Medicine 37(7): 697-698
De Kock, I.; Mortelé, K.J.; Smet, B.; Gillardin, P.; Pauwels, W.; De Backer, A.I. 2014: Hepatic adenomatosis: MR imaging features. Jbr-Btr: Organe de la Societe Royale Belge de Radiologie 97(2): 105-108
Lucas, E.; Pareja, E.; Carvajal, N.ás.; Pacheco, A.; Moya, A. 2014: Hepatic adenomatosis: a disease with controversial treatment. Cirugia Espanola 92(4): 284-286
Raman, S.P.; Hruban, R.H.; Fishman, E.K. 2013: Hepatic adenomatosis: spectrum of imaging findings. Abdominal Imaging 38(3): 474-481
Qin, Y.; Tian, Y.-P. 2010: Hepatic adiponectin receptor R2 expression is up-regulated in normal adult male mice by chronic exogenous growth hormone levels. Molecular Medicine Reports 3(3): 525-530
Shin, Y.M. 2010: Hepatic adrenal rest tumor mimicking hepatocellular carcinoma. Korean Journal of Hepatology 16(3): 338-341
Soo, K.Ling.; Azhar, R.; Ooi, L.Lucien. 2014: Hepatic adrenal rest tumour (HART): a case report. Annals of the Academy of Medicine Singapore 43(2): 120-122
Lindh, J. 2009: Hepatic adverse effects of allopurinol. Lakartidningen 106(38): 2374-2375
Schultz, A.; Neil, D.; Aguila, M.B.; Mandarim-de-Lacerda, C.A. 2013: Hepatic adverse effects of fructose consumption independent of overweight/obesity. International Journal of Molecular Sciences 14(11): 21873-21886
Anonymous 2010: Hepatic adverse effects of pregabalin (Lyrica). Lakartidningen 107(4): 194
Sherlock, S.; Walshe, V. 1947: Hepatic alkaline phosphatase; histological and microchemical studies on liver tissue in normal subjects and in liver and in bone disease. Journal of Pathology and Bacteriology 59(4): 615-630
Cabello Muriel, A.; Marín Pozo, J.F.; Alcalá Sanz, A.; Carrillo Ortiz, D. 2011: Hepatic alteration after treatment using tolvaptan. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 35(2): 94-96
De Melo, G.C.; Donatti, L.él.; Rudniki, C.ác.A.M.; Fanta, E. 2008: Hepatic alterations in the fish Rhamdia quelen contaminated with Folidol 600®. Ecotoxicology and Environmental Safety 71(3): 821-829
Yapici, O.; Erturk, S.M.; Ulusay, M.; Ozel, A.; Halefoglu, A.; Karpat, Z.; Basak, M. 2011: Hepatic alveolar echinococcosis: a diagnostic challenge. Jbr-Btr: Organe de la Societe Royale Belge de Radiologie 94(1): 21-23
Guinet, C.; Guiot, E.; De Miscault, G.; Galloy, M.-A.; Rivier, A.; Petit, C.; Morali, A. 2012: Hepatic alveolar echinococcosis: a rare cause of recurrent, surgically curable abdominal pain in children. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 19(11): 1200-1204
Skelding, A.; Brooks, A.; Stalker, M.; Mercer, N.; de Villa, E.; Gottstein, B.; Peregrine, A.S. 2014: Hepatic alveolar hydatid disease (Echinococcus multilocularis) in a boxer dog from southern Ontario. Canadian Veterinary Journal 55(6): 551-553
Rao, S.; Solaymani-Mohammadi, S.; Petri, W.A.; Parker, S.K. 2009: Hepatic amebiasis: a reminder of the complications. Current Opinion in Pediatrics 21(1): 145-149
Alemán, G.; Ortiz, V.; Contreras, A.V.; Quiroz, G.; Ordaz-Nava, G.; Langley, E.; Torres, N.; Tovar, A.R. 2013: Hepatic amino acid-degrading enzyme expression is downregulated by natural and synthetic ligands of PPARα in rats. Journal of nutrition 143(8): 1211-1218
Shin, Y.Moon. 2011: Hepatic amyloidosis. Korean Journal of Hepatology 17(1): 80-83
Janssens, F.; Spahr, L.; Rubbia-Brandt, L.; Giostra, E.; Bihl, F. 2010: Hepatic amyloidosis increases liver stiffness measured by transient elastography. Acta Gastro-Enterologica Belgica 73(1): 52-54
Wee, J.W.; Jeong, S.W.; Jang, J.Y. 2012: Hepatic amyloidosis presenting as a large hepatic mass. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 10(9): E73-E74
Juárez Olguín, H.; Figueroa Hernández, J.L.; Sandoval Ramírez, E.; Villalobos Romero, F.; Tena Suck, M.; Calderón Guzmán, D. 2008: Hepatic anatomophatologic injuries by extrahepatic biliar tract obstruction in mice. Revista de Gastroenterologia de Mexico 73(1): 17-20
Anonymous 1940: Hepatic and Renal Lesions after Severe Burns. British Medical Journal 2(4164): 559-560
Pischke, S.E.; Tronstad, C.; Holhjem, L.; Line, P.ål.D.; Haugaa, H.åk.; Tønnessen, T.I. 2012: Hepatic and abdominal carbon dioxide measurements detect and distinguish hepatic artery occlusion and portal vein occlusion in pigs. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 18(12): 1485-1494
Andrews, M.; Arredondo, M. 2012: Hepatic and adipocyte cells respond differentially to iron overload, hypoxic and inflammatory challenge. Biometals: An International Journal on the Role of Metal Ions in Biology Biochemistry and Medicine 25(4): 749-759
Kamath, S.M.; Nagaraj, H.K.; Mysorekar, V.V. 2013: Hepatic and adrenal hemangioendothelioma-a case report. Journal of Clinical and Diagnostic Research: Jcdr 7(11): 2583-2584
Das, A.K. 2014: Hepatic and biliary ascariasis. Journal of Global Infectious Diseases 6(2): 65-72
Sun, Z.; Li, G.; Ai, X.; Luo, B.; Wen, Y.; Zhao, Z.; Dong, S.; Guan, J. 2011: Hepatic and biliary damage after transarterial chemoembolization for malignant hepatic tumors: incidence, diagnosis, treatment, outcome and mechanism. Critical Reviews in Oncology/Hematology 79(2): 164-174
Gyorgy, P. 1947: Hepatic and biliary disorders. Philadelphia Medicine 43(19): 629
Godinov, V.M. 1952: Hepatic and biliary nerves in man. Arkhiv Anatomii Gistologii i Embriologii 29(3): 41-47
Burlamaqui, I.ál.M.B.; Dornelas, C.ção.A.; Valença, J.é T.; Mesquita, F.J.C.; Veras, L.B.; Rodrigues, L.V. 2011: Hepatic and biochemical repercussions of a polyunsaturated fat-rich hypercaloric and hyperlipidic diet in Wistar rats. Arquivos de Gastroenterologia 48(2): 153-158
O'Glasser, A.Y.; Scott, D.L.; Corless, C.L.; Zaman, A.; Sasaki, A.; Gopal, D.V.; Rayhill, S.C.; Orloff, S.L.; Ham, J.M.; Rabkin, J.M.; Flora, K.; Davies, C.H.; Broberg, C.S.; Schwartz, J.M. 2010: Hepatic and cardiac iron overload among patients with end-stage liver disease referred for liver transplantation. Clinical Transplantation 24(5): 643-651
Bugianesi, E.; Gastaldelli, A. 2012: Hepatic and cardiac steatosis: are they coupled?. Heart Failure Clinics 8(4): 663-670
Petrova, Z.V.; Korshunov, D.A.; Slepichev, V.A.; Zyuz'kova, Y.G.; Yanovskaya, E.A.; Stykon, G.A.; Udut, V.V. 2010: Hepatic and cerebral energy production system in rats with acute and chronic ethanol intoxication. Bulletin of Experimental Biology and Medicine 149(2): 208-212
El Ouahabi, H.; Do Cao, C.; Janicki, E.; Mulliez, E.; Ajdi, F.; Wémeau, J.-L. 2011: Hepatic and cutaneous affections induced by antithyroid drugs revealing haemochromatosis and porphyria cutanea tarda. Presse Medicale 40(3): 319-323
Faustini, A.; Colais, P.; Fabrizi, E.; Bargagli, A.M.; Davoli, M.; Di Lallo, D.; Di Napoli, A.; Pezzotti, P.; Sorge, C.; Grillo, R.; Maresca, C.; Recchia, O.; Perucci, C.A. 2010: Hepatic and extra-hepatic sequelae, and prevalence of viral hepatitis C infection estimated from routine data in at-risk groups. Bmc Infectious Diseases 10: 97
Jin, Y.; Wang, W.; Sheng, G.D.; Liu, W.; Fu, Z. 2008: Hepatic and extrahepatic expression of estrogen-responsive genes in male adult zebrafish (Danio rerio) as biomarkers of short-term exposure to 17beta-estradiol. Environmental Monitoring and Assessment 146(1-3): 105-111
Saremi, B.; Mielenz, M.; Rahman, M.M.; Hosseini, A.; Kopp, C.; Dänicke, S.; Ceciliani, F.; Sauerwein, H. 2013: Hepatic and extrahepatic expression of serum amyloid A3 during lactation in dairy cows. Journal of Dairy Science 96(11): 6944-6954
Werner, M.år.; Almer, S.; Prytz, H.; Lindgren, S.; Wallerstedt, S.; Björnsson, E.; Bergquist, A.; Sandberg-Gertzén, H.; Hultcrantz, R.; Sangfelt, P.; Weiland, O.; Danielsson, A. 2009: Hepatic and extrahepatic malignancies in autoimmune hepatitis. a long-term follow-up in 473 Swedish patients. Journal of Hepatology 50(2): 388-393
Chen, Y.; Zhang, W.; Li, D.; Ai, J.; Meng, Y.; Ying, X.; Kang, T. 2013: Hepatic and gastrointestinal first-pass effects of vitexin-4″-O-glucoside in rats. Journal of Pharmacy and Pharmacology 65(10): 1500-1507
Pal, A.; Vasishta, R.k.; Prasad, R. 2013: Hepatic and hippocampus iron status is not altered in response to increased serum ceruloplasmin and serum "free" copper in Wistar rat model for non-Wilsonian brain copper toxicosis. Biological Trace Element Research 154(3): 403-411
Osselaere, A.; De Bock, L.; Eeckhaut, V.; De Backer, P.; Van Bocxlaer, J.; Boussery, K.; Croubels, S. 2013: Hepatic and intestinal CYP3A expression and activity in broilers. Journal of Veterinary Pharmacology and Therapeutics 36(6): 588-593
Yoshida, K.; Maeda, K.; Sugiyama, Y. 2013: Hepatic and intestinal drug transporters: prediction of pharmacokinetic effects caused by drug-drug interactions and genetic polymorphisms. Annual Review of Pharmacology and Toxicology 53: 581-612
Vannozzi, G.; Tozzi, A.; Chibbaro, G.; Mello, G.; Ponzalli, M. 2008: Hepatic and mesenteric sarcoidosis without thoracic involvement: a case of severe noncirrhotic portal hypertension and successful pregnancy. European Journal of Gastroenterology and Hepatology 20(10): 1032-1035
Underwood, C.; Southwood, L.L.; Walton, R.M.; Johnson, A.L. 2010: Hepatic and metabolic changes in surgical colic patients: a pilot study. Journal of Veterinary Emergency and Critical Care 20(6): 578-586
Kalisinska, E.; Gorecki, J.; Okonska, A.; Pilarczyk, B.; Tomza-Marciniak, A.; Budis, H.; Lanocha, N.; Kosik-Bogacka, D.I.; Kavetska, K.M.; Macherzynski, M.; Golas, J. 2014: Hepatic and nephric mercury and selenium concentrations in common mergansers, Mergus merganser, from Baltic Region, Europe. Environmental Toxicology and Chemistry 33(2): 421-430
Resić, J.; Cikes-Culić, V.; Zemunik, T.; Markotić, A. 2011: Hepatic and pancreatic glycosphingolipid phenotypes of the neurological different rat strains. Collegium Antropologicum 35(Suppl 1): 259-263
Barbas, A.S.; Speicher, P.J.; Clary, B.M. 2014: Hepatic and pancreatic resection in patients with end-stage renal disease: a propensity analysis. Hpb: the Official Journal of the International Hepato Pancreato Biliary Association 16(11): 1016-1022
Kordes, C.; Sawitza, I.; Häussinger, D. 2009: Hepatic and pancreatic stellate cells in focus. Biological Chemistry 390(10): 1003-1012
Egorov, V.I. 2007: Hepatic and pancreatic surgery at university hospitals of Germany. Khirurgiia 2007(9): 77-79
Marolf, A.J.; Stewart, J.A.; Dunphy, T.R.; Kraft, S.L. 2011: Hepatic and pancreaticobiliary MRi and mr cholangiopancreatography with and without secretin stimulation in normal cats. Veterinary Radiology and Ultrasound: the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association 52(4): 415-421
Beranger-Gibert, S.; Lagadec, M.; Boulay-Coletta, I.; Petit, E.; Barrau, V.; Zins, M.; Vilgrain, V.ér.; Ronot, M. 2015: Hepatic and perihepatic involvement of female genital diseases and pregnancy: a review. Abdominal Imaging 40(5): 1331-1349
Cohn, C.; Levine, R.; Kolinsky, M. 1948: Hepatic and peripheral removal rates, in the dog, for intravenously injected bromsulphalein. American Journal of Physiology 155(2): 286-289
Marks, K.A.; Kitson, A.P.; Stark, K.D. 2013: Hepatic and plasma sex differences in saturated and monounsaturated fatty acids are associated with differences in expression of elongase 6, but not stearoyl-CoA desaturase in Sprague-Dawley rats. Genes and Nutrition 8(3): 317-327
Bozgeyik, Z.; Ozdemir, H.; Kocakoc, E.; Simsek, M. 2009: Hepatic and portal venous Doppler waveforms and flow velocities in normal pregnancy. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 15(12): Cr624-Cr627
Develoux, M.; Enache-Angoulvant, A.; Gounant, V.; Brian, E.; Khalil, A.; Bazelly, B.; Hennequin, C. 2011: Hepatic and pulmonary cystic echinococcosis in a patient from the Central African Republic. Travel Medicine and Infectious Disease 9(2): 88-90
Yim, H.E.; Choi, B.M.; Rhie, Y.J.; Yoo, K.H.; Hong, Y.S.; Lee, J.W. 2011: Hepatic and pulmonary nodular lesions in pediatric urinary tract infections. Pediatric Nephrology 26(3): 425-431
Bourdon, J.A.; Halappanavar, S.; Saber, A.T.; Jacobsen, N.R.; Williams, A.; Wallin, Håkan.; Vogel, U.; Yauk, C.L. 2012: Hepatic and pulmonary toxicogenomic profiles in mice intratracheally instilled with carbon black nanoparticles reveal pulmonary inflammation, acute phase response, and alterations in lipid homeostasis. Toxicological Sciences: An Official Journal of the Society of Toxicology 127(2): 474-484
Lossnitzer, D.; Schwenger, V.; Lehrke, S.; Giannitsis, E.; Zeier, M.; Katus, H.A.; Steen, H. 2010: Hepatic and renal failure after anterior myocardial infarction induced apical ventricular septal defect. Case Reports in Medicine 2010: 645236
Deo, S.V.; Sharma, V.; Altarabsheh, S.E.; Hasin, T.; Dillon, J.; Shah, I.K.; Durham, L.A.; Stulak, J.M.; Daly, R.C.; Joyce, L.D.; Park, S.J. 2014: Hepatic and renal function with successful long-term support on a continuous flow left ventricular assist device. Heart Lung and Circulation 23(3): 229-233
Yıldız, N.; Barlas, N. 2013: Hepatic and renal functions in growing male rats after bisphenol a and octylphenol exposure. Human and Experimental Toxicology 32(7): 675-686
Qiao, H-Xiang.; Liu, Y-Ye.; Wu, L-Mao.; Li, L-Da. 2008: Hepatic and renal injury induced by Radix Aristolochiae or Guanxin Suhe Wan for a long-term in rats. Zhongguo Zhong Yao Za Zhi 33(9): 1044-1048
Van Gulick, J.J.M.; Gevers, T.J.G.; van Keimpema, L.; Drenth, J.P.H. 2011: Hepatic and renal manifestations in autosomal dominant polycystic kidney disease: a dichotomy of two ends of a spectrum. Netherlands Journal of Medicine 69(9): 367-371
Herbut, P.A.; Watson, J.S.; Perkins, E. 1946: Hepatic and renal necrosis in alloxan diabetes of rabbits. Archives of Pathology 41: 516-525
Diaz, G.C.; Moitra, V.; Sladen, R.N. 2008: Hepatic and renal protection during cardiac surgery. Anesthesiology Clinics 26(3): 565-590
Ribeiro-Rama, A.C.; Figueiredo, I.V.ór.; Veiga, F.J.é; Castel-Branco, M.M.; Cabrita, A.ón.M.S.ér.; Caramona, M.M. 2011: Hepatic and renal toxicities of indomethacin acid, salt form and complexed forms with hydroxypropyl-β-cyclodextrin on Wistar rats after oral administration. Fundamental and Clinical Pharmacology 25(5): 599-607
Cadranel, J.-F.; Demontis, R.; Seddik, M.; Ramdani, S.; Belloula, D.; Biour, M. 2008: Hepatic and renal toxicity to fluindione (Previscan). Gastroenterologie Clinique et Biologique 32(10): 816-818
Coman, I.; Crişan, N.; Petrut, B.; Bungărdean, C.ăt.ăl.; Cristea, T.; Crişan, D. 2007: Hepatic and skin metastases after laparoscopic radical prostatectomy for prostate cancer. Journal of Gastrointestinal and Liver Diseases: Jgld 16(3): 333-335
Fisichella, P.M.; Donaldson, K.; Helton, W.S. 2008: Hepatic and splenic hydatidosis managed with percutaneous aspiration, injection, and reaspiration (PAIR) of the hepatic cyst and laparoscopic splenectomy. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 12(9): 1615-1617
Jang, H.Y.; Cha, S.-W.; Lee, B.H.; Jung, H.E.; Choo, J.W.; Cho, Y.-J.; Ju, H.Y.; Cho, Y.D. 2013: Hepatic and splenic infarction and bowel ischemia following endoscopic ultrasound-guided celiac plexus neurolysis. Clinical Endoscopy 46(3): 306-309
Zhang, W.; Chen, B.; Deng, H.; Yang, T.; Ou, X. 2013: Hepatic and splenic uptake on bone scintigraphy in patients with intravenous administration of 99mTc methylene diphosphonate prior to gadolinium-containing contrast. Clinical Nuclear Medicine 38(3): 219-220
Olteanu, D.; Nagy, A.; Dudea, M.; Filip, A.; Muresan, A.; Catoi, C.; Mircea, P.A.; Clichici, S. 2012: Hepatic and systemic effects of rosuvastatin on an experimental model of bile duct ligation in rats. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 63(5): 483-496
Garg, H.; Kumar, A.; Garg, V.; Kumar, M.; Kumar, R.; Sharma, B.Chander.; Sarin, S.Kumar. 2013: Hepatic and systemic hemodynamic derangements predict early mortality and recovery in patients with acute-on-chronic liver failure. Journal of Gastroenterology and Hepatology 28(8): 1361-1367
Kotenko, O.G.; Grinenko, A.V.; Popov, A.O.; Korshak, A.A.; Gusev, A.V.; Fedorov, D.A.; Andreeshchev, S.A. 2007: Hepatic and the portal vein resection in the surgical treatment of hepatocellular carcinoma. Klinichna Khirurhiia 2007(1): 5-11
Bugiak, B.; Weber, L.P. 2009: Hepatic and vascular mRNA expression in adult zebrafish (Danio rerio) following exposure to benzo-a-pyrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin. Aquatic Toxicology 95(4): 299-306
Bouanane, S.; Merzouk, H.; Benkalfat, N.Batoul.; Soulimane, N.; Merzouk, S.Ahmed.; Gresti, J.; Tessier, C.; Narce, M. 2010: Hepatic and very low-density lipoprotein fatty acids in obese offspring of overfed dams. Metabolism, Clinical and Experimental 59(12): 1701-1709
Hulsberg, P.; Garza-Jordan, J.d.l.; Jordan, R.; Matusz, P.; Tubbs, R.S.; Loukas, M. 2011: Hepatic aneurysm: a review. American Surgeon 77(5): 586-591
Stabile Ianora, A.A.; Telegrafo, M.; Fucilli, F.; Scardapane, A.; Moschetta, M. 2014: Hepatic angio-sarcoma: An unusual source of intra-hepatic bleeding. International Journal of Surgery Case Reports 5(4): 203-205
Misselbeck, T.S.; Teicher, E.J.; Cipolle, M.D.; Pasquale, M.D.; Shah, K.T.; Dangleben, D.A.; Badellino, M.M. 2009: Hepatic angioembolization in trauma patients: indications and complications. Journal of Trauma 67(4): 769-773
Lamy, M.; Jammet, M.L.; Pellerin, D.; Guibert, C. 1961: Hepatic angiomatosis. Revue Medicale de France 42: 205-210
Petrolla, A.A.; Xin, W. 2008: Hepatic angiomyolipoma. Archives of Pathology and Laboratory Medicine 132(10): 1679-1682
Hassani, K.I.M.; Souiki, T. 2013: Hepatic angiomyolipoma. Pan African Medical Journal 16: 107
Marsilia, G.M.; Boscaino, A.; La Mura, A.; Ceriello, A.; De Ritis, R. 2010: Hepatic angiomyolipoma and intramural small intestinal schwannoma: a coincidence or a relationship?. International Journal of Surgical Pathology 18(6): 537-539
Levi Sandri, G.B.; Ettorre, G.M.; Vennarecci, G. 2014: Hepatic angiomyolipoma and neurofibromatosis type 2: a novel association. Liver international: official journal of the International Association for the Study of the Liver 34(9): 1445
Bilbao, I.; Castro, E.; Dopazo, C.; Castro, S.; Allende, E.; Genesca, J.; Tallada, N.; Quiroga, S.; Margarit, C. 2007: Hepatic angiomyolipoma in two patients infected with hepatitis C virus. Gastroenterologia y Hepatologia 30(4): 222-228
Chen, P.; Yuan, T.; Liu, H. 2009: Hepatic angiomyolipoma mimicking hepatic clear cell carcinoma. Journal of International Medical Research 37(1): 257-263
Tani, A.; Yoshida, H.; Mamada, Y.; Taniai, N.; Mineta, S.; Yoshioka, M.; Kawano, Y.; Ueda, J.; Naito, Z.; Uchida, E. 2011: Hepatic angiomyolipoma with a giant hemangioma. Journal of Nippon Medical School 78(5): 317-321
Lee, S.J.; Kim, S.Y.; Kim, K.W.; Shin, Y.M.; Kim, H.J.; Lee, J.S.; Kim, S.A. 2012: Hepatic angiomyolipoma with minimal fat, mimicking hepatocellular carcinoma. Clinical and Molecular Hepatology 18(3): 330-335
Hwang, I.; Yu, E.; Cho, K.-j. 2012: Hepatic angiomyolipoma with variable histologic features: 8 cases resembling hepatocellular carcinoma or inflammatory pseudotumor. Korean Journal of Gastroenterology 60(4): 242-248
Cai, P.-q.; Wu, Y.-p.; Xie, C.-m.; Zhang, W.-d.; Han, R.; Wu, P.-h. 2013: Hepatic angiomyolipoma: CT and MR imaging findings with clinical-pathologic comparison. Abdominal Imaging 38(3): 482-489
Nakashima, A.; Murakami, Y.; Uemura, K.; Hayashidani, Y.; Sudo, T.; Hashimoto, Y.; Arihiro, K.; Sueda, T. 2010: Hepatic angiomyolipoma: a case report. Hiroshima Journal of Medical Sciences 59(1): 17-19
Gupta, A.; Ramakrishna, B. 2013: Hepatic angiomyolipoma: a case report with diagnostic challenge. Indian Journal of Pathology and Microbiology 56(3): 279-281
Iribarren Díaz, M.; Lojo Sánchez, J.L.; Carracedo Iglesias, R.; de Castro Parga, G.; Díaz Cardamas, P.; Tardío Baiges, A.; Casal Nuñez, E. 2008: Hepatic angiomyolipoma: a challenging preoperative diagnosis. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 100(10): 661-663
Zeng, J.-P.; Dong, J.-H.; Zhang, W.-Z.; Wang, J.; Pang, X.-P. 2010: Hepatic angiomyolipoma: a clinical experience in diagnosis and treatment. Digestive Diseases and Sciences 55(11): 3235-3240
Li, T.; Wang, L.; Yu, H-Hua.; Sun, H-Chuan.; Qin, L-Xiu.; Ye, Q-Hai.; Fan, J.; Tang, Z-You. 2008: Hepatic angiomyolipoma: a retrospective study of 25 cases. Surgery Today 38(6): 529-535
Agaimy, A.; Vassos, N.; Croner, R.S.; Strobel, D.; Lell, M. 2012: Hepatic angiomyolipoma: a series of six cases with emphasis on pathological-radiological correlations and unusual variants diagnosed by core needle biopsy. International Journal of Clinical and Experimental Pathology 5(6): 512-521
Wei, R.-X.; Wang, W.-P.; Ding, H.; Huang, B.-J.; Li, C.-L.; Fan, P.-L.; Hou, J.; He, N.-A. 2012: Hepatic angiomyolipoma: contrast patterns with SonoVue-enhanced real-time gray-scale ultrasonography. Asian Pacific Journal of Cancer Prevention: Apjcp 13(2): 493-497
Kamimura, K.; Nomoto, M.; Aoyagi, Y. 2012: Hepatic angiomyolipoma: diagnostic findings and management. International Journal of Hepatology 2012: 410781
Yang, B.; Chen, W.-H.; Li, Q.-Y.; Xiang, J.-J.; Xu, R.-J. 2009: Hepatic angiomyolipoma: dynamic computed tomography features and clinical correlation. World Journal of Gastroenterology 15(27): 3417-3420
Xu, L.; Shao, Y.; Zhang, H.; Wang, H. 2002: Hepatic angiomyolipoma: report of 8 cases and review of literature. Asian Journal of Surgery 25(1): 82
Barbier, L.; Torrents, J.; Hardwigsen, J. 2014: Hepatic angiomyolipoma: what management?. Acta Chirurgica Belgica 114(2): 139-142
Terzi, Aşen.; Deniz, E.Ebru.; Haberal, N.; Moray, Gökhan.; Özdemir, B.Handan. 2014: Hepatic angiosarcoma and liver transplant: a report of 2 cases with diagnostic difficulties. Experimental and Clinical Transplantation: Official Journal of the Middle East Society for Organ Transplantation 12 Suppl. 1: 126-128
Kulkarni, M.P.; Agashe, S.R.; Singh, R.V.; Sulhyan, K.R. 2010: Hepatic angiosarcoma arising in an adult mesenchymal hamartoma. Indian Journal of Pathology and Microbiology 53(2): 322-324
Cioffi-Pretti, J.L.; Kalof, A.N.; Ebert, G.; McCahill, L.E. 2009: Hepatic angiosarcoma five years following spontaneous intraperitoneal bleed of a hepatic mass. Rare Tumors 1(2): E33
Smith, P.M.; Williams, D.M.; Evans, D.M.; Path, F.R. 1976: Hepatic angiosarcoma in a vinyl chloride worker. Bulletin of the New York Academy of Medicine 52(4): 447-452
Lee, S.-W.; Song, C.-Y.; Gi, Y.-H.; Kang, S.-B.; Kim, Y.-S.; Nam, S.-W.; Lee, D.-S.; Kim, J.-O. 2008: Hepatic angiosarcoma manifested as recurrent hemoperitoneum. World Journal of Gastroenterology 14(18): 2935-2938
Geramizadeh, B.; Safari, A.; Bahador, A.; Nikeghbalian, S.; Salahi, H.; Kazemi, K.; Dehghani, S-Mohsen.; Malek-Hosseini, S-Ali. 2011: Hepatic angiosarcoma of childhood: a case report and review of literature. Journal of Pediatric Surgery 46(1): E9-11
Yasunaka, T.; Ikeda, F.; Kobashi, H.; Miyake, Y.; Takaki, A.; Iwasaki, Y.; Hada, H.; Yamamoto, K.; Nakano, M. 2012: Hepatic angiosarcoma with characteristic laparoscopic findings. Digestive Endoscopy: Official Journal of the Japan Gastroenterological Endoscopy Society 24(2): 124
Huang, H.; Le, X.-H.; Zhou, B.-P.; Lu, P.-X. 2014: Hepatic angiosarcoma with multiple metastases in a young man. Quantitative Imaging in Medicine and Surgery 4(4): 291-293
Egea Valenzuela, J.; López Poveda, M.J.; Pérez Fuenzalida, F.J.; Garre Sánchez, C.; Martínez Barba, E.; Carballo Alvarez, F. 2009: Hepatic angiosarcoma. Presentation of two cases. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 101(6): 430
Matsumoto, M.; Tamura, M.; Komiya, T.; Aridome, G.; Narita, R.; Hisaoka, M.; Ohtsuki, M.; Otsuji, Y. 2009: Hepatic angiosarcoma: a rare liver tumor in a hemodialysis patient. Clinical Nephrology 71(5): 590-592
Meng, S.Long.; Chen, J.Zhang.; Xu, P.; Qu, J.Hong.; Fan, L.Min.; Song, C.; Qiu, L.Ping. 2014: Hepatic antioxidant enzymes SOD and CAT of Nile tilapia (Oreochromis niloticus) in response to pesticide methomyl and recovery pattern. Bulletin of Environmental Contamination and Toxicology 92(4): 388-392
Hegseth, M.N.øs.; Camus, L.; Helgason, L.B.; Bocchetti, R.; Gabrielsen, G.W.; Regoli, F. 2011: Hepatic antioxidant responses related to levels of PCBs and metals in chicks of three Arctic seabird species. Comparative Biochemistry and Physiology. Toxicology and Pharmacology: Cbp 154(1): 28-35
Sai-Ching, J.Y.; Chan, L. 1998: Hepatic apolipoprotein B biogenesis: an update. Trends in Cardiovascular Medicine 8(1): 8-14
Liu, M.; Seo, J.; Allegood, J.; Bi, X.; Zhu, X.; Boudyguina, E.; Gebre, A.K.; Avni, D.; Shah, D.; Sorci-Thomas, M.G.; Thomas, M.J.; Shelness, G.S.; Spiegel, S.; Parks, J.S. 2014: Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein. Journal of Biological Chemistry 289(5): 2801-2814
Marshall, A.H.; Brooks, N.C.; Hiyama, Y.; Qa'aty, N.; Al-Mousawi, A.; Finnerty, C.C.; Jeschke, M.G. 2013: Hepatic apoptosis postburn is mediated by c-Jun N-terminal kinase 2. Shock 39(2): 183-188
Yu, Y.; Zhang, C.; Liu, L.; Li, X. 2013: Hepatic arterial administration of ginsenoside Rg3 and transcatheter arterial embolization for the treatment of VX2 liver carcinomas. Experimental and Therapeutic Medicine 5(3): 761-766
Lyass, S.; Lyass, O.; Gabizon, A.; Peretz, T.; Eid, A.; Muggiasullam, M.; Durst, A.; Shiloni, E. 1996: Hepatic arterial bolus chemotherapy for colorectal metastases using an implantable port. International Journal of Oncology 9(6): 1295-1299
Sanada, Y.; Mizuta, K.; Urahashi, T.; Ihara, Y.; Wakiya, T.; Okada, N.; Yamada, N.; Egami, S.; Hishikawa, S.; Ushijima, K.; Otomo, S.; Sakamoto, K.; Yasuda, Y.; Kawarasaki, H. 2011: Hepatic arterial buffer response after pediatric living donor liver transplantation: report of a case. Transplantation Proceedings 43(10): 4019-4024
Sharma, K.V.; Gould, J.E.; Harbour, J.W.; Linette, G.P.; Pilgram, T.K.; Dayani, P.N.; Brown, D.B. 2008: Hepatic arterial chemoembolization for management of metastatic melanoma. AJR. American Journal of Roentgenology 190(1): 99-104
Gaur, S.K.; Friese, J.L.; Sadow, C.A.; Ayyagari, R.; Binkert, C.A.; Schenker, M.P.; Kulke, M.; Baum, R. 2011: Hepatic arterial chemoembolization using drug-eluting beads in gastrointestinal neuroendocrine tumor metastatic to the liver. Cardiovascular and Interventional Radiology 34(3): 566-572
Iida, T.; Kaido, T.; Yagi, S.; Hori, T.; Uchida, Y.; Jobara, K.; Tanaka, H.; Sakamoto, S.; Kasahara, M.; Ogawa, K.; Ogura, Y.; Mori, A.; Uemoto, S. 2014: Hepatic arterial complications in adult living donor liver transplant recipients: a single-center experience of 673 cases. Clinical Transplantation 28(9): 1025-1030
Van den Hoven, A.F.; van Leeuwen, M.S.; Lam, M.G.E.H.; van den Bosch, M.A.A.J. 2015: Hepatic arterial configuration in relation to the segmental anatomy of the liver; observations on MDCT and DSA relevant to radioembolization treatment. Cardiovascular and Interventional Radiology 38(1): 100-111
Kobayashi, K.; Szklaruk, J.; Trent, J.C.; Ensor, J.; Ahrar, K.; Wallace, M.J.; Madoff, D.C.; Murthy, R.; Hicks, M.E.; Gupta, S. 2009: Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors. American Journal of Clinical Oncology 32(6): 574-581
Kamat, P.P.; Gupta, S.; Ensor, J.E.; Murthy, R.; Ahrar, K.; Madoff, D.C.; Wallace, M.J.; Hicks, M.E. 2008: Hepatic arterial embolization and chemoembolization in the management of patients with large-volume liver metastases. Cardiovascular and Interventional Radiology 31(2): 299-307
Ou, H.-Y.; Concejero, A.M.; Yu, C.-Y.; Huang, T.-L.; Chen, T.-Y.; Tsang, L.L.-c.; Chen, C.-L.; Wang, S.-H.; Cheng, Y.-F. 2011: Hepatic arterial embolization for massive bleeding from an intrahepatic artery pseudoaneurysm using N-butyl-2-cyanoacrylate after living donor liver transplantation. Transplant International: Official Journal of the European Society for Organ Transplantation 24(3): E19-E22
Lee, E.; Leon Pachter, H.; Sarpel, U. 2012: Hepatic arterial embolization for the treatment of metastatic neuroendocrine tumors. International Journal of Hepatology 2012: 471203
Del Prete, M.; Fiore, F.; Modica, R.; Marotta, V.; Marciello, F.; Ramundo, V.; Di Sarno, A.; Carratù, A.; di Roseto, C.d.L.; Tafuto, S.; Tatangelo, F.; Baldelli, R.; Colao, A.; Faggiano, A. 2014: Hepatic arterial embolization in patients with neuroendocrine tumors. Journal of Experimental and Clinical Cancer Research: Cr 33: 43
Letoublon, C.; Morra, I.; Chen, Y.; Monnin, V.; Voirin, D.; Arvieux, C. 2011: Hepatic arterial embolization in the management of blunt hepatic trauma: indications and complications. Journal of Trauma 70(5): 1032-1036; Discussion: 1036-1037
Maire, F.éd.ér.; Lombard-Bohas, C.; O'Toole, D.; Vullierme, M.-P.; Rebours, V.; Couvelard, A.; Pelletier, A.L.; Zappa, M.; Pilleul, F.; Hentic, O.; Hammel, P.; Ruszniewski, P. 2012: Hepatic arterial embolization versus chemoembolization in the treatment of liver metastases from well-differentiated midgut endocrine tumors: a prospective randomized study. Neuroendocrinology 96(4): 294-300
Pohlen, U.; Buhr, H.J.; Berger, G.; Ritz, J.ör.-P.; Holmer, C. 2012: Hepatic arterial infusion (HAI) with PEGylated liposomes containing 5-FU improves tumor control of liver metastases in a rat model. Investigational new Drugs 30(3): 927-935
Bolton, J.S.; O'Connell, M.J.; Mahoney, M.R.; Farr, G.H.; Fitch, T.R.; Maples, W.J.; Nagorney, D.M.; Rubin, J.; Fuloria, J.; Steen, P.D.; Alberts, S.R. 2012: Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase Ii study, 92-46-52. Clinical Colorectal Cancer 11(1): 31-37
Sperling, J.; Schäfer, T.; Benz-Weißer, A.; Ziemann, C.; Scheuer, C.; Kollmar, O.; Schilling, M.K.; Menger, M.D. 2013: Hepatic arterial infusion but not systemic application of cetuximab in combination with oxaliplatin significantly reduces growth of CC531 colorectal rat liver metastases. International Journal of Colorectal Disease 28(4): 555-562
Matsumoto, T.; Yamagami, T.; Yoshimatsu, R.; Morishita, H.; Kitamura, N.; Sato, O.; Hasebe, T. 2014: Hepatic arterial infusion chemotherapy by the fixed-catheter-tip method: retrospective comparison of percutaneous left subclavian and femoral port-catheter system implantation. Ajr. American Journal of Roentgenology 202(1): 211-215